TY 2020 Form 990

- TIN:

Form990

Department of the TreasuryInternal Revenue Service

Return of Organization Exempt From Income Tax

Under section 501(c), 527, or 4947(a)(1) of the Internal Revenue Code (except private foundations)

Do not enter social security numbers on this form as it may be made public.

Go to www.irs.gov/Form990 for instructions and the latest information.

OMB No. 1545-0047

2020

Open to Public Inspection

A For the 2020 calendar year, or tax year beginning 01-01-2020 , and ending 12-31-2020

BCheck if applicable: Address change Name change Initial return Final return/terminated Amended return Application pending

CName of organization
PATH

Doing business as

Number and street (or P.O. box if mail is not delivered to street address)
2201 WESTLAKE AVENUE NO 200

Room/suite

City or town, state or province, country, and ZIP or foreign postal code
SEATTLE, WA98121

D Employer identification number

91-1157127

E Telephone number

G Gross receipts $ 357,796,602

F Name and address of principal officer:
KELLY PRIESTLEY
2201 WESTLAKE AVENUE NO 200
SEATTLE,WA98121

Tax-exempt status: 501(c)(3) 501(c) ( ) LeftBullet

(insert no.) 4947(a)(1) or 527

Website:

WWW.PATH.ORG

H(a)

Is this a group return for
subordinates? Yes No

H(b)

Are all subordinates
included?

Yes No

If "No," attach a list. (see instructions)

H(c)

Group exemption number MediumBullet

K Form of organization: Corporation Trust Association Other MediumBullet

L Year of formation: 1981

M State of legal domicile: WA

Part I

Summary

1	Briefly describe the organization’s mission or most significant activities: SEE PART III, LINE 1.
2	Check this box
3	Number of voting members of the governing body (Part VI, line 1a) ........	3	15
4	Number of independent voting members of the governing body (Part VI, line 1b) .....	4	15
5	Total number of individuals employed in calendar year 2020 (Part V, line 2a) ......	5	714
6	Total number of volunteers (estimate if necessary) .............	6	0
7a	Total unrelated business revenue from Part VIII, column (C), line 12 ........	7a	0
b	Net unrelated business taxable income from Form 990-T, line 39 .........	7b	0

		Prior Year	Current Year
8	Contributions and grants (Part VIII, line 1h) .........	286,808,545	287,454,383
9	Program service revenue (Part VIII, line 2g) .........	2,038	0
10	Investment income (Part VIII, column (A), lines 3, 4, and 7d ) ....	6,723,428	12,502,251
11	Other revenue (Part VIII, column (A), lines 5, 6d, 8c, 9c, 10c, and 11e)	836,870	1,030,112
12	Total revenue—add lines 8 through 11 (must equal Part VIII, column (A), line 12)	294,370,881	300,986,746
13	Grants and similar amounts paid (Part IX, column (A), lines 1–3 )...	55,619,080	67,994,827
14	Benefits paid to or for members (Part IX, column (A), line 4).....	0	0
15	Salaries, other compensation, employee benefits (Part IX, column (A), lines 5–10)	131,590,498	132,096,396
16a	Professional fundraising fees (Part IX, column (A), line 11e) .....	0	0
b	Total fundraising expenses (Part IX, column (D), line 25) 2,409,886
17	Other expenses (Part IX, column (A), lines 11a–11d, 11f–24e)....	105,099,261	92,968,260
18	Total expenses. Add lines 13–17 (must equal Part IX, column (A), line 25)	292,308,839	293,059,483
19	Revenue less expenses. Subtract line 18 from line 12.......	2,062,042	7,927,263
		Beginning of Current Year	End of Year
20	Total assets (Part X, line 16).............	243,064,155	283,556,203
21	Total liabilities (Part X, line 26).............	204,045,574	234,982,056
22	Net assets or fund balances. Subtract line 21 from line 20.....	39,018,581	48,574,147

Part II

Signature Block

Under penalties of perjury, I declare that I have examined this return, including accompanying schedules and statements, and to the best of my knowledge and belief, it is true, correct, and complete. Declaration of preparer (other than officer) is based on all information of which preparer has any knowledge.

Sign Here

	Signature of officer	Date

	Type or print name and title

Paid Preparer Use Only

Print/Type preparer's name

Preparer's signature

Date

Check if
self-employed

PTIN

Firm's name MediumBullet

Firm's EIN MediumBullet

Firm's address MediumBullet

Phone no.

May the IRS discuss this return with the preparer shown above? (see instructions) ..........YesNo

For Paperwork Reduction Act Notice, see the separate instructions.

Cat. No. 11282Y Form 990 (2020)

Form 990 (2020)

Page 2

Part III

Statement of Program Service Accomplishments

Check if Schedule O contains a response or note to any line in this Part III..............

Briefly describe the organization’s mission: PATH'S MISSION IS TO ADVANCE HEALTH EQUITY THROUGH INNOVATION AND PARTNERSHIPS. (CONTINUED ON SCHEDULE O)

Did the organization undertake any significant program services during the year which were not listed on
the prior Form 990 or 990-EZ? ..................... Yes No

If "Yes," describe these new services on Schedule O.

Did the organization cease conducting, or make significant changes in how it conducts, any program
services? ........................... Yes No

If "Yes," describe these changes on Schedule O.

Describe the organization’s program service accomplishments for each of its three largest program services, as measured by expenses. Section 501(c)(3) and 501(c)(4) organizations are required to report the amount of grants and allocations to others, the total expenses, and revenue, if any, for each program service reported.


4a	(Code: ) (Expenses $ 115,045,810 including grants of $ 20,527,002 ) (Revenue $ )
	GLOBAL HEALTH PROGRAMS: PATH'S GLOBAL HEALTH PROGRAMS DIVISION IS RESPONSIBLE FOR PATH'S SCIENTIFIC EXPERTISE IN MALARIA AND NEGLECTED TROPICAL DISEASES; HIV AND TUBERCULOSIS; MATERNAL, NEWBORN, AND CHILD HEALTH AND NUTRITION; SEXUAL AND REPRODUCTIVE HEALTH; AND NONCOMMUNICABLE DISEASES. THE DIVISION ALSO OVERSEES PATH'S WORK IN HEALTH SYSTEMS INNOVATION AND DELIVERY, AND MANAGES OUR COUNTRY OFFICES.(CONTINUED ON SCHEDULE O)MALARIA AND NEGLECTED TROPICAL DISEASESPATH PARTNERS WITH GOVERNMENTS, THE PRIVATE SECTOR, AND FUNDERS ACROSS THE GLOBE TO BRING THE WORLD CLOSER TO MALARIA ERADICATION. OUR MALARIA AND NEGLECTED TROPICAL DISEASES PROGRAM INCLUDES MORE THAN 100 PATH STAFF MEMBERS IN MORE THAN TEN COUNTRIES. OUR STRATEGY INCLUDES OPTIMIZING THE DELIVERY OF CURRENT TOOLS AND APPROACHES TO ENSURE THEY REACH THE PEOPLE WHO NEED THEM, DESIGNING NEW STRATEGIES AND DEVELOPING NEXT-GENERATION TOOLS TO OVERCOME EMERGING CHALLENGES, AND CREATING INNOVATIVE PARTNERSHIPS AND FUNDING MODELS TO ENSURE OUR PROGRAMS ARE SUSTAINABLE AND EFFECTIVE. PATH-PIONEERED APPROACHES HAVE CONTRIBUTED TO REMARKABLE PROGRESS IN MALARIA, WITH NEARLY 7 MILLION LIVES SAVED SINCE 2000.IN 2020, OUR MALARIA CONTROL AND ELIMINATION PARTNERSHIP IN AFRICA (MACEPA) PROGRAM CONTINUED TO SUPPORT THE GOVERNMENTS OF ETHIOPIA, SENEGAL, AND ZAMBIA TOWARD THEIR MALARIA ELIMINATION GOALS. MACEPA'S WORK INCLUDED EVALUATING THE LATEST, MOST SENSITIVE DIAGNOSTIC TESTS; ESTABLISHING RAPID REPORTING SYSTEMS; AND CONTINUING TO SUPPORT POPULATION-WIDE, DRUG-BASED STRATEGIES SUCH AS MASS DRUG ADMINISTRATION. WITH A NEW GRANT FROM THE BILL & MELINDA GATES FOUNDATION, MACEPA BEGAN IDENTIFYING OPPORTUNITIES IN ADDITIONAL HIGH-MALARIA-BURDEN GEOGRAPHIES SUCH AS THE DEMOCRATIC REPUBLIC OF THE CONGO (DRC), MALAWI, MALI, AND NIGERIA.PATH WAS ALSO AWARDED AN ADD-ON TO OUR PROGRAM FOR THE ADVANCEMENT OF MALARIA OUTCOMES (PAMO), FUNDED BY THE US PRESIDENT'S MALARIA INITIATIVE (PMI). CALLED PAMO PLUS, THE PROJECT CONTINUES ITS PREDECESSOR'S MISSION OF ASSISTING THE GOVERNMENT OF ZAMBIA TO ELIMINATE MALARIA WITHIN ITS BORDERS. IN 2020, PAMO PROVIDED TECHNICAL SUPPORT AND MENTORSHIP TO MORE THAN 2,000 HEALTH CARE PROVIDERS AND TRAINED 1,098 COMMUNITY HEALTH WORKERS AND THEIR 272 SUPERVISORS IN COMMUNITY-LEVEL CASE MANAGEMENT AND SURVEILLANCE. PAMO/PAMO PLUS ALSO SUPPORTED THE DISTRIBUTION OF 122,602 INSECTICIDE-TREATED BEDNETS, ORGANIZED SOCIAL BEHAVIOR CHANGE ACTIVITIES (INCLUDING IN SCHOOLS), AND PROVIDED TECHNICAL AND MATERIAL SUPPORT FOR DATA QUALITY AUDITS IN HEALTH FACILITIES.PATH CONTINUED TO EVALUATE NEW VECTOR CONTROL TOOLS IN 2020 WITH OUR PARTNERS UNDER PMI VECTORLINK, THE US AGENCY FOR INTERNATIONAL DEVELOPMENT'S (USAID'S) FLAGSHIP MALARIA VECTOR CONTROL PROJECT. SIMILARLY, UNDER THE NEW NETS PROJECT FUNDED BY UNITAID AND THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA, WE HELPED GENERATE EVIDENCE FOR THE ADOPTION OF BEDNETS EFFECTIVE AGAINST PYRETHROID-RESISTANT MOSQUITOES. IN ZAMBIA, PATH LED THE DESIGN AND IMPLEMENTATION OF LABORATORY AND FIELD ACTIVITIES TO TEST ANOTHER NEW TOOL FOR MALARIA VECTOR CONTROL, THE ATTRACTIVE TARGETED SUGAR BAIT (ATSB); WE ALSO COORDINATED PARTNERS WORKING ON ATSB RESEARCH IN KENYA, MALI, AND ZAMBIA, TOGETHER WITH ISRAEL-BASED MANUFACTURER WESTHAM LTD. AND UK-BASED FUNDER INNOVATIVE VECTOR CONTROL CONSORTIUM. IN ADDITION, PATH LED A USAID INITIATIVE TO SUPPORT US GOVERNMENT INVESTMENTS IN MALARIA OPERATIONAL RESEARCH AND PROGRAM EVALUATION. UNDER THE PMI INSIGHTS PROJECT, PATH COORDINATED THE WORK OF SEVERAL PARTNERS TO STRENGTHEN POLICIES, STRATEGIES, AND GUIDELINES FOR MALARIA CONTROL AND ELIMINATION INTERVENTIONS. IN SENEGAL AND DRC, PATH BEGAN WORK TO INTEGRATE THE DATA VISUALIZATION DASHBOARDS OF THE NATIONAL EMERGENCY OPERATIONS CENTERS AND NATIONAL MALARIA CONTROL PROGRAMS AND DEVELOP IN-COUNTRY CAPACITY FOR DATA USE. THESE EFFORTS HELPED BOTH COUNTRIES RESPOND TO COVID-19 AND MITIGATE THE VIRUS' IMPACT ON MALARIA CONTROL AND ELIMINATION. PATH AND A PRIVATE-SECTOR TECHNOLOGY PARTNER, BLUESQUARE, SUPPORTED THE DRC MINISTRY OF HEALTH (MOH) TO STRENGTHEN COVID-19 CASE TRACKING AND CONTACT TRACING.AT THE ONSET OF COVID-19, THE PATH LABORATORY TEAM IN ZAMBIA PIVOTED FROM MALARIA TO WHOLE GENOME SEQUENCING OF SARS-COV-2 (THE VIRUS RESPONSIBLE FOR COVID-19) THROUGH FUNDING FROM THE BILL & MELINDA GATES FOUNDATION AND IN COLLABORATION WITH THE UNIVERSITY OF ZAMBIA SCHOOL OF VETERINARY MEDICINE. THE LABORATORY'S WORK ENABLED IDENTIFICATION OF THE BETA (B.1.351) VARIANT OF CONCERN IN ZAMBIA, WHICH WAS ASSOCIATED WITH A MAJOR SECOND WAVE OF COVID-19 IN THE COUNTRY. THE LABORATORY'S WORK ALSO LED TO ESTABLISHMENT OF A NATIONAL SPECIMEN COLLECTION SYSTEM THROUGH THE ZAMBIA NATIONAL PUBLIC HEALTH INSTITUTE.THE VIVACCESS PROJECT, WHICH FOCUSES ON RADICAL CURE (ELIMINATION OF DORMANT LIVER-STAGE PARASITES) OF PLASMODIUM VIVAX MALARIA, CONTINUED TO SUPPORT INTRODUCTION OF G6PD TESTS AND OTHER RADICAL CURE PRODUCTS IN BRAZIL, CAMBODIA, COLOMBIA, ETHIOPIA, INDIA, LAOS, MYANMAR, PERU, THAILAND, AND VIETNAM. VIVACCESS ENGAGED WITH NORMATIVE POLICY BODIES SUCH AS THE WORLD HEALTH ORGANIZATION (WHO), PROMOTED MULTISTAKEHOLDER DISCUSSIONS THROUGH REGIONAL AND GLOBAL EVENTS, AND MUCH MORE. (ADDITIONAL WORK IN MALARIA IS COVERED IN THE CENTER FOR VACCINE INNOVATION AND ACCESS SECTION.)PATH'S EFFORTS TO ELIMINATE NEGLECTED TROPICAL DISEASES CONTINUED IN 2020 IN THE DRC, WHERE WE WORKED TO COMBAT HUMAN AFRICAN TRYPANOSOMIASIS (HAT, OR "SLEEPING SICKNESS") IN COLLABORATION WITH THE COUNTRY'S NATIONAL PROGRAM FOR THE CONTROL OF HAT (PNLTHA). WITH FUNDING FROM THE BILL & MELINDA GATES FOUNDATION, PATH PROVIDED LOGISTICAL AND OPERATIONAL SUPPORT TO THE PNLTHA IN ACTIVE AND PASSIVE CASE DETECTION AND VECTOR CONTROL. WE ALSO SUPPORTED ADVOCACY, SENSITIZATION, AND PROMOTION ACTIVITIES TO STRENGTHEN HAT ELIMINATION EFFORTS AT THE NATIONAL, PROVINCIAL, AND COMMUNITY LEVELS. IN INDIA, PATH CONTINUED TO PROVIDE STRATEGIC TECHNICAL ASSISTANCE AT THE NATIONAL, STATE, AND SUB-STATE LEVELS. IN THE STATE OF UTTAR PRADESH, WE HELPED ENSURE TRANSMISSION OF VISCERAL LEISHMANIASIS STAYED AT OR BELOW ELIMINATION LEVEL IN ENDEMIC DISTRICTS THROUGH HIGH-QUALITY SURVEILLANCE, ACTIVE CASE DETECTION, AND VECTOR CONTROL. PATH ALSO PROVIDED TECHNICAL ASSISTANCE FOR LYMPHATIC FILARIASIS (ELEPHANTIASIS) ELIMINATION THROUGH MASS DRUG ADMINISTRATION AND HELPED ESTABLISH A TECHNICAL SUPPORT UNIT FOR DENGUE-CHIKUNGUNYA CONTROL AND MALARIA ELIMINATION. HIV AND TUBERCULOSISPATH'S HIV AND TUBERCULOSIS (TB) PROGRAMMING REACHES GENERAL POPULATIONS AS WELL AS KEY POPULATIONS AFFECTED BY HIV/TB.IN 2020, AS THE COVID-19 RESPONSE HINDERED ACCESS TO HEALTH FACILITIES IN MANY COUNTRIES, PATH MOVED RAPIDLY TO MINIMIZE THE IMPACT ON HIV AND TB SERVICES. PATH USED AN APPROACH OF PROTECT-MITIGATE-SUPPORT: UNDER THE "PROTECT" PILLAR, WE EQUIPPED AND TRAINED FRONTLINE HEALTH CARE PROVIDERS TO TRIAGE AND DELIVER SERVICES TO PEOPLE WITH COVID-19 EXPOSURE OR SYMPTOMS. UNDER THE "MITIGATE" PILLAR, WE ADAPTED WHERE AND HOW HIV AND TB SERVICES WERE OFFERED, SHIFTING TOWARD VIRTUAL, COMMUNITY, AND PRIVATE-SECTOR DELIVERY MODALITIES AND MULTI-MONTH DRUG DISPENSING TO REDUCE THE NEED FOR CLINIC VISITS. UNDER THE "SUPPORT" PILLAR, WE USED EXISTING HIV AND TB PLATFORMS TO DISSEMINATE INFORMATION ON COVID-19, AND WE ADAPTED TB SCREENING PROTOCOLS TO INCLUDE SCREENING AND TRIAGE FOR COVID-19 (AND VICE VERSA). IN THE DRC, UNDER THE USAID-FUNDED INTEGRATED HIV/AIDS PROJECT, PATH INTRODUCED ASSISTED HIV SELF-TESTING (HIVST) VIA PHARMACISTS, ALTERNATIVE MEDICINE PROVIDERS, AND COMMUNITY HEALTH WORKERS. WE TESTED APPROXIMATELY 180,000 PEOPLE, ENROLLED AROUND 12,400 NEWLY IDENTIFIED PEOPLE LIVING WITH HIV (PLHIV) ON ANTIRETROVIRAL THERAPY (ART), AND SUPPORTED MORE THAN 43,800 INDIVIDUALS TO CONTINUE TREATMENT. IN WESTERN KENYA, UNDER THE US PRESIDENT'S EMERGENCY PLAN FOR AIDS RELIEF-FUNDED AFYA ZIWANI PROJECT, PATH EVOLVED OUR APPROACH, PARTICULARLY FOR HIV-NEGATIVE AGYW. THE PROJECT CREATED WHATSAPP-BASED VIRTUAL SAFE SPACES AND MOBILE, HOME-BASED SAFE SPACES TO ENSURE AGYW CONTINUED TO RECEIVE INFORMATION, COUNSELING, AND OTHER SERVICES DURING THE COVID-19 PANDEMIC; WE ALSO USED THESE SPACES TO DISSEMINATE INFORMATION ON COVID-19. THE PROJECT HOME-DELIVERED APPROXIMATELY 800 HIV PRE-EXPOSURE PROPHYLAXIS REFILLS AND MORE THAN 8,000 HIVST KITS FOR AGYW, WITH NO HIV-POSITIVE RESULTS. ACROSS ALL POPULATION GROUPS, AFYA ZIWANI TESTED MORE THAN 140,000 PEOPLE FOR HIV, LINKED ABOUT 3,500 NEWLY IDENTIFIED PLHIV TO ART, AND SUPPORTED A COHORT OF 25,600 PEOPLE ON TREATMENT.

4b	(Code: ) (Expenses $ 92,606,261 including grants of $ 34,739,083 ) (Revenue $ )
	ESSENTIAL MEDICINES: PATH'S ESSENTIAL MEDICINES DIVISION DEVELOPS AND DELIVERS LIFESAVING VACCINES AND DRUGS FOR WOMEN, CHILDREN, AND COMMUNITIES AROUND THE GLOBE.(CONTINUED ON SCHEDULE O)CENTER FOR VACCINE INNOVATION AND ACCESSPATH'S CENTER FOR VACCINE INNOVATION AND ACCESS ALIGNS EXPERTISE ACROSS EVERY STAGE OF VACCINE RESEARCH, DEVELOPMENT, AND INTRODUCTION TO MAKE VACCINES AVAILABLE TO MORE COMMUNITIES, PARTICULARLY IN LOW- AND MIDDLE-INCOME COUNTRIES. OUR PORTFOLIO INCLUDES MORE THAN TWO DOZEN VACCINE PRODUCTS IN DEVELOPMENT OR ALREADY IN USE, WITH AN EMPHASIS ON THE LEADING INFECTIOUS CAUSES OF CHILD DEATH AND DISEASE WORLDWIDE. IN RESPONSE TO THE COVID-19 PANDEMIC, PATH MOBILIZED QUICKLY TO DEPLOY OUR END-TO-END IMMUNIZATION EXPERTISE. WE PROVIDED POLICY AND FINANCIAL ADVICE TO GAVI ON DESIGN OF THE COVAX FACILITY WITH THE GOAL OF EQUITABLE COVID-19 VACCINE ACCESS AND DELIVERY WORLDWIDE. WE SECURED INITIAL FUNDING TO ADVANCE A LOW-COST COVID-19 VACCINE CANDIDATE (NDV-HXP-S) BASED ON TECHNOLOGIES DEVELOPED BY THE ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI AND THE UNIVERSITY OF TEXAS AT AUSTIN THAT IS TARGETED FOR EMERGING COUNTRY VACCINE MANUFACTURERS. ACROSS THE COVID-19 VACCINE DEVELOPMENT ECOSYSTEM, WE SUPPORTED VACCINE DEVELOPMENT AND CLINICAL SITE READINESS; PROVIDED CHEMISTRY, MANUFACTURING, AND CONTROL EXPERTISE TO MANUFACTURERS; AND LENT OUR CLINICAL, TECHNICAL, AND REGULATORY EXPERTISE TO DEVELOPERS AND COVID-19 CONSORTIA.IN 2020, PATH CONTINUED TO PROVIDE TECHNICAL SUPPORT TO POLIO VACCINE MANUFACTURERS AND ADVANCE RESEARCH ON NEW INACTIVATED POLIO VACCINE AND ORAL POLIO VACCINE CANDIDATES. THE NOVEL ORAL POLIO VACCINE AGAINST TYPE 2 POLIOVIRUS (NOPV2) ACHIEVED A MAJOR MILESTONE WHEN IT BECAME THE FIRST VACCINE TO RECEIVE A WHO EMERGENCY USE LISTING (EUL). AS THE CONVENOR OF THE NOPV2 CONSORTIUM, PATH CONTRIBUTED KEY EVIDENCE AND SUPPORTED THE MANUFACTURER'S SUCCESSFUL EUL APPLICATION. THROUGHOUT 2020, PATH AND OUR COUNTRY PARTNERS EXPANDED COVERAGE OF JAPANESE ENCEPHALITIS (JE) VACCINATION AND DEVELOPED AND DISSEMINATED EVIDENCE TO SUPPORT JE VACCINE DECISION-MAKING. WRAPPING UP A REMARKABLE 17-YEAR GLOBAL PARTNERSHIP, PATH COMPLETED TWO STUDIES EXAMINING JE VACCINE DURATION OF PROTECTION AND CO-ADMINISTRATION AND FINALIZED A SUITE OF MATERIALS OUTLINING THE LESSONS AND STORY OF JE VACCINATION EFFORTS. ALSO IN 2020, WE CONTINUED A PIVOTAL, PHASE 3 STUDY OF A POLYVALENT MENINGOCOCCAL MENINGITIS CONJUGATE VACCINE. THE VACCINE, DEVELOPED BY SERUM INSTITUTE OF INDIA PVT. LTD., BUILDS ON THE SUCCESS OF MENAFRIVAC, A GROUNDBREAKING VACCINE AGAINST SEROGROUP A MENINGOCOCCAL MENINGITIS THAT WAS DEVELOPED THROUGH AN EARLIER PATH PARTNERSHIP. THE POLYVALENT VACCINE TARGETS SEROGROUPS A, C, W, X, AND Y. AS THE FIRST VACCINE TO TARGET SEROGROUP X, THE VACCINE HAS THE POTENTIAL TO ELIMINATE MENINGITIS EPIDEMICS FROM AFRICA'S "MENINGITIS BELT" REGION. WE ALSO CONTRIBUTED TECHNICAL AND STRATEGIC EXPERTISE TO THE GLOBAL "DEFEATING MENINGITIS BY 2030" INITIATIVE, WHICH CULMINATED IN WORLD HEALTH ASSEMBLY ADOPTION OF THE FIRST-EVER RESOLUTION ON MENINGITIS PREVENTION AND CONTROL AND ENDORSEMENT OF A GLOBAL ROAD MAP TO DEFEAT MENINGITIS.TO PREVENT MALARIA, PATH ACCELERATED THE DEVELOPMENT OF A WIDE VARIETY OF MALARIA VACCINE CANDIDATES AND APPROACHES. FOR EXAMPLE, WE WORKED WITH WHO AND OTHER PARTNERS, INCLUDING THE MINISTRIES OF HEALTH IN GHANA, KENYA, AND MALAWI, TO INTRODUCE THE WORLD'S FIRST MALARIA VACCINE, KNOWN AS RTS,S, IN SELECTED AREAS OF THOSE COUNTRIES. WE ALSO CONTINUED TO ADVANCE RESEARCH INTO WHETHER REDUCING THE DOSE LEVEL OF RTS,S AND DELAYING THE ADMINISTRATION OF DOSES HAS THE POTENTIAL TO FURTHER AID MALARIA ELIMINATION EFFORTS BY STRETCHING LIMITED VACCINE SUPPLIES AND PROTECTING AS MANY PEOPLE AS POSSIBLE. ADDITIONALLY, WORK CONTINUED ON EFFORTS TO IDENTIFY IMMUNE CORRELATES OF PROTECTION AND STUDY THE USE OF MONOCLONAL ANTIBODIES TO COMBAT MALARIA. IN 2020, PATH RECEIVED A FIVE-YEAR GRANT FROM USAID TO ADVANCE PRE-ERYTHROCYTIC, BLOOD-STAGE, AND COMBINATION MALARIA VACCINE CANDIDATE APPROACHES.THE DEFEAT DIARRHEAL DISEASE (DEFEATDD) INITIATIVE CONTINUED ITS ROLE AS A DIGITAL HUB FOR INFORMATION ON PREVENTING AND TREATING CHILDHOOD DIARRHEAL DISEASE. A MAJOR FOCUS OF 2020 WAS A CAMPAIGN TO MAINTAIN CHILD HEALTH INVESTMENTS DURING THE COVID-19 PANDEMIC, INCLUDING STEADY ACCESS TO ESSENTIAL MEDICINES AND ROUTINE IMMUNIZATION. IN ONGOING EFFORTS TO SUPPORT LOCAL VACCINE PRODUCTION, PATH SUPPORTED VIETNAM-BASED MANUFACTURER POLYVAC TO COMPLETE CLINICAL TRIALS FOR THE LIQUID FORMULATION OF ROTAVIN VACCINE. OUR PHASE 3 STUDY FOUND THAT ROTAVIN IS AS SAFE AND IMMUNOGENIC AS THE CURRENTLY LICENSED FROZEN FORMULATION, ROTAVIN-M1. WE COMPLETED THE CLINICAL PHASE OF A PHASE 1 STUDY IN THE UNITED STATES OF A NOVEL, INJECTABLE SUBUNIT SHIGELLA VACCINE CANDIDATE AND INITIATED FOLLOW-ON EXPLORATORY IMMUNOLOGY ANALYSES USING SAMPLES FROM THE STUDY. AND WE CONTINUED TO HELP INTRODUCE AND ADVANCE ACCESS TO CURRENTLY AVAILABLE ROTAVIRUS VACCINES.PATH CONTINUED TO ADVANCE PRECLINICAL DEVELOPMENT OF A VACCINE AGAINST GROUP B STREPTOCOCCUS, THE LEADING CAUSE OF BACTERIAL SEPSIS AND MENINGITIS IN YOUNG INFANTS WORLDWIDE. WE SUPPORTED INVENTPRISE, A BIOTECHNOLOGY COMPANY, AS IT WORKS TO DEVELOP A MULTIVALENT, CONJUGATE VACCINE FOR LOW- AND MIDDLE-INCOME COUNTRIES. THE INTENDED RECIPIENTS ARE PREGNANT WOMEN-PART OF A STRATEGY THAT BOOSTS IMMUNITY AGAINST THE BACTERIUM AND TRANSFERS PROTECTIVE ANTIBODIES TO THE DEVELOPING BABY. AS PART OF THE TYPHOID VACCINE ACCELERATION CONSORTIUM, PATH WORKED TO ADVANCE TYPHOID CONJUGATE VACCINE (TCV) INTRODUCTION IN GAVI-ELIGIBLE COUNTRIES. WITH OUR SUPPORT, THE GOVERNMENTS OF MALAWI AND NEPAL MADE THE DECISION TO INTRODUCE TCV AND SUCCESSFULLY APPLIED FOR ASSISTANCE FROM GAVI. PATH ALSO WORKED WITH THE GOVERNMENT OF KENYA ON ITS DECISION TO INTRODUCE TCV AND BEGIN PLANNING. TO ACCOUNT FOR CHALLENGES BROUGHT ON BY THE COVID-19 PANDEMIC, WE HELPED THE GOVERNMENTS OF LIBERIA, PAKISTAN, AND ZIMBABWE ADJUST THEIR TCV CAMPAIGNS.ALSO IN 2020, PATH CONTINUED TO COORDINATE A CONSORTIUM OF NINE INDEPENDENT RESEARCH INSTITUTIONS TO ANALYZE EVIDENCE ON SINGLE-DOSE HPV VACCINATION. FOR COUNTRIES WITH FINANCIAL, LOGISTICAL, OR OTHER BARRIERS TO INTRODUCTION, A SINGLE-DOSE REGIMEN COULD BE TRANSFORMATIVE. AMONG OTHER ASSISTANCE, OUR GLOBAL TEAM AND PARTNERS HELPED GAVI-ELIGIBLE COUNTRIES RESPOND TO THE COVID-19 PANDEMIC BY PIVOTING HPV VACCINATION PROGRAMS TO REACH OUT-OF-SCHOOL GIRLS.DRUG DEVELOPMENTTHROUGH OUR WORK ON DRUG DEVELOPMENT AND INTRODUCTION, PATH HELPS ENSURE THAT PEOPLE AROUND THE WORLD, ESPECIALLY CHILDREN IN LOW-RESOURCE SETTINGS, HAVE RELIABLE ACCESS TO LIFESAVING MEDICINES. OVER THE YEARS, OUR WORK HAS ADVANCED SOLUTIONS FOR A RANGE OF URGENT GLOBAL HEALTH CHALLENGES, INCLUDING ENTERIC AND DIARRHEAL DISEASES, NEGLECTED TROPICAL DISEASES, HIV/AIDS, AND MALARIA. DRAWING ON AN ENDURING COMMITMENT TO HEALTH EQUITY AND A UNIQUE PARTNERSHIP APPROACH THAT SPANS THE ACADEMIC, PRIVATE, NONPROFIT, AND GOVERNMENT SECTORS, OUR WORK OVERTURNS BARRIERS TO HEALTH AT EVERY STAGE OF DRUG DEVELOPMENT AND USE-FROM EARLY RESEARCH TO INTRODUCTION.IN 2020, WE COMPLETED A PHASE 2 PROOF-OF-CONCEPT CLINICAL TRIAL OF IOWH032, A NOVEL ANTISECRETORY DRUG CANDIDATE FOR THE TREATMENT OF CHOLERA. WHILE IOWH032 WAS NOT EFFICACIOUS IN THIS STUDY, WE LEARNED IMPORTANT LESSONS FOR FUTURE DRUG TRIALS AND CONTINUE TO EXPLORE OTHER USES OF THIS COMPOUND, INCLUDING FOR TREATMENT OF COVID-19, CYSTIC FIBROSIS, AND POTENTIALLY OTHER INDICATIONS.IN ADDITION, WE CONTINUED OUR WORK ON DEVELOPING NEW THERAPEUTICS FOR CRYPTOSPORIDIUM, A DEADLY DIARRHEA-CAUSING PARASITE FOR WHICH NO HIGHLY EFFECTIVE TREATMENT IS AVAILABLE. WE CONDUCTED KEY PRECLINICAL STUDIES AND SELECTED A COMPOUND FOR LARGE-ANIMAL EFFICACY TRIALS.THE DIARRHEA INNOVATIONS GROUP, AN INTERNATIONAL NETWORK OF CHILD HEALTH STAKEHOLDERS HOUSED WITHIN AND CO-CHAIRED BY PATH, CONTINUED TO ADVOCATE IN SUPPORT OF A LIFESAVING TREATMENT FOR DIARRHEA IN CHILDREN: THE USE OF CO-PACKAGED ORAL REHYDRATION SOLUTION AND ZINC, RECOGNIZED BY WHO AS AN ESSENTIAL MEDICINE. INCREASED ACCESS TO THIS TREATMENT COULD ACCELERATE PROGRESS TOWARD CHILD HEALTH GOALS.WITH OUR MANUFACTURING PARTNER QUANSYS BIOSCIENCES, WE MOVED TOWARD COMMERCIALIZATION OF A NEW TOOL FOR ASSESSING ENVIRONMENTAL ENTERIC DYSFUNCTION-AN INTESTINAL DISORDER RESPONSIBLE FOR A SIGNIFICANT PORTION OF THE GROWTH STUNTING OF APPROXIMATELY 140 MILLION CHILDREN WORLDWIDE.

4c	(Code: ) (Expenses $ 32,223,655 including grants of $ 7,574,230 ) (Revenue $ )
	TECHNOLOGY, ANALYTICS, AND MARKET INNOVATION: PATH'S TECHNOLOGY, ANALYTICS, AND MARKET INNOVATION (TAMI) DIVISION IS AN INTEGRATED GLOBAL PLATFORM FOR END-TO-END ADVANCEMENT OF HIGH-IMPACT MEDICAL DEVICES, HEALTH TECHNOLOGIES, DIAGNOSTICS, AND IN-COUNTRY "IMPACT LABS" THAT ADDRESS GLOBAL, REGIONAL, AND COUNTRY HEALTH NEEDS. TAMI ALSO MANAGES PATH'S WORK IN MARKET DYNAMICS AND DIGITAL AND DATA EXCELLENCE.(CONTINUED ON SCHEDULE O)MEDICAL DEVICES AND HEALTH TECHNOLOGIESTHE MEDICAL DEVICES AND HEALTH TECHNOLOGIES (MDHT) PROGRAM WITHIN TAMI IS PATH'S PRODUCT DEVELOPMENT ARM. THE PROGRAM WORKS WITH PUBLIC- AND PRIVATE-SECTOR PARTNERS AROUND THE WORLD TO DEVELOP, TEST, INTRODUCE, AND SCALE UP AFFORDABLE INNOVATIONS TO IMPROVE THE HEALTH OF PEOPLE IN LOW- AND MIDDLE-INCOME COUNTRIES.MILESTONES IN 2020 INCLUDED BEGINNING THE WORLD'S FIRST FREEZE-PREVENTIVE COLD BOX EVALUATION IN NEPAL; COMPLETING A THREE-YEAR INTRODUCTION AND SCALE-UP OF 7.1 PERCENT CHLORHEXIDINE FOR UMBILICAL CORD CARE IN FRANCOPHONE WEST AFRICA; RECEIVING REGULATORY APPROVAL IN GHANA AND KENYA FOR THE ELLAVI UTERINE BALLOON TAMPONADE-A PATH-DEVELOPED, LIFESAVING MEDICAL DEVICE FOR POSTPARTUM HEMORRHAGE; AND SERVING AS A KEY PARTNER ON THE GAVI-LED VACCINE INNOVATION PRIORITIZATION STRATEGY.MDHT ALSO ADDRESSED THE COVID-19 PANDEMIC: ONE EFFORT AIMED TO ACCELERATE EQUITABLE GLOBAL ACCESS TO COVID-19 VACCINES THROUGH A COLLABORATION WITH UNICEF AND THE COALITION FOR EPIDEMIC PREPAREDNESS INNOVATIONS. WORKING CLOSELY WITH PATH'S CENTER FOR VACCINE INNOVATION AND ACCESS, MDHT ASSESSED THE GLOBAL SUPPLY CHAIN FOR VACCINE COMPONENTS, VACCINE MANUFACTURING CAPACITY, SYRINGE AVAILABILITY, AND COLD CHAIN AND ULTRA-COLD CHAIN CAPACITY. WE ALSO ASSESSED COVID-19 VACCINE COLLATERAL MATERIALS AND INFORMATION-FOR EXAMPLE, NEW PACKAGING AND DELIVERY TECHNOLOGIES, WHO LABELING GUIDELINES, AND E-LEARNING MODULES.MDHT'S LIVING LABS INITIATIVE USED HUMAN-CENTERED DESIGN METHODS IN KENYA AND ZAMBIA TO IDENTIFY CHALLENGES AND PROPOSE SOLUTIONS TO THE MANY OBSTACLES IMMUNIZATION WORKERS FACE. IN KENYA, THE LIVING LABS TEAM ENGAGED HEALTH CARE WORKERS TO IDENTIFY CHALLENGES IN MANAGING POSTPARTUM HEMORRHAGE AND PRIORITIZE SOLUTIONS FOR GOVERNMENT RESPONSE. IN 2020, MDHT STAFF PRODUCED NINE PEER-REVIEWED JOURNAL ARTICLES AND RESEARCH REPORTS ON TOPICS RANGING FROM FREEZE-DRIED TABLETS FOR ORAL VACCINE DELIVERY TO CHLORHEXIDINE FOR FACILITY-BASED UMBILICAL CORD CARE.LAST, A CONSULTANT HIRED BY THE PATH SOUTH AFRICA IMPACT LAB WORKED CLOSELY WITH THE GLOBAL HEALTH INNOVATION ACCELERATOR/SOUTH AFRICAN MEDICAL RESEARCH COUNCIL ON A MEDICAL DEVICE LANDSCAPING ACTIVITY DESIGNED TO ACCELERATE PRODUCTION AND INTRODUCTION OF NOVEL HEALTH TECHNOLOGIES.DIAGNOSTICSPATH'S DIAGNOSTICS PROGRAM ADVANCES EQUITABLE AND SUSTAINABLE ACCESS TO AFFORDABLE, QUALITY-ASSURED DIAGNOSTICS FOR BETTER DIAGNOSIS AND TREATMENT IN LOW-RESOURCE SETTINGS.IN 2020, OUR PIONEERING WORK INCLUDED DEVELOPING, VALIDATING, EVALUATING, AND COMMERCIALIZING TESTS, REFERENCE ASSAYS, AND TOOLS; CONDUCTING LABORATORY PERFORMANCE EVALUATIONS AND CLINICAL STUDIES TO INFORM PATIENT CARE; FACILITATING A G6PD OPERATIONAL RESEARCH COMMUNITY OF PRACTICE; AND PUBLISHING 15 PEER-REVIEWED JOURNAL ARTICLES.THE DIAGNOSTICS TEAM RAPIDLY RESPONDED TO THE GLOBAL COVID-19 PANDEMIC WITH LABORATORY-BASED ACTIVITIES TO SUPPORT DIAGNOSTIC DEVELOPERS. THIS INCLUDED CREATING A BIOREPOSITORY OF QUALIFIED COVID-19 CLINICAL SAMPLES TO ACCELERATE THE DEVELOPMENT AND VALIDATION OF NEW COVID-19 DIAGNOSTIC TESTS (PROVIDED FREE OF CHARGE TO DEVELOPERS INTENDING TO SUPPLY GLOBAL MARKETS); CREATING FIVE DIGITAL, INTERACTIVE COVID-19 DIAGNOSTICS DASHBOARDS THAT AGGREGATE AND VISUALIZE PUBLICLY AVAILABLE INFORMATION ON THE DEVELOPMENT, SUPPLY, REGULATORY APPROVAL, AND PERFORMANCE OF COVID-19 DIAGNOSTIC TESTS (TO SUPPORT PRODUCT SELECTION AND PROCUREMENT DECISIONS WORLDWIDE); CONDUCTING IN-HOUSE EVALUATIONS OF NEW COMMERCIAL RAPID DIAGNOSTIC TESTS TO VERIFY PERFORMANCE CLAIMS AND FIT-FOR-PURPOSE IN INTERNATIONAL SETTINGS; ENSURING THE QUALITY OF COVID-19 RAPID DIAGNOSTIC TESTS WITH A BENCHMARKING PANEL THAT ENABLES UNBIASED, COMPARATIVE EVALUATIONS BETWEEN COVID-19 TESTS; SUPPORTING THE NATIONAL RESPONSE IN INDONESIA, MALAWI, NEPAL, AND PAKISTAN WITH ENVIRONMENTAL SURVEILLANCE DATA COLLECTION PROJECTS TO DETECT AND QUANTIFY THE PRESENCE OF SARS-COV-2 IN IMPACTED WASTEWATER; AND ENSURING THAT COVID-19 POINT-OF-CARE TESTS ARE SUITABLE FOR CLINICAL AND OPERATIONAL STUDIES IN BRAZIL.IN PARTNERSHIP WITH THE UNIVERSITY OF QUEENSLAND, THE DIAGNOSTICS TEAM SUPPORTED THE COMMERCIALIZATION OF CUSTOM MALARIA PROTEINS TO FACILITATE PERFORMANCE BENCHMARKING OF RAPID, ACCURATE, AND SPECIES-SPECIFIC MALARIA DIAGNOSTIC TESTS.THE TEAM ALSO SUBMITTED REGULATORY DOSSIERS FOR THE SD BIOSENSOR STANDARD G6PD TEST, WHICH GUIDES THE TREATMENT OF PLASMODIUM VIVAX MALARIA, TO THE AUSTRALIAN THERAPEUTIC GOODS ADMINISTRATION, THE US FOOD AND DRUG ADMINISTRATION, AND WHO FOR PREQUALIFICATION. IN 2020, NEARLY 75,000 OF THESE TESTS WERE DISTRIBUTED TO 30 COUNTRIES.INDIA IMPACT LABINDIA HAS A RICH INNOVATION ECOSYSTEM WITH UNIVERSITIES, PRIVATE-SECTOR FIRMS, AND A GROWING NUMBER OF ENTREPRENEURS FOCUSED ON DEVELOPING PRODUCTS AND SERVICES THAT MAKE HEALTH CARE MORE AFFORDABLE, ACCESSIBLE, AND EFFECTIVE. PATH'S INDIA IMPACT LAB, A PARTNERSHIP WITH TATA TRUSTS AND THE INDIAN INSTITUTE OF TECHNOLOGY DELHI, IS A PLATFORM TO ENABLE LATE-STAGE MEDICAL TECHNOLOGY INNOVATIONS TO ACHIEVE MARKET ENTRY, ADOPTION, AND SCALE. THE IMPACT LAB PARTNERS WITH TOP INDIAN TECHNOLOGY AND BUSINESS INCUBATORS IN THE LIFE SCIENCE AND HEALTH CARE INDUSTRIES. IN 2020, THE IMPACT LAB LED PATH'S PARTNERSHIP WITH THE CENTRE FOR CELLULAR AND MOLECULAR PLATFORMS, A PUBLIC-PRIVATE INITIATIVE THAT LAUNCHED THE COVID-19 INNOVATIONS DEPLOYMENT ACCELERATOR (C-CIDA) IN MARCH 2020. C-CIDA HELPS FAST-TRACK INNOVATIONS IN SCREENING, DIAGNOSIS, TREATMENT, MONITORING, CARE, AND MANAGEMENT OF COVID-19. THE IMPACT LAB CONTINUED TO SUPPORT THE MARKET ACCESS PROGRAM OF THE INDIA NATIONAL HEALTH AUTHORITY AND PARTNERED WITH XYNTEO INDIA ON PROJECT TEJ, AN INITIATIVE OF THE TELANGANA STATE GOVERNMENT AND MEDTECH CONNECT TO ACCELERATE INDIAN MEDICAL TECHNOLOGY INNOVATIONS. IN ADDITION, THE IMPACT LAB MANAGED A PIPELINE OF INNOVATIONS BEING EXPLORED FOR INTEGRATION WITH PRIMARY HEALTH CARE, IMMUNIZATION, NUTRITION, TB, COVID-19, FAMILY PLANNING, AND REPRODUCTIVE, MATERNAL, NEWBORN, CHILD, AND ADOLESCENT HEALTH PROGRAMS.THE IMPACT LAB ALSO CONTINUED ITS CROSSCUTTING SUPPORT OF VARIOUS PROGRAMS AT PATH; FOR EXAMPLE, EVALUATING LOW-FIELD MAGNETIC RESONANCE IMAGING, IMPROVING ACCESS TO COVID-19 TESTING IN INDIA THROUGH SYSTEM STRENGTHENING, EVALUATING A BLOW-FILL-SEAL ORAL VACCINE RECONSTITUTION DELIVERY SYSTEM, AND MARKET RESEARCH FOR NEWBORN SCREENING AND G6PD TESTING IN THE PRIVATE HEALTH SECTOR. MARKET DYNAMICSPATH'S MARKET DYNAMICS PROGRAM WORKS TO IMPROVE HEALTH EQUITY AND HEALTH OUTCOMES BY EVALUATING MARKETS, ASSESSING ROOT CAUSES OF LIMITED ACCESS TO HEALTH CARE PRODUCTS AND SERVICES, AND DESIGNING AND IMPLEMENTING MARKET-BASED INTERVENTIONS TO INCREASE ACCESS. THIS WORK COMPLEMENTS PATH'S OTHER EFFORTS, SUCH AS PRODUCT DEVELOPMENT/INTRODUCTION AND HEALTH SYSTEMS STRENGTHENING AND IS DONE IN CLOSE COLLABORATION WITH NATIONAL MINISTRIES OF HEALTH, GLOBAL AGENCIES, COMMERCIAL PARTNERS, AND PATH'S COUNTRY PROGRAMS.IN 2020, OUR WORK WAS FOCUSED PRIMARILY ON IMPROVING ACCESS TO MEDICAL OXYGEN AND RELATED RESPIRATORY CARE PRODUCTS FOR COVID-19 TREATMENT AS WELL AS MALARIA DRUGS AND DIAGNOSTICS.CENTER OF DIGITAL AND DATA EXCELLENCEPATH USES DIGITAL TECHNOLOGIES AND DATA-LED ACTION TO ADVANCE HEALTH EQUITY. IN 2020, PATH'S CENTER OF DIGITAL AND DATA EXCELLENCE (CODE) APPLIED ITS EXPERTISE TO ACCELERATE COUNTRY-LED DIGITAL HEALTH, DEEPEN THE USE OF DATA, AND SUPPORT THE GLOBAL COVID-19 RESPONSE. KEY ACCOMPLISHMENTS INCLUDED CO-AUTHORING WHO'S DIGITAL IMPLEMENTATION INVESTMENT GUIDE, WHICH OFFERS A SYSTEMIC PROCESS FOR COUNTRIES TO DEVELOP COSTED IMPLEMENTATION PLANS FOR DIGITAL HEALTH. DIGITAL SQUARE, A PATH-LED INITIATIVE, CONTINUED TO BRING DONORS AND PARTNERS TOGETHER TO IMPROVE HOW THE GLOBAL COMMUNITY DESIGNS, USES, AND PAYS FOR DIGITAL HEALTH TOOLS AND APPROACHES. DIGITAL SQUARE LED THE HEALTH DATA SCIENCE EXCHANGE, AN EXPLORATORY EFFORT TO UNDERSTAND HOW THE GREATER COORDINATION OF DATA SCIENCE TOOLS AND APPROACHES COULD IMPROVE HEALTH IMPACT. DIGITAL SQUARE ALSO BEGAN WORK ON MAP & MATCH, A LANDSCAPING ACTIVITY TO IDENTIFY EXISTING NATIONAL-LEVEL SOFTWARE TOOLS AND TECHNOLOGIES THAT CAN BE ADAPTED FOR COVID-19 RESPONSE.

	(Code: ) (Expenses $ 23,015,170 including grants of $ 5,154,512 ) (Revenue $ )
	ADVOCACY AND PUBLIC POLICYPATH'S ADVOCACY AND PUBLIC POLICY TEAM WORKS IN THE UNITED STATES, AT THE GLOBAL LEVEL WITH MULTILATERAL AGENCIES, AND IN COUNTRIES AND COMMUNITIES AROUND THE WORLD. WE HELP POLICYMAKERS UNDERSTAND ISSUES AND MOTIVATE THEM TO COMMIT FUNDING, CRAFT POLICIES, AND SPONSOR INITIATIVES TO STRENGTHEN GLOBAL HEALTH. IN 2020, PATH LED EFFORTS TO ENSURE SUPPORT AMONG POLICYMAKERS IN THE UNITED STATES, EUROPE, AND MULTILATERAL AGENCIES TO MAINTAIN AND STRENGTHEN WORK IN RESEARCH AND DEVELOPMENT, MATERNAL AND CHILD HEALTH, IMMUNIZATION, AND PANDEMIC PREPAREDNESS AND RESPONSE. SUCCESSES INCLUDED PROTECTING KEY US GOVERNMENT FUNDING FOR PATH'S PRIORITY HEALTH AREAS, ENSURING US RE-INVESTMENT IN THE NEXT PHASE OF GAVI, AND HELPING DECISION-MAKERS CRAFT EMERGENCY FUNDING FOR THE GLOBAL RESPONSE TO COVID-19. WORKING WITH PARTNERS IN AFRICA, WE HELPED ADVANCE POLICIES TO IMPROVE THE HEALTH OF WOMEN AND CHILDREN AND PROTECT ESSENTIAL HEALTH SERVICES AS THE COVID-19 PANDEMIC TOOK AN UNPRECEDENTED TOLL ON HEALTH SYSTEMS; FOR EXAMPLE, IN KENYA, OUR ADVOCACY RESULTED IN ESTABLISHMENT OF THE GLOBAL FINANCING FACILITY'S MULTI-STAKEHOLDER COUNTRY PLATFORM, WHICH GIVES CIVIL SOCIETY A VOICE IN GOVERNMENT FUNDING OF MATERNAL AND CHILD HEALTH PROGRAMS. IN SOUTH AFRICA, WE SUPPORTED THE COUNTRY'S HEALTH REGULATORY AGENCY AS IT STREAMLINED AND DISSEMINATED INFORMATION ABOUT THE APPROVAL PIPELINE FOR COVID-19 TOOLS AND TREATMENTS. IN UGANDA, WE SUCCESSFULLY ADVOCATED FOR INCREASED FUNDING FOR PRIMARY HEALTH CARE AND SUPPORTED THE NATIONAL IMMUNIZATION PROGRAM IN DEVELOPING A PLAN TO ROLL OUT COVID-19 VACCINATION AND CATCH UP ON MISSED IMMUNIZATIONS DURING THE PANDEMIC. AND IN THE DRC, WE SUCCESSFULLY ADVOCATED FOR FULL DISBURSEMENT OF THE GOVERNMENT'S CO-FINANCING COMMITMENTS TO GAVI AS WELL AS ADDITIONAL FUNDS FOR IMMUNIZATION IN THREE PROVINCES.SPECIAL INITIATIVESPATH IS ENGAGED IN A VARIETY OF SPECIAL INITIATIVES THAT GALVANIZE OUR EXPERTISE AND RESOURCES AND THOSE OF OUR GLOBAL PARTNERS TO SAVE MORE LIVES, MORE QUICKLY. BY THE END OF 2020, WE HAD ACTIVE HEALTH IMPACT TEAMS IN SEVEN HEALTH AREAS. EACH HEALTH IMPACT TEAM HAS BEEN ONGOING FOR AT LEAST THREE YEARS, WORKING TO BUILD STRUCTURED COLLABORATION ACROSS PROGRAMS AND GEOGRAPHIES TO INCREASE PATH'S IMPACT.

4d	Other program services (Describe in Schedule O.)
	(Expenses $ 23,015,170 including grants of $ 5,154,512 ) (Revenue $ )
4e	Total program service expenses262,890,896

Form 990 (2020)

Page 3

Part IV

Checklist of Required Schedules

Yes

Is the organization described in section 501(c)(3) or 4947(a)(1) (other than a private foundation)? If "Yes," complete Schedule A Click to see attachment

.....................

Yes

Is the organization required to complete Schedule B, Schedule of Contributors (see instructions)? Click to see attachment

...

Yes

Did the organization engage in direct or indirect political campaign activities on behalf of or in opposition to candidates for public office? If "Yes," complete Schedule C, Part I Click to see attachment

.............

Section 501(c)(3) organizations. Did the organization engage in lobbying activities, or have a section 501(h) election in effect during the tax year? If "Yes," complete Schedule C, Part II Click to see attachment

.........

Yes

Is the organization a section 501(c)(4), 501(c)(5), or 501(c)(6) organization that receives membership dues, assessments, or similar amounts as defined in Revenue Procedure 98-19? If "Yes," complete Schedule C, Part III Click to see attachment

Did the organization maintain any donor advised funds or any similar funds or accounts for which donors have the right to provide advice on the distribution or investment of amounts in such funds or accounts? If "Yes," complete Schedule D, Part I Click to see attachment

.........................

Did the organization receive or hold a conservation easement, including easements to preserve open space,
the environment, historic land areas, or historic structures? If "Yes," complete Schedule D, Part II Click to see attachment

....

Did the organization maintain collections of works of art, historical treasures, or other similar assets? If "Yes,"
complete Schedule D, Part III Click to see attachment

..............

Did the organization report an amount in Part X, line 21 for escrow or custodial account liability; serve as a custodian for amounts not listed in Part X; or provide credit counseling, debt management, credit repair, or debt negotiation services? If "Yes," complete Schedule D, Part IV Click to see attachment

..............

Did the organization, directly or through a related organization, hold assets in temporarily restricted endowments, permanent endowments, or quasi endowments? If "Yes," complete Schedule D, Part V......

Yes

If the organization’s answer to any of the following questions is "Yes," then complete Schedule D, Parts VI, VII, VIII, IX, or X as applicable.

Did the organization report an amount for land, buildings, and equipment in Part X, line 10? If "Yes," complete
Schedule D, Part VI. Click to see attachment

...................

11a

Yes

Did the organization report an amount for investments—other securities in Part X, line 12 that is 5% or more of its total assets reported in Part X, line 16? If "Yes," complete Schedule D, Part VII Click to see attachment

.......

11b

Did the organization report an amount for investments—program related in Part X, line 13 that is 5% or more of its total assets reported in Part X, line 16? If "Yes," complete Schedule D, Part VIII Click to see attachment

.......

11c

Did the organization report an amount for other assets in Part X, line 15 that is 5% or more of its total assets reported in Part X, line 16? If "Yes," complete Schedule D, Part IX Click to see attachment

............

11d

Did the organization report an amount for other liabilities in Part X, line 25? If "Yes," complete Schedule D, Part X Click to see attachment

11e

Did the organization’s separate or consolidated financial statements for the tax year include a footnote that addresses the organization’s liability for uncertain tax positions under FIN 48 (ASC 740)? If "Yes," complete Schedule D, Part X Click to see attachment

11f

12a

Did the organization obtain separate, independent audited financial statements for the tax year? If "Yes," complete
Schedule D, Parts XI and XII Click to see attachment

......................

12a

Was the organization included in consolidated, independent audited financial statements for the tax year? If "Yes," and if the organization answered "No" to line 12a, then completing Schedule D, Parts XI and XII is optional Click to see attachment

12b

Yes

Is the organization a school described in section 170(b)(1)(A)(ii)? If "Yes," complete Schedule E

14a

Did the organization maintain an office, employees, or agents outside of the United States? .....

14a

Yes

Did the organization have aggregate revenues or expenses of more than $10,000 from grantmaking, fundraising, business, investment, and program service activities outside the United States, or aggregate foreign investments valued at $100,000 or more? If "Yes," complete Schedule F, Parts I and IV......... Click to see attachment

14b

Yes

Did the organization report on Part IX, column (A), line 3, more than $5,000 of grants or other assistance to or for any foreign organization? If “Yes,” complete Schedule F, Parts II and IV..... Click to see attachment

Yes

Did the organization report on Part IX, column (A), line 3, more than $5,000 of aggregate grants or other assistance to or for foreign individuals? If “Yes,” complete Schedule F, Parts III and IV... Click to see attachment

Did the organization report a total of more than $15,000 of expenses for professional fundraising services on Part IX, column (A), lines 6 and 11e? If "Yes," complete Schedule G, Part I(see instructions) ....

Did the organization report more than $15,000 total of fundraising event gross income and contributions on Part VIII, lines 1c and 8a? If "Yes," complete Schedule G, Part II............

Did the organization report more than $15,000 of gross income from gaming activities on Part VIII, line 9a? If "Yes," complete Schedule G, Part III...................

20a

Did the organization operate one or more hospital facilities? If "Yes," complete Schedule H....

20a

If "Yes" to line 20a, did the organization attach a copy of its audited financial statements to this return?

20b

Did the organization report more than $5,000 of grants or other assistance to any domestic organization or domestic government on Part IX, column (A), line 1? If “Yes,” complete Schedule I, Parts I and II..... Click to see attachment

Yes

Form 990 (2020)

Page 4

Part IV

Checklist of Required Schedules (continued)

Yes

Did the organization report more than $5,000 of grants or other assistance to or for domestic individuals on Part IX, column (A), line 2? If “Yes,” complete Schedule I, Parts I and III........ Click to see attachment

Did the organization answer "Yes" to Part VII, Section A, line 3, 4, or 5 about compensation of the organization’s current and former officers, directors, trustees, key employees, and highest compensated employees? If "Yes," complete Schedule J....................... Click to see attachment

Yes

24a

Did the organization have a tax-exempt bond issue with an outstanding principal amount of more than $100,000 as of the last day of the year, that was issued after December 31, 2002? If “Yes,” answer lines 24b through 24d and complete Schedule K. If “No,” go to line 25a...............

24a

Did the organization invest any proceeds of tax-exempt bonds beyond a temporary period exception?...

24b

Did the organization maintain an escrow account other than a refunding escrow at any time during the year
to defease any tax-exempt bonds? ...............

24c

Did the organization act as an "on behalf of" issuer for bonds outstanding at any time during the year?...

24d

25a

Section 501(c)(3), 501(c)(4), and 501(c)(29) organizations. Did the organization engage in an excess benefit transaction with a disqualified person during the year? If "Yes," complete Schedule L, Part I ....

25a

Is the organization aware that it engaged in an excess benefit transaction with a disqualified person in a prior year, and that the transaction has not been reported on any of the organization’s prior Forms 990 or 990-EZ? If "Yes," complete Schedule L, Part I.......................

25b

Did the organization report any amount on Part X, line 5 or 22 for receivables from or payables to any current or former officer, director, trustee, key employee, creator or founder, substantial contributor, or 35% controlled entity or family member of any of these persons? If "Yes," complete Schedule L, Part II...........

Did the organization provide a grant or other assistance to any current or former officer, director, trustee, key employee, creator or founder, substantial contributor, or employee thereof, a grant selection committee member, or to a 35% controlled entity (including an employee thereof) or family member of any of these persons?

If "Yes," complete

Schedule L, Part III.........................

Was the organization a party to a business transaction with one of the following parties (see Schedule L, Part IV instructions for applicable filing thresholds, conditions, and exceptions):

A current or former officer, director, trustee, key employee, creator or founder, or substantial contributor? If "Yes," complete Schedule L, Part IV......................

28a

A family member of any individual described in line 28a? If "Yes," complete Schedule L, Part IV.....

28b

A 35% controlled entity of one or more individuals and/or organizations described in lines 28a or 28b? If "Yes," complete Schedule L, Part IV.....................

28c

Did the organization receive more than $25,000 in non-cash contributions? If "Yes," complete Schedule M.. Click to see attachment

Yes

Did the organization receive contributions of art, historical treasures, or other similar assets, or qualified conservation contributions? If "Yes," complete Schedule M ................. Click to see attachment

Did the organization liquidate, terminate, or dissolve and cease operations? If "Yes," complete Schedule N, Part I

Did the organization sell, exchange, dispose of, or transfer more than 25% of its net assets? If "Yes," complete Schedule N, Part II........................

Did the organization own 100% of an entity disregarded as separate from the organization under Regulations sections 301.7701-2 and 301.7701-3? If "Yes," complete Schedule R, Part I............ Click to see attachment

Was the organization related to any tax-exempt or taxable entity? If "Yes," complete Schedule R, Part II, III, or IV, and Part V, line 1......................... Click to see attachment

Yes

35a

Did the organization have a controlled entity within the meaning of section 512(b)(13)?

35a

Yes

If ‘Yes’ to line 35a, did the organization receive any payment from or engage in any transaction with a controlled entity within the meaning of section 512(b)(13)? If "Yes," complete Schedule R, Part V, line 2 ... Click to see attachment

35b

Yes

Section 501(c)(3) organizations. Did the organization make any transfers to an exempt non-charitable related organization? If "Yes," complete Schedule R, Part V, line 2............. Click to see attachment

Did the organization conduct more than 5% of its activities through an entity that is not a related organization and that is treated as a partnership for federal income tax purposes? If "Yes," complete Schedule R, Part VI Click to see attachment

Did the organization complete Schedule O and provide explanations in Schedule O for Part VI, lines 11b and 19? Note. All Form 990 filers are required to complete Schedule O. ............

Yes

Part V

Statements Regarding Other IRS Filings and Tax Compliance
Check if Schedule O contains a response or note to any line in this Part V...........

Yes

Enter the number reported in Box 3 of Form 1096. Enter -0- if not applicable ..

221

Enter the number of Forms W-2G included in line 1a. Enter -0- if not applicable .

Did the organization comply with backup withholding rules for reportable payments to vendors and reportable gaming (gambling) winnings to prize winners? ..................

Yes

Form 990 (2020)

Page 5

Part V

Statements Regarding Other IRS Filings and Tax Compliance (continued)

Enter the number of employees reported on Form W-3, Transmittal of Wage and
Tax Statements, filed for the calendar year ending with or within the year covered by this return ..................

714

If at least one is reported on line 2a, did the organization file all required federal employment tax returns?
Note. If the sum of lines 1a and 2a is greater than 250, you may be required to e-file (see instructions)

Yes

Did the organization have unrelated business gross income of $1,000 or more during the year?...

If “Yes,” has it filed a Form 990-T for this year? If “No” to line 3b, provide an explanation in Schedule O...

At any time during the calendar year, did the organization have an interest in, or a signature or other authority over, a financial account in a foreign country (such as a bank account, securities account, or other financial account)? ..

Yes

If "Yes," enter the name of the foreign country: MediumBullet

BE , CH , ET , GH , IN , KE , MZ , PE , SG , SZ , TZ , UG , UK , VM , ZA , CG , MI , BM , SF , UP
See instructions for filing requirements for FinCEN Form 114, Report of Foreign Bank and Financial Accounts (FBAR).

Was the organization a party to a prohibited tax shelter transaction at any time during the tax year? ..

Did any taxable party notify the organization that it was or is a party to a prohibited tax shelter transaction?

If "Yes," to line 5a or 5b, did the organization file Form 8886-T? ............

Does the organization have annual gross receipts that are normally greater than $100,000, and did the organization solicit any contributions that were not tax deductible as charitable contributions? ...

If "Yes," did the organization include with every solicitation an express statement that such contributions or gifts were not tax deductible? ......................

Organizations that may receive deductible contributions under section 170(c).

Did the organization receive a payment in excess of $75 made partly as a contribution and partly for goods and services provided to the payor? ....................

If "Yes," did the organization notify the donor of the value of the goods or services provided? .....

Did the organization sell, exchange, or otherwise dispose of tangible personal property for which it was required to file Form 8282? .........................

If "Yes," indicate the number of Forms 8282 filed during the year ....

Did the organization receive any funds, directly or indirectly, to pay premiums on a personal benefit contract?

Did the organization, during the year, pay premiums, directly or indirectly, on a personal benefit contract? ..

If the organization received a contribution of qualified intellectual property, did the organization file Form 8899 as required? ......................

If the organization received a contribution of cars, boats, airplanes, or other vehicles, did the organization file a Form 1098-C? ..........................

Sponsoring organizations maintaining donor advised funds. Did a donor advised fund maintained by the sponsoring organization have excess business holdings at any time during the year? ........

Sponsoring organizations maintaining donor advised funds.

Did the sponsoring organization make any taxable distributions under section 4966?........

Did the sponsoring organization make a distribution to a donor, donor advisor, or related person?...

Section 501(c)(7) organizations. Enter:

Initiation fees and capital contributions included on Part VIII, line 12 ...

10a

Gross receipts, included on Form 990, Part VIII, line 12, for public use of club facilities

10b

Section 501(c)(12) organizations. Enter:

Gross income from members or shareholders .........

11a

Gross income from other sources (Do not net amounts due or paid to other sources against amounts due or received from them.) ..........

11b

12a

Section 4947(a)(1) non-exempt charitable trusts. Is the organization filing Form 990 in lieu of Form 1041?

12a

If "Yes," enter the amount of tax-exempt interest received or accrued during the year.

12b

Section 501(c)(29) qualified nonprofit health insurance issuers.

Is the organization licensed to issue qualified health plans in more than one state? .........
Note. See the instructions for additional information the organization must report on Schedule O.

13a

Enter the amount of reserves the organization is required to maintain by the states in which the organization is licensed to issue qualified health plans ....

13b

Enter the amount of reserves on hand ............

13c

14a

Did the organization receive any payments for indoor tanning services during the tax year?.....

14a

If "Yes," has it filed a Form 720 to report these payments? If "No," provide an explanation in Schedule O..

14b

Is the organization subject to the section 4960 tax on payment(s) of more than $1,000,000 in remuneration or excess parachute payment(s) during the year? ....................
If "Yes," see instructions and file Form 4720, Schedule N.

Is the organization an educational institution subject to the section 4968 excise tax on net investment income? ..
If "Yes," complete Form 4720, Schedule O.

Form 990 (2020)

Page 6

Part VI

Governance, Management, and Disclosure For each "Yes" response to lines 2 through 7b below, and for a "No" response to lines 8a, 8b, or 10b below, describe the circumstances, processes, or changes in Schedule O. See instructions.

Check if Schedule O contains a response or note to any line in this Part VI..............

Section A. Governing Body and Management

Yes

Enter the number of voting members of the governing body at the end of the tax year

If there are material differences in voting rights among members of the governing body, or if the governing body delegated broad authority to an executive committee or similar committee, explain in Schedule O.

Enter the number of voting members included in line 1a, above, who are independent

Did any officer, director, trustee, or key employee have a family relationship or a business relationship with any other officer, director, trustee, or key employee? .................

Did the organization delegate control over management duties customarily performed by or under the direct supervision of officers, directors or trustees, or key employees to a management company or other person? .

Did the organization make any significant changes to its governing documents since the prior Form 990 was filed? .

Did the organization become aware during the year of a significant diversion of the organization’s assets? .

Did the organization have members or stockholders? ................

Did the organization have members, stockholders, or other persons who had the power to elect or appoint one or more members of the governing body? ....................

Are any governance decisions of the organization reserved to (or subject to approval by) members, stockholders, or persons other than the governing body? ...................

Did the organization contemporaneously document the meetings held or written actions undertaken during the year by the following:

The governing body? .......................

Yes

Each committee with authority to act on behalf of the governing body? ............

Yes

Is there any officer, director, trustee, or key employee listed in Part VII, Section A, who cannot be reached at the organization’s mailing address? If "Yes," provide the names and addresses in Schedule O.......

Section B. Policies (This Section B requests information about policies not required by the Internal Revenue Code.)

Yes

10a

Did the organization have local chapters, branches, or affiliates? ............

10a

If "Yes," did the organization have written policies and procedures governing the activities of such chapters, affiliates, and branches to ensure their operations are consistent with the organization's exempt purposes?

10b

11a

Has the organization provided a complete copy of this Form 990 to all members of its governing body before filing the form? ............................

11a

Yes

Describe in Schedule O the process, if any, used by the organization to review this Form 990. .....

12a

Did the organization have a written conflict of interest policy? If "No," go to line 13.......

12a

Yes

Were officers, directors, or trustees, and key employees required to disclose annually interests that could give rise to conflicts? ..........................

12b

Yes

Did the organization regularly and consistently monitor and enforce compliance with the policy? If "Yes," describe in Schedule O how this was done...................

12c

Yes

Did the organization have a written whistleblower policy? ...............

Yes

Did the organization have a written document retention and destruction policy? .........

Yes

Did the process for determining compensation of the following persons include a review and approval by independent persons, comparability data, and contemporaneous substantiation of the deliberation and decision?

The organization’s CEO, Executive Director, or top management official ...........

15a

Yes

Other officers or key employees of the organization ................

15b

Yes

If "Yes" to line 15a or 15b, describe the process in Schedule O (see instructions).

16a

Did the organization invest in, contribute assets to, or participate in a joint venture or similar arrangement with a taxable entity during the year? ......................

16a

If "Yes," did the organization follow a written policy or procedure requiring the organization to evaluate its participation in joint venture arrangements under applicable federal tax law, and take steps to safeguard the organization’s exempt status with respect to such arrangements? ............

16b

Section C. Disclosure

List the states with which a copy of this Form 990 is required to be filed MediumBullet

AL , AR , CA , CT , FL , IL , KS , KY , MA , MD , MI , MN , MS , NC , NH , NJ , NM , NY , OK , OR , PA , RI , SC , TN , UT , VA , WI , WV

Section 6104 requires an organization to make its Form 1023 (or 1024-A if applicable), 990, and 990-T (501(c)(3)s only) available for public inspection. Indicate how you made these available. Check all that apply.

Own website Another's website Upon request Other (explain in Schedule O)

Describe in Schedule O whether (and if so, how) the organization made its governing documents, conflict of interest policy, and financial statements available to the public during the tax year.

State the name, address, and telephone number of the person who possesses the organization's books and records:
MediumBullet

KELLY PRIESTLEY CONTROLLER2201 WESTLAKE AVE SUITE 200 SEATTLE,WA98121 (206) 285-3500

Form 990 (2020)

Page 7

Part VII

Compensation of Officers, Directors,Trustees, Key Employees, Highest Compensated Employees, and Independent Contractors

Check if Schedule O contains a response or note to any line in this Part VII..............

Section A. Officers, Directors, Trustees, Key Employees, and Highest Compensated Employees

1a Complete this table for all persons required to be listed. Report compensation for the calendar year ending with or within the organization’s tax year.
RoundBullet

List all of the organization’s current officers, directors, trustees (whether individuals or organizations), regardless of amount
of compensation. Enter -0- in columns (D), (E), and (F) if no compensation was paid.

List all of the organization’s current key employees, if any. See instructions for definition of "key employee."

List the organization’s five current highest compensated employees (other than an officer, director, trustee or key employee)
who received reportable compensation (Box 5 of Form W-2 and/or Box 7 of Form 1099-MISC) of more than $100,000 from the
organization and any related organizations.

List all of the organization’s former officers, key employees, or highest compensated employees who received more than $100,000
of reportable compensation from the organization and any related organizations.

List all of the organization’s former directors or trustees that received, in the capacity as a former director or trustee of the
organization, more than $10,000 of reportable compensation from the organization and any related organizations.

See instructions for the order in which to list the persons above.

Check this box if neither the organization nor any related organization compensated any current officer, director, or trustee.

(A) Name and title	(B) Average hours per week (list any hours for related organizations below dotted line)	(C) Position (do not check more than one box, unless person is both an officer and a director/trustee)		(D) Reportable compensation from the organization (W-2/1099-MISC)	(E) Reportable compensation from related organizations (W-2/1099-MISC)	(F) Estimated amount of other compensation from the organization and related organizations
(A) Name and title
(1) DAVID KING...................................................................... CHAIR	2.00 ................. 0.00	X	X	0	0	0
(2) BETH GALETTI...................................................................... VICE CHAIR	2.00 ................. 0.00	X	X	0	0	0
(3) YEHONG ZHANG...................................................................... SECRETARY	2.00 ................. 0.00	X	X	0	0	0
(4) BRUCE MCNAMER...................................................................... TREASURER	2.00 ................. 0.00	X	X	0	0	0
(5) FELIX OLALE...................................................................... DIRECTOR	2.00 ................. 0.00	X		0	0	0
(6) JO ADDY...................................................................... DIRECTOR	2.00 ................. 0.00	X		0	0	0
(7) IREENA VITTAL...................................................................... DIRECTOR	2.00 ................. 0.00	X		0	0	0
(8) DEANNA OPPENHEIMER...................................................................... DIRECTOR (BEGAN 6/2020)	2.00 ................. 0.00	X		0	0	0
(9) JOHN-ARNE ROTTINGEN...................................................................... DIRECTOR	2.00 ................. 0.00	X		0	0	0
(10) JOEL HOLSINGER...................................................................... DIRECTOR	2.00 ................. 0.00	X		0	0	0
(11) HELENA WAYTH...................................................................... DIRECTOR	2.00 ................. 0.00	X		0	0	0
(12) SANFORD MELZER...................................................................... DIRECTOR	2.00 ................. 0.00	X		0	0	0
(13) ABAYOMI SULE...................................................................... DIRECTOR	2.00 ................. 0.00	X		0	0	0
(14) LISA ANDERSON...................................................................... DIRECTOR	2.00 ................. 0.00	X		0	0	0
(15) RACHEL SIBANDE...................................................................... DIRECTOR	2.00 ................. 0.00	X		0	0	0
(16) STEPHEN B DAVIS...................................................................... PRESIDENT AND CEO (RESIGNED 1/2020)	39.00 ................. 1.00		X	249,057	0	13,602
(17) NIKOLAJ JESTED GILBERT...................................................................... PRESIDENT AND CEO (FROM 1/2020)	39.00 ................. 1.00		X	256,555	315,385	44,054

Form 990 (2020)

Page 8

Part VII

Section A. Officers, Directors, Trustees, Key Employees, and Highest Compensated Employees (continued)

(A) Name and title	(B) Average hours per week (list any hours for related organizations below dotted line)				(D) Reportable compensation from the organization (W-2/1099-MISC)	(E) Reportable compensation from related organizations (W-2/1099-MISC)	(F) Estimated amount of other compensation from the organization and related organizations
(A) Name and title
(18) JERRY KUO........................................................................ CHIEF OF STRATEGIC FINANCE	39.00 .......................1.00	X			252,897	0	58,226
(19) BRIAN N NEVILLE........................................................................ CHIEF OF ACCOUNTING	39.00 .......................1.00	X			260,514	0	36,826
(20) PHILIPPE GUINOT........................................................................ CHIEF OF BUSINESS, FIN. & OPS.	39.00 .......................1.00	X			0	258,031	22,877
(21) DAVID C KASLOW........................................................................ VP - ESSENTIAL MEDICNES	39.00 .......................1.00		X		427,937	0	69,391
(22) JEFFREY D BERNSON........................................................................ VP - TECH, ANALYTICS, MRKT INNOV.	40.00 .......................0.00		X		322,741	0	57,193
(23) DAVID W FLEMING........................................................................ VP - PUBLIC HEALTH	40.00 .......................0.00		X		364,555	0	44,832
(24) ELAINE L GIBBONS........................................................................ VP - GLOBAL ENGAGEMENT	39.00 .......................1.00		X		291,278	0	76,724
(25) MOLLI M BARNES........................................................................ CHIEF PEOPLE OFFICER	40.00 .......................0.00		X		278,509	0	52,067
(26) ERICA JANE SESSLE........................................................................ CHIEF OF STAFF	40.00 .......................0.00		X		238,815	0	54,599
(27) SABRINA L POWERS........................................................................ GENERAL COUNSEL	40.00 .......................0.00		X		232,450	0	37,202
(28) TRAD M HATTON........................................................................ COUNTRY DIRECTOR	40.00 .......................0.00			X	376,676	0	54,537
(29) JAMES B MCKENNA........................................................................ DEPUTY DIRECTOR	40.00 .......................0.00			X	321,745	0	84,937
(30) ASHLEY J BIRKETT........................................................................ GLOBAL HEAD, MALARIA VACCINES	40.00 .......................0.00			X	346,772	0	56,185
(31) BRUCE LAMONT INNIS........................................................................ GLOBAL HEAD, RESPIRATORY INFECTIONS	40.00 .......................0.00			X	357,737	0	32,603
(32) JOHN O KONZ........................................................................ GLOBAL HEAD, FINANCIAL MANAGEMENT	40.00 .......................0.00			X	346,902	0	67,132

1b	Sub-Total................
c	Total from continuation sheets to Part VII, Section A....
d	Total (add lines 1b and 1c)...........	4,925,140	573,416	862,987

Total number of individuals (including but not limited to those listed above) who received more than $100,000 of reportable compensation from the organization MediumBullet

373

Yes

Did the organization list any former officer, director or trustee, key employee, or highest compensated employee on line 1a? If "Yes," complete Schedule J for such individual ..............

For any individual listed on line 1a, is the sum of reportable compensation and other compensation from the organization and related organizations greater than $150,000? If "Yes," complete Schedule J for such
individual...........................

Yes

Did any person listed on line 1a receive or accrue compensation from any unrelated organization or individual for services rendered to the organization? If "Yes," complete Schedule J for such person ........

Section B. Independent Contractors

Complete this table for your five highest compensated independent contractors that received more than $100,000 of compensation from the organization. Report compensation for the calendar year ending with or within the organization’s tax year.

(A) Name and business address	(B) Description of services	(C) Compensation
RANDSTAD INDIA PVT LTD SUIT NO 001 002 COPIA NEW DELHI 110025 IN	STAFFING SERVICES	996,065
SAFEGUARD WORLD INT'L MOSS LANE EDWIN FODEN BUS CENTRE SANDBACH CW113AE UK	GENERAL CONTRACTOR	890,294
WMBE PAYROLLING DBA TARGETCW 9475 CHESAPEAKE DR SAN DIEGO,CA92123	GENERAL CONTRACTOR	736,559
JAMES G DAVIS CONTRUCTION CORPORATION 12530 PARKLAND DRIVE ROCKVILLE,MD20852	GENERAL CONTRACTOR	622,327
INSTRUMENT LLC 3529 NORTH WILLIAMS AVENUE PORTLAND,OR97227	CONSULTING	488,228
2 Total number of independent contractors (including but not limited to those listed above) who received more than $100,000 of compensation from the organization 45

Form 990 (2020)

Page 9

Part VIII

Statement of Revenue

Check if Schedule O contains a response or note to any line in this Part VIII.............

(A)
Total revenue

(B)
Related or
exempt
function
revenue

(D)
Revenue
excluded from
tax under sections
512 - 514

1a	Federated campaigns..		1a
b	Membership dues..		1b
c	Fundraising events..		1c
d	Related organizations		1d	4,386,562
e	Government grants (contributions)		1e	98,650,801

f	All other contributions, gifts, grants, and similar amounts not included above		1f	184,417,020

g	Noncash contributions included in lines 1a - 1f:$		1g	761,052

h Total. Add lines 1a-1f.......		287,454,383

		Business Code
2a
b
c
d
e
f	All other program service revenue.
g	Total. Add lines 2a–2f .....

3 Investment income (including dividends, interest, and othersimilar amounts) ......			12,207,084			12,207,084
4 Income from investment of tax-exempt bond proceeds
5 Royalties...........
		(ii) Personal	(i) Real
6a	Gross rents			6a
b	Less: rental expenses			6b
c	Rental income or (loss)			6c
d	Net rental income or (loss).......
		(ii) Other	(i) Securities
7a	Gross amount from sales of assets other than inventory	21,954	57,083,069	7a
b	Less: cost or other basis and sales expenses	12,461	56,797,395	7b
c	Gain or (loss)	9,493	285,674	7c
d	Net gain or (loss).........			295,167			295,167
8a	Gross income from fundraising events (not including $ of contributions reported on line 1c). See Part IV, line 18 ....
			8a
b	Less: direct expenses ...		8b
c	Net income or (loss) from fundraising events..
9a	Gross income from gaming activities. See Part IV, line 19 ...
			9a
b	Less: direct expenses ...		9b
c	Net income or (loss) from gaming activities..
10a	Gross sales of inventory, less returns and allowances ..
			10a
b	Less: cost of goods sold ..		10b
c	Net income or (loss) from sales of inventory..
Business Code			Miscellaneous Revenue
11a	REIMBURSEMENTS		900099	705,455			705,455
b	OTHER		900099	324,657			324,657
c
d	All other revenue ....
e	Total. Add lines 11a–11d ......			1,030,112
12	Total revenue. See instructions.....			300,986,746	0	0	13,532,363

Form 990 (2020)

Page 10

Part IX

Statement of Functional Expenses

Section 501(c)(3) and 501(c)(4) organizations must complete all columns. All other organizations must complete column (A).Check if Schedule O contains a response or note to any line in this Part IX..............

Do not include amounts reported on lines 6b, 7b, 8b, 9b, and 10b of Part VIII.		(A) Total expenses	(B) Program service expenses	(C) Management and general expenses	(D) Fundraising expenses

1	Grants and other assistance to domestic organizations and domestic governments. See Part IV, line 21 ....	19,808,249	19,808,249
2	Grants and other assistance to domestic individuals. See Part IV, line 22 ...........
3	Grants and other assistance to foreign organizations, foreign governments, and foreign individuals. See Part IV, lines 15 and 16. .............	48,186,578	48,186,578
4	Benefits paid to or for members .......
5	Compensation of current officers, directors, trustees, and key employees ...........	3,696,147	443,030	3,230,480	22,637
6	Compensation not included above, to disqualified persons (as defined under section 4958(f)(1)) and persons described in section 4958(c)(3)(B) .........
7	Other salaries and wages........	95,455,775	89,233,434	4,839,226	1,383,115
8	Pension plan accruals and contributions (include section 401(k) and 403(b) employer contributions) ....	9,902,096	6,999,543	2,788,845	113,708
9	Other employee benefits .......	16,637,172	13,244,535	3,259,730	132,907
10	Payroll taxes ...........	6,405,206	4,527,542	1,804,106	73,558
11	Fees for services (non-employees):
a	Management ......
b	Legal .........	805,000	428,419	376,581
c	Accounting ...........	478,838	186,280	292,558
d	Lobbying ...........	1,845	1,845
e	Professional fundraising services. See Part IV, line 17
f	Investment management fees ......	177,923		177,923
g	Other (If line 11g amount exceeds 10% of line 25, column (A) amount, list line 11g expenses on Schedule O)	15,387,022	12,189,851	3,136,788	60,383
12	Advertising and promotion ....	286,728	220,391	3,897	62,440
13	Office expenses .......	7,780,893	6,665,971	1,027,428	87,494
14	Information technology ......	1,392,563	390,928	981,124	20,511
15	Royalties ..	337,136	337,136
16	Occupancy ...........	12,679,852	272,765	12,407,087
17	Travel ............	7,889,458	7,460,553	423,813	5,092
18	Payments of travel or entertainment expenses for any federal, state, or local public officials .
19	Conferences, conventions, and meetings ....	5,292,304	5,113,342	174,332	4,630
20	Interest ...........	1,904	154	1,750
21	Payments to affiliates .......
22	Depreciation, depletion, and amortization ..	3,101,076	12,403	3,088,673
23	Insurance ...	849,014	210,678	638,336
24	Other expenses. Itemize expenses not covered above (List miscellaneous expenses in line 24e. If line 24e amount exceeds 10% of line 25, column (A) amount, list line 24e expenses on Schedule O.)
a	SUBCONTRACTORS	26,935,850	26,932,945	2,905
b	EQUIP RENT & MAINT	6,595,821	5,287,573	1,303,962	4,286
c	DIRECT AID TO BENEFICIA	1,393,030	1,393,030
d	FACILITIES ALLOC	0	13,189,972	-13,402,840	212,868
e	All other expenses	1,582,003	153,749	1,201,997	226,257
25	Total functional expenses. Add lines 1 through 24e	293,059,483	262,890,896	27,758,701	2,409,886
26	Joint costs. Complete this line only if the organization reported in column (B) joint costs from a combined educational campaign and fundraising solicitation. Check here if following SOP 98-2 (ASC 958-720).

Form 990 (2020)

Page 11

Part X

Balance Sheet

Check if Schedule O contains a response or note to any line in this Part IX..............

				(A) Beginning of year		(B) End of year

1	Cash–non-interest-bearing ........			8,845,877	1	7,194,550
2	Savings and temporary cash investments .........			17,517,988	2	9,719,000
3	Pledges and grants receivable, net ......			44,215,907	3	39,742,632
4	Accounts receivable, net .............			16,731,594	4	258,036
5	Loans and other receivables from any current or former officer, director, trustee, key employee, creator or founder, substantial contributor, or 35% controlled entity or family member of any of these persons .......
					5
6	Loans and other receivables from other disqualified persons (as defined under section 4958(f)(1)), and persons described in section 4958(c)(3)(B) ...
					6
7	Notes and loans receivable, net ...........				7
8	Inventories for sale or use ............				8
9	Prepaid expenses and deferred charges ......			7,170,218	9	7,008,112
10a	Land, buildings, and equipment: cost or other basis. Complete Part VI of Schedule D	10a	38,112,788
b	Less: accumulated depreciation	10b	29,699,485	9,991,630	10c	8,413,303
11	Investments—publicly traded securities .			138,590,941	11	211,220,570
12	Investments—other securities. See Part IV, line 11 .....				12
13	Investments—program-related. See Part IV, line 11 ..				13
14	Intangible assets ...............				14
15	Other assets. See Part IV, line 11 ...........				15
16	Total assets. Add lines 1 through 15 (must equal line 33)...			243,064,155	16	283,556,203

17	Accounts payable and accrued expenses .....	204,045,574	17	234,982,056
18	Grants payable ...		18
19	Deferred revenue .........		19
20	Tax-exempt bond liabilities .........		20
21	Escrow or custodial account liability. Complete Part IV of Schedule D		21
22	Loans and other payables to any current or former officer, director, trustee, key employee, creator or founder, substantial contributor, or 35% controlled entity or family member of any of these persons .........
			22
23	Secured mortgages and notes payable to unrelated third parties ..		23
24	Unsecured notes and loans payable to unrelated third parties ..		24
25	Other liabilities (including federal income tax, payables to related third parties, and other liabilities not included on lines 17 - 24). Complete Part X of Schedule D		25
26	Total liabilities. Add lines 17 through 25..	204,045,574	26	234,982,056

	Organizations that follow FASB ASC 958, check here and complete lines 27, 28, 32, and 33.
27	Net assets without donor restrictions ..........	20,518,990	27	21,554,594
28	Net assets with donor restrictions ...........	18,499,591	28	27,019,553
	Organizations that do not follow FASB ASC 958, check here and complete lines 29 through 33.
29	Capital stock or trust principal, or current funds .....		29
30	Paid-in or capital surplus, or land, building or equipment fund ...		30
31	Retained earnings, endowment, accumulated income, or other funds		31
32	Total net assets or fund balances ...........	39,018,581	32	48,574,147
33	Total liabilities and net assets/fund balances ........	243,064,155	33	283,556,203

Form 990 (2020)

Page 12

Part XI

Reconcilliation of Net Assets

Check if Schedule O contains a response or note to any line in this Part XI..............

Total revenue (must equal Part VIII, column (A), line 12) ............

300,986,746

Total expenses (must equal Part IX, column (A), line 25) ............

293,059,483

Revenue less expenses. Subtract line 2 from line 1 ..............

7,927,263

Net assets or fund balances at beginning of year (must equal Part X, line 32, column (A)) ..

39,018,581

Net unrealized gains (losses) on investments ...............

1,628,303

Donated services and use of facilities .................

Investment expenses .....................

Prior period adjustments .....................

Other changes in net assets or fund balances (explain in Schedule O) ........

Net assets or fund balances at end of year. Combine lines 3 through 9 (must equal Part X, line 32, column (B))

48,574,147

Part XII

Financial Statements and Reporting

Check if Schedule O contains a response or note to any line in this Part XII.............

Yes

Accounting method used to prepare the Form 990: Cash Accrual Other
If the organization changed its method of accounting from a prior year or checked "Other," explain in
Schedule O.

Were the organization’s financial statements compiled or reviewed by an independent accountant?

If ‘Yes,’ check a box below to indicate whether the financial statements for the year were compiled or reviewed on a separate basis, consolidated basis, or both:

Separate basis Consolidated basis Both consolidated and separate basis

Were the organization’s financial statements audited by an independent accountant?

Yes

If ‘Yes,’ check a box below to indicate whether the financial statements for the year were audited on a separate basis, consolidated basis, or both:

Separate basis Consolidated basis Both consolidated and separate basis

If "Yes," to line 2a or 2b, does the organization have a committee that assumes responsibility for oversight of the audit, review, or compilation of its financial statements and selection of an independent accountant?

Yes

If the organization changed either its oversight process or selection process during the tax year, explain in Schedule O.

As a result of a federal award, was the organization required to undergo an audit or audits as set forth in the Single Audit Act and OMB Circular A-133?

Yes

If "Yes," did the organization undergo the required audit or audits? If the organization did not undergo the required audit or audits, explain why in Schedule O and describe any steps taken to undergo such audits.

Yes

Form 990 (2020)

Additional Data

Software ID:
Software Version:

Form 990, Special Condition Description:

Special Condition Description

- TIN:

SCHEDULE A
(Form 990 or 990EZ)

Department of the Treasury
Internal Revenue Service

Public Charity Status and Public Support

Complete if the organization is a section 501(c)(3) organization or a section 4947(a)(1) nonexempt charitable trust.
right arrow

Attach to Form 990 or Form 990-EZ.
right arrow

Go to www.irs.gov/Form990 for instructions and the latest information.

OMB No. 1545-0047

2020

Open to Public
Inspection

Name of the organization

PATH

Employer identification number

91-1157127

Part I

Reason for Public Charity Status (All organizations must complete this part.) See instructions.

The organization is not a private foundation because it is: (For lines 1 through 12, check only one box.)

A church, convention of churches, or association of churches described in section 170(b)(1)(A)(i).

A school described in section 170(b)(1)(A)(ii). (Attach Schedule E (Form 990 or 990-EZ).)

A hospital or a cooperative hospital service organization described in section 170(b)(1)(A)(iii).

A medical research organization operated in conjunction with a hospital described in section 170(b)(1)(A)(iii). Enter the hospital's name, city, and state:

An organization operated for the benefit of a college or university owned or operated by a governmental unit described in section 170(b)(1)(A)(iv). (Complete Part II.)

A federal, state, or local government or governmental unit described in section 170(b)(1)(A)(v).

An organization that normally receives a substantial part of its support from a governmental unit or from the general public described in section 170(b)(1)(A)(vi). (Complete Part II.)

A community trust described in section 170(b)(1)(A)(vi). (Complete Part II.)

An agricultural research organization described in 170(b)(1)(A)(ix) operated in conjunction with a land-grant college or university or a non-land grant college of agriculture. See instructions. Enter the name, city, and state of the college or university:

An organization that normally receives: (1) more than 331/3% of its support from contributions, membership fees, and gross receipts from activities related to its exempt functions—subject to certain exceptions, and (2) no more than 331/3% of its support from gross investment income and unrelated business taxable income (less section 511 tax) from businesses acquired by the organization after June 30, 1975. See section 509(a)(2). (Complete Part III.)

An organization organized and operated exclusively to test for public safety. See section 509(a)(4).

An organization organized and operated exclusively for the benefit of, to perform the functions of, or to carry out the purposes of one or more publicly supported organizations described in section 509(a)(1) or section 509(a)(2). See section 509(a)(3). Check the box in lines 12a through 12d that describes the type of supporting organization and complete lines 12e, 12f, and 12g.

Type I. A supporting organization operated, supervised, or controlled by its supported organization(s), typically by giving the supported organization(s) the power to regularly appoint or elect a majority of the directors or trustees of the supporting organization. You must complete Part IV, Sections A and B.

Type II. A supporting organization supervised or controlled in connection with its supported organization(s), by having control or management of the supporting organization vested in the same persons that control or manage the supported organization(s). You must complete Part IV, Sections A and C.

Type III functionally integrated. A supporting organization operated in connection with, and functionally integrated with, its supported organization(s) (see instructions). You must complete Part IV, Sections A, D, and E.

Type III non-functionally integrated. A supporting organization operated in connection with its supported organization(s) that is not functionally integrated. The organization generally must satisfy a distribution requirement and an attentiveness requirement (see instructions). You must complete Part IV, Sections A and D, and Part V.

Check this box if the organization received a written determination from the IRS that it is a Type I, Type II, Type III functionally integrated, or Type III non-functionally integrated supporting organization.

Enter the number of supported organizations ...............................

Provide the following information about the supported organization(s).

(i) Name of supported organization	(ii) EIN	(iv) Is the organization listed in your governing document?		(v) Amount of monetary support (see instructions)	(vi) Amount of other support (see instructions)
(i) Name of supported organization	(ii) EIN	Yes	No	(v) Amount of monetary support (see instructions)	(vi) Amount of other support (see instructions)


Total

For Paperwork Reduction Act Notice, see the Instructions for
Form 990 or 990-EZ.

Cat. No. 11285F

Schedule A (Form 990 or 990-EZ) 2020

Page 2

Part II

Support Schedule for Organizations Described in Sections 170(b)(1)(A)(iv) and 170(b)(1)(A)(vi)
(Complete only if you checked the box on line 5, 7, or 8 of Part I or if the organization failed to qualify under Part III. If the organization failed to qualify under the tests listed below, please complete Part III.)

Section A. Public Support

Calendar year (or fiscal year beginning in)		(a) 2016	(b) 2017	(c) 2018	(d) 2019	(e) 2020	(f) Total
1	Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grant.") ..	298,315,988	347,844,394	305,316,107	286,808,545	287,454,383	1,525,739,417
2	Tax revenues levied for the organization's benefit and either paid to or expended on its behalf....
3	The value of services or facilities furnished by a governmental unit to the organization without charge..
4	Total. Add lines 1 through 3	298,315,988	347,844,394	305,316,107	286,808,545	287,454,383	1,525,739,417
5	The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f)..						686,241,805
6	Public support. Subtract line 5 from line 4.						839,497,612

Section B. Total Support

Calendar year (or fiscal year beginning in)		(a) 2016	(b) 2017	(c) 2018	(d) 2019	(e) 2020	(f) Total
7	Amounts from line 4..	298,315,988	347,844,394	305,316,107	286,808,545	287,454,383	1,525,739,417
8	Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources...	1,797,794	2,050,888	2,963,587	6,310,221	12,207,084	25,329,574
9	Net income from unrelated business activities, whether or not the business is regularly carried on..
10	Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.)..	4,668,393	5,225,302	980,560	836,870	1,030,112	12,741,237
11	Total support. Add lines 7 through 10						1,563,810,228

Gross receipts from related activities, etc. (see instructions) ..................

74,952

First 5 years. If the Form 990 is for the organization's first, second, third, fourth, or fifth tax year as a section 501(c)(3) organization, check this box and stop here........................................ right arrow

Section C. Computation of Public Support Percentage

Public support percentage for 2020 (line 6, column (f) divided by line 11, column (f)) .........

53.680 %

Public support percentage for 2019 Schedule A, Part II, line 14 ...............

56.000 %

16a

33 1/3% support test—2020. If the organization did not check the box on line 13, and line 14 is 33 1/3% or more, check this box
and stop here. The organization qualifies as a publicly supported organization ....................... right arrow

33 1/3% support test—2019. If the organization did not check a box on line 13 or 16a, and line 15 is 33 1/3% or more, check this
box and stop here. The organization qualifies as a publicly supported organization ..................... right arrow

17a

10%-facts-and-circumstances test—2020. If the organization did not check a box on line 13, 16a, or 16b, and line 14
is 10% or more, and if the organization meets the "facts-and-circumstances" test, check this box and stop here. Explain
in Part VI how the organization meets the "facts-and-circumstances" test. The organization qualifies as a publicly supported
organization ..................................................... right arrow

10%-facts-and-circumstances test—2019. If the organization did not check a box on line 13, 16a, 16b, or 17a, and line
15 is 10% or more, and if the organization meets the "facts-and-circumstances" test, check this box and stop here.
Explain in Part VI how the organization meets the "facts-and-circumstances" test. The organization qualifies as a publicly
supported organization ................................................ right arrow

Private foundation. If the organization did not check a box on line 13, 16a, 16b, 17a, or 17b, check this box and see
instructions ..................................................... right arrow

Schedule A (Form 990 or 990-EZ) 2020

Page 3

Part III

Support Schedule for Organizations Described in Section 509(a)(2)
(Complete only if you checked the box on line 10 of Part I or if the organization failed to qualify under Part II. If the organization fails to qualify under the tests listed below, please complete Part II.)

Section A. Public Support

Calendar year (or fiscal year beginning in)		(a) 2016	(b) 2017	(c) 2018	(d) 2019	(e) 2020	(f) Total
1	Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") .
2	Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose
3	Gross receipts from activities that are not an unrelated trade or business under section 513 .....
4	Tax revenues levied for the organization's benefit and either paid to or expended on its behalf...
5	The value of services or facilities furnished by a governmental unit to the organization without charge
6	Total. Add lines 1 through 5
7a	Amounts included on lines 1, 2, and 3 received from disqualified persons
b	Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year.
c	Add lines 7a and 7b..
8	Public support. (Subtract line 7c from line 6.)

Section B. Total Support

Calendar year (or fiscal year beginning in)		(a) 2016	(b) 2017	(c) 2018	(d) 2019	(e) 2020	(f) Total
9	Amounts from line 6...
10a	Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources..
b	Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975.
c	Add lines 10a and 10b.
11	Net income from unrelated business activities not included in line 10b, whether or not the business is regularly carried on.
12	Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.) ..
13	Total support. (Add lines 9, 10c, 11, and 12.)..

First 5 years. If the Form 990 is for the organization's first, second, third, fourth, or fifth tax year as a section 501(c)(3) organization,
check this box and stop here............................................. right arrow

Section C. Computation of Public Support Percentage

Public support percentage for 2020 (line 8, column (f) divided by line 13, column (f)) .........

Public support percentage from 2019 Schedule A, Part III, line 15 ...............

Section D. Computation of Investment Income Percentage

Investment income percentage for 2020 (line 10c, column (f) divided by line 13, column (f)) ......

Investment income percentage from 2019 Schedule A, Part III, line 17 .............

19a

331/3% support tests—2020. If the organization did not check the box on line 14, and line 15 is more than 33 1/3%, and line 17 is not more than 33 1/3%, check this box and stop here. The organization qualifies as a publicly supported organization ....... right arrow

33 1/3% support tests—2019. If the organization did not check a box on line 14 or line 19a, and line 16 is more than 33 1/3% and line 18 is not more than 33 1/3%, check this box and stop here. The organization qualifies as a publicly supported organization .... right arrow

Private foundation. If the organization did not check a box on line 14, 19a, or 19b, check this box and see instructions .... right arrow

Schedule A (Form 990 or 990-EZ) 2020

Page 4

Part IV

Supporting Organizations

(Complete only if you checked a box on line 12 of Part I. If you checked box 12a, of Part I, complete Sections A and B. If you checked box 12b, of Part I, complete Sections A and C. If you checked box 12c, of Part I, complete Sections A, D, and E. If you checked box12d, of Part I, complete Sections A and D, and complete Part V.)

Section A. All Supporting Organizations

Yes

Are all of the organization’s supported organizations listed by name in the organization’s governing documents?
If "No," describe in Part VI how the supported organizations are designated. If designated by class or purpose,
describe the designation. If historic and continuing relationship, explain.

Did the organization have any supported organization that does not have an IRS determination of status under section 509(a)(1) or (2)? If "Yes," explain in Part VI how the organization determined that the supported organization was described in section 509(a)(1) or (2).

Did the organization have a supported organization described in section 501(c)(4), (5), or (6)? If "Yes," answer lines 3b and 3c below.

Did the organization confirm that each supported organization qualified under section 501(c)(4), (5), or (6) and satisfied the public support tests under section 509(a)(2)? If "Yes," describe in Part VI when and how the organization made the determination.

Did the organization ensure that all support to such organizations was used exclusively for section 170(c)(2)(B) purposes? If "Yes," explain in Part VI what controls the organization put in place to ensure such use.

Was any supported organization not organized in the United States ("foreign supported organization")? If “Yes” and if you checked box 12a or 12b in Part I, answer lines 4b and 4c below.

Did the organization have ultimate control and discretion in deciding whether to make grants to the foreign supported organization? If “Yes,” describe in Part VI how the organization had such control and discretion despite being controlled or supervised by or in connection with its supported organizations.

Did the organization support any foreign supported organization that does not have an IRS determination under sections 501(c)(3) and 509(a)(1) or (2)? If “Yes,” explain in Part VI what controls the organization used to ensure that all support to the foreign supported organization was used exclusively for section 170(c)(2)(B) purposes.

Did the organization add, substitute, or remove any supported organizations during the tax year? If “Yes,” answer lines 5b and 5c below (if applicable). Also, provide detail in Part VI, including (i) the names and EIN numbers of the supported organizations added, substituted, or removed; (ii) the reasons for each such action; (iii) the authority under the organization's organizing document authorizing such action; and (iv) how the action was accomplished (such as by amendment to the organizing document).

Type I or Type II only. Was any added or substituted supported organization part of a class already designated in the organization's organizing document?

Substitutions only. Was the substitution the result of an event beyond the organization's control?

Did the organization provide support (whether in the form of grants or the provision of services or facilities) to anyone other than (i) its supported organizations, (ii) individuals that are part of the charitable class benefited by one or more of its supported organizations, or (iii) other supporting organizations that also support or benefit one or more of the filing organization’s supported organizations? If “Yes,” provide detail in Part VI.

Did the organization provide a grant, loan, compensation, or other similar payment to a substantial contributor (defined in section 4958(c)(3)(C)), a family member of a substantial contributor, or a 35% controlled entity with regard to a substantial contributor? If “Yes,” complete Part I of Schedule L (Form 990 or 990-EZ) .

Did the organization make a loan to a disqualified person (as defined in section 4958) not described in line 7? If “Yes,” complete Part I of Schedule L (Form 990 or 990-EZ).

Was the organization controlled directly or indirectly at any time during the tax year by one or more disqualified persons, as defined in section 4946 (other than foundation managers and organizations described in section 509(a)(1) or (2))? If “Yes,” provide detail in Part VI.

Did one or more disqualified persons (as defined in line 9a) hold a controlling interest in any entity in which the supporting organization had an interest? If “Yes,” provide detail in Part VI.

Did a disqualified person (as defined in line 9a) have an ownership interest in, or derive any personal benefit from, assets in which the supporting organization also had an interest? If “Yes,” provide detail in Part VI.

10a

Was the organization subject to the excess business holdings rules of section 4943 because of section 4943(f) (regarding certain Type II supporting organizations, and all Type III non-functionally integrated supporting organizations)? If “Yes,” answer line 10b below.

10a

Did the organization have any excess business holdings in the tax year? (Use Schedule C, Form 4720, to determine whether the organization had excess business holdings).

10b

Schedule A (Form 990 or 990-EZ) 2020

Page 5

Part IV

Supporting Organizations (continued)

Yes

Has the organization accepted a gift or contribution from any of the following persons?

A person who directly or indirectly controls, either alone or together with persons described in lines 11b and 11c below, the governing body of a supported organization?

11a

A family member of a person described in 11a above?

11b

A 35% controlled entity of a person described in line 11a or 11b above? If “Yes” to 11a, 11b, or 11c, provide detail in Part VI.

11c

Section B. Type I Supporting Organizations

Yes

Did the officers, directors, trustees, or membership of one or more supported organizations have the power to regularly appoint or elect at least a majority of the organization’s directors or trustees at all times during the tax year? If “No,” describe in Part VI how the supported organization(s) effectively operated, supervised, or controlled the organization’s activities. If the organization had more than one supported organization, describe how the powers to appoint and/or remove directors or trustees were allocated among the supported organizations and what conditions or restrictions, if any, applied to such powers during the tax year.

Did the organization operate for the benefit of any supported organization other than the supported organization(s) that operated, supervised, or controlled the supporting organization? If “Yes,” explain in Part VI how providing such benefit carried out the purposes of the supported organization(s) that operated, supervised or controlled the supporting organization.

Section C. Type II Supporting Organizations

Yes

Were a majority of the organization’s directors or trustees during the tax year also a majority of the directors or trustees of each of the organization’s supported organization(s)? If “No,” describe in Part VI how control or management of the supporting organization was vested in the same persons that controlled or managed the supported organization(s).

Section D. All Type III Supporting Organizations

Yes

Did the organization provide to each of its supported organizations, by the last day of the fifth month of the organization’s tax year, (i) a written notice describing the type and amount of support provided during the prior tax year, (ii) a copy of the Form 990 that was most recently filed as of the date of notification, and (iii) copies of the organization’s governing documents in effect on the date of notification, to the extent not previously provided?

Were any of the organization’s officers, directors, or trustees either (i) appointed or elected by the supported organization(s) or (ii) serving on the governing body of a supported organization? If "No," explain in Part VI how the organization maintained a close and continuous working relationship with the supported organization(s).

By reason of the relationship described in line 2 above, did the organization’s supported organizations have a significant voice in the organization’s investment policies and in directing the use of the organization’s income or assets at all times during the tax year? If "Yes," describe in Part VI the role the organization’s supported organizations played in this regard.

Section E. Type III Functionally-Integrated Supporting Organizations

Check the box next to the method that the organization used to satisfy the Integral Part Test during the year (see instructions):

The organization satisfied the Activities Test. Complete line 2 below.

The organization is the parent of each of its supported organizations. Complete line 3 below.

The organization supported a governmental entity. Describe in Part VI how you supported a government entity (see instructions)

Activities Test. Answer lines 2a and 2b below.

Yes

Did substantially all of the organization’s activities during the tax year directly further the exempt purposes of the supported organization(s) to which the organization was responsive? If "Yes," then in Part VI identify those supported organizations and explain how these activities directly furthered their exempt purposes, how the organization was responsive to those supported organizations, and how the organization determined that these activities constituted substantially all of its activities.

Did the activities described in line 2a, above constitute activities that, but for the organization’s involvement, one or more of the organization’s supported organization(s) would have been engaged in? If "Yes," explain in Part VI the reasons for the organization’s position that its supported organization(s) would have engaged in these activities but for the organization’s involvement.

Parent of Supported Organizations. Answer lines 3a and 3b below.

Did the organization have the power to regularly appoint or elect a majority of the officers, directors, or trustees of each of the supported organizations?If "Yes" or "No", provide details in Part VI.

Did the organization exercise a substantial degree of direction over the policies, programs and activities of each of its supported organizations? If "Yes," describe in Part VI. the role played by the organization in this regard.

Schedule A (Form 990 or 990-EZ) 2020

Page 6

Part V

Type III Non-Functionally Integrated 509(a)(3) Supporting Organizations

Check here if the organization satisfied the Integral Part Test as a qualifying trust on Nov. 20, 1970 (explain in Part VI). See instructions. All other Type III non-functionally integrated supporting organizations must complete Sections A through E.

	Section A - Adjusted Net Income		(A) Prior Year	(B) Current Year (optional)
1	Net short-term capital gain	1
2	Recoveries of prior-year distributions	2
3	Other gross income (see instructions)	3
4	Add lines 1 through 3	4
5	Depreciation and depletion	5
6	Portion of operating expenses paid or incurred for production or collection of gross income or for management, conservation, or maintenance of property held for production of income (see instructions)	6
7	Other expenses (see instructions)	7
8	Adjusted Net Income (subtract lines 5, 6 and 7 from line 4)	8

	Section B - Minimum Asset Amount		(A) Prior Year	(B) Current Year (optional)
1	Aggregate fair market value of all non-exempt-use assets (see instructions for short tax year or assets held for part of year):	1
a	Average monthly value of securities	1a
b	Average monthly cash balances	1b
c	Fair market value of other non-exempt-use assets	1c
d	Total (add lines 1a, 1b, and 1c)	1d
e	Discount claimed for blockage or other factors (explain in detail in Part VI):
2	Acquisition indebtedness applicable to non-exempt use assets	2
3	Subtract line 2 from line 1d	3
4	Cash deemed held for exempt use. Enter 0.015 of line 3 (for greater amount, see instructions).	4
5	Net value of non-exempt-use assets (subtract line 4 from line 3)	5
6	Multiply line 5 by 0.035	6
7	Recoveries of prior-year distributions	7
8	Minimum Asset Amount (add line 7 to line 6)	8

	Section C - Distributable Amount		Current Year
1	Adjusted net income for prior year (from Section A, line 8, Column A)	1
2	Enter 85% of line 1	2
3	Minimum asset amount for prior year (from Section B, line 8, Column A)	3
4	Enter greater of line 2 or line 3	4
5	Income tax imposed in prior year	5
6	Distributable Amount. Subtract line 5 from line 4, unless subject to emergency temporary reduction (see instructions)	6

Check here if the current year is the organization's first as a non-functionally-integrated Type III supporting organization (see instructions)

Schedule A (Form 990 or 990-EZ) 2020

Page 7

Part V

Type III Non-Functionally Integrated 509(a)(3) Supporting Organizations(continued)

Section D - Distributions		Current Year
1 Amounts paid to supported organizations to accomplish exempt purposes	1
2 Amounts paid to perform activity that directly furthers exempt purposes of supported organizations, in excess of income from activity	2
3 Administrative expenses paid to accomplish exempt purposes of supported organizations	3
4 Amounts paid to acquire exempt-use assets	4
5 Qualified set-aside amounts (prior IRS approval required - provide details in Part VI)	5
6 Other distributions (describe in Part VI). See instructions	6
7Total annual distributions. Add lines 1 through 6.	7
8 Distributions to attentive supported organizations to which the organization is responsive (provide details in Part VI). See instructions	8
9 Distributable amount for 2020 from Section C, line 6	9
10 Line 8 amount divided by Line 9 amount	10

Section E - Distribution Allocations (see instructions)		(i) Excess Distributions	(ii) Underdistributions Pre-2020	(iii) Distributable Amount for 2020
1 Distributable amount for 2020 from Section C, line 6
2 Underdistributions, if any, for years prior to 2019 (reasonable cause required-- explain in Part VI). See instructions.
3 Excess distributions carryover, if any, to 2020:
a From 2015.......
b From 2016.......
c From 2017.......
d From 2018.......
e From 2019.......
fTotal of lines 3a through e
g Applied to underdistributions of prior years
h Applied to 2020 distributable amount
i Carryover from 2015 not applied (see instructions)
j Remainder. Subtract lines 3g, 3h, and 3i from line 3f.
4Distributions for 2020 from Section D, line 7:
$
a Applied to underdistributions of prior years
b Applied to 2020 distributable amount
c Remainder. Subtract lines 4a and 4b from line 4.
5 Remaining underdistributions for years prior to 2020, if any. Subtract lines 3g and 4a from line 2. If the amount is greater than zero, explain in Part VI. See instructions.
6 Remaining underdistributions for 2020. Subtract lines 3h and 4b from line 1. If the amount is greater than zero, explain in Part VI. See instructions.
7 Excess distributions carryover to 2021. Add lines 3j and 4c.
8 Breakdown of line 7:
a Excess from 2016.....
b Excess from 2017.....
c Excess from 2018.....
d Excess from 2019.....
e Excess from 2020.....

Schedule A (Form 990 or 990-EZ) (2020)

Schedule A (Form 990 or 990-EZ) 2020

Page 8

Part VI

Supplemental Information. Provide the explanations required by Part II, line 10; Part II, line 17a or 17b; Part III, line 12; Part IV, Section A, lines 1, 2, 3b, 3c, 4b, 4c, 5a, 6, 9a, 9b, 9c, 11a, 11b, and 11c; Part IV, Section B, lines 1 and 2; Part IV, Section C, line 1; Part IV, Section D, lines 2 and 3; Part IV, Section E, lines 1c, 2a, 2b, 3a and 3b; Part V, line 1; Part V, Section B, line 1e; Part V Section D, lines 5, 6, and 8; and Part V, Section E, lines 2, 5, and 6. Also complete this part for any additional information. (See instructions).

Facts And Circumstances Test

Return Reference	Explanation

Schedule A (Form 990 or 990-EZ) 2020

Additional Data

Software ID:
Software Version:

- TIN:

Schedule B
(Form 990, 990-EZ,
or 990-PF)

Department of the Treasury
Internal Revenue Service

Schedule of Contributors

Attach to Form 990, 990-EZ, or 990-PF.

Go to www.irs.gov/Form990 for the latest information.

OMB No. 1545-0047

2020

Name of the organization

PATH

Employer identification number

91-1157127

Organization type (check one):

Filers of:

Section:

Form 990 or 990-EZ

501(c)( ) (enter number) organization

4947(a)(1) nonexempt charitable trust not treated as a private foundation

527 political organization

Form 990-PF

501(c)(3) exempt private foundation

4947(a)(1) nonexempt charitable trust treated as a private foundation

501(c)(3) taxable private foundation

Check if your organization is covered by the General Rule or a Special Rule.
Note: Only a section 501(c)(7), (8), or (10) organization can check boxes for both the General Rule and a Special Rule. See instructions.

General Rule

For an organization filing Form 990, 990-EZ, or 990-PF that received, during the year, contributions totaling $5,000 or more (in money or other property) from any one contributor. Complete Parts I and II. See instructions for determining a contributor's total contributions.

Special Rules

For an organization described in section 501(c)(3) filing Form 990 or 990-EZ that met the 33¹/3% support test of the regulations
under sections 509(a)(1) and 170(b)(1)(A)(vi), that checked Schedule A (Form 990 or 990-EZ), Part II, line 13, 16a, or 16b, and that received from any one contributor, during the year, total contributions of the greater of (1) $5,000 or (2) 2% of the amount on (i) Form 990, Part VIII, line 1h, or (ii) Form 990-EZ, line 1. Complete Parts I and II.

For an organization described in section 501(c)(7), (8), or (10) filing Form 990 or 990-EZ that received from any one contributor,
during the year, total contributions of more than $1,000 exclusively for religious, charitable, scientific, literary, or educational purposes, or for the prevention of cruelty to children or animals. Complete Parts I, II, and III.

For an organization described in section 501(c)(7), (8), or (10) filing Form 990 or 990-EZ that received from any one contributor,
during the year, contributions exclusively for religious, charitable, etc., purposes, but no such contributions totaled more than $1,000. If this box is checked, enter here the total contributions that were received during the year for an exclusively religious, charitable, etc., purpose. Don't complete any of the parts unless the General Rule applies to this organization because it received nonexclusively religious, charitable, etc., contributions totaling $5,000 or more during the year ......... Arrow Bullet

Caution: An organization that isn't covered by the General Rule and/or the Special Rules doesn't file Schedule B (Form 990,
990-EZ, or 990-PF), but it must answer “No” on Part IV, line 2, of its Form 990; or check the box on line H of its Form 990-EZ
or on its Form 990PF, Part I, line 2, to certify that it doesn't meet the filing requirements of Schedule B (Form 990,
990-EZ, or 990-PF).

For Paperwork Reduction Act Notice, see the Instructions
for Form 990, 990-EZ, or 990-PF.

Cat. No. 30613XSchedule B (Form 990, 990-EZ, or 990-PF) (2020)

Schedule B (Form 990, 990-EZ, or 990-PF) (2020) Page 2

Name of organization PATH

Part I Contributors	Contributors (see instructions). Use duplicate copies of Part I if additional space is needed.
(a) No.	(b) Name, address, and ZIP + 4	(c) Total contributions	(d) Type of contribution
RESTRICTED	,	$ RESTRICTED	Person Payroll Noncash (Complete Part II for noncash contributions.)
(a) No.	(b) Name, address, and ZIP + 4	(c) Total contributions	(d) Type of contribution
		$	Person Payroll Noncash (Complete Part II for noncash contributions.)
(a) No.	(b) Name, address, and ZIP + 4	(c) Total contributions	(d) Type of contribution
		$	Person Payroll Noncash (Complete Part II for noncash contributions.)
(a) No.	(b) Name, address, and ZIP + 4	(c) Total contributions	(d) Type of contribution
		$	Person Payroll Noncash (Complete Part II for noncash contributions.)
(a) No.	(b) Name, address, and ZIP + 4	(c) Total contributions	(d) Type of contribution
		$	Person Payroll Noncash (Complete Part II for noncash contributions.)
(a) No.	(b) Name, address, and ZIP + 4	(c) Total contributions	(d) Type of contribution
		$	Person Payroll Noncash (Complete Part II for noncash contributions.)
Schedule B (Form 990, 990-EZ, or 990-PF) (2020)

Schedule B (Form 990, 990-EZ, or 990-PF) (2020)

Page 3

Name of organization PATH		Employer identification number 91-1157127

Part II	Noncash Property (see instructions). Use duplicate copies of Part II if additional space is needed.
(a) No. from Part I	(b) Description of noncash property given	(c) FMV (or estimate) (See instructions)	(d) Date received
		$
(a) No. from Part I	(b) Description of noncash property given	(c) FMV (or estimate) (See instructions)	(d) Date received
		$
(a) No. from Part I	(b) Description of noncash property given	(c) FMV (or estimate) (See instructions)	(d) Date received
		$
(a) No. from Part I	(b) Description of noncash property given	(c) FMV (or estimate) (See instructions)	(d) Date received
		$
(a) No. from Part I	(b) Description of noncash property given	(c) FMV (or estimate) (See instructions)	(d) Date received
		$
(a) No. from Part I	(b) Description of noncash property given	(c) FMV (or estimate) (See instructions)	(d) Date received
		$
Schedule B (Form 990, 990-EZ, or 990-PF) (2020)

Schedule B (Form 990, 990-EZ, or 990-PF) (2020)

Page 4


Name of organization PATH			Employer identification number 91-1157127
Part III Exclusively religious, charitable, etc., contributions to organizations described in section 501(c)(7), (8), or (10) that total more than $1,000 for the year from any one contributor. Complete columns (a) through (e) and the following line entry. For organizations completing Part III, enter the total of exclusively religious, charitable, etc., contributions of $1,000 or less for the year. (Enter this information once. See instructions.) $ Use duplicate copies of Part III if additional space is needed.

(a)
No. from Part I

(b) Purpose of gift

(d) Description of how gift is held

(e) Transfer of gift
Transferee's name, address, and ZIP 4	Relationship of transferor to transferee

(a)
No. from Part I

(b) Purpose of gift

(d) Description of how gift is held

(e) Transfer of gift
Transferee's name, address, and ZIP 4	Relationship of transferor to transferee

(a)
No. from Part I

(b) Purpose of gift

(d) Description of how gift is held

(e) Transfer of gift
Transferee's name, address, and ZIP 4	Relationship of transferor to transferee

(a)
No. from Part I

(b) Purpose of gift

(d) Description of how gift is held

(e) Transfer of gift
Transferee's name, address, and ZIP 4	Relationship of transferor to transferee

Schedule B (Form 990, 990-EZ, or 990-PF) (2020)

Additional Data

Software ID:
Software Version:

- TIN:

SCHEDULE C
(Form 990 or 990-EZ)

Department of the Treasury
Internal Revenue Service

Political Campaign and Lobbying Activities

For Organizations Exempt From Income Tax Under section 501(c) and section 527

SchCMd Bullet

Complete if the organization is described below. SchCMd Bullet

Attach to Form 990 or Form 990-EZ.
SchCMd Bullet

Go to www.irs.gov/Form990 for instructions and the latest information.

OMB No. 1545-0047

2020

Open to Public
Inspection

If the organization answered "Yes" on Form 990, Part IV, Line 3, or Form 990-EZ, Part V, line 46 (Political Campaign Activities), then
Round Bullet

Section 501(c)(3) organizations: Complete Parts I-A and B. Do not complete Part I-C.
Round Bullet

Section 501(c) (other than section 501(c)(3)) organizations: Complete Parts I-A and C below. Do not complete Part I-B.
Round Bullet

Section 527 organizations: Complete Part I-A only.
If the organization answered "Yes" on Form 990, Part IV, Line 4, or Form 990-EZ, Part VI, line 47 (Lobbying Activities), then
Round Bullet

Section 501(c)(3) organizations that have filed Form 5768 (election under section 501(h)): Complete Part II-A. Do not complete Part II-B.
Round Bullet

Section 501(c)(3) organizations that have NOT filed Form 5768 (election under section 501(h)): Complete Part II-B. Do not complete Part II-A.
If the organization answered "Yes" on Form 990, Part IV, Line 5 (Proxy Tax) (see separate instructions) or Form 990-EZ, Part V, line 35c (Proxy Tax) (see separate instructions), then
Round Bullet

Section 501(c)(4), (5), or (6) organizations: Complete Part III.

Name of the organization

PATH

Employer identification number

91-1157127

Part I-A

Complete if the organization is exempt under section 501(c) or is a section 527 organization.

Provide a description of the organization’s direct and indirect political campaign activities in Part IV (see instructions for definition of “political campaign activities")

Political campaign activity expenditures (see instructions) .................................................................... SchCMd Bullet

Volunteer hours for political campaign activities (see instructions) ..................................................................

Part I-B

Complete if the organization is exempt under section 501(c)(3).

Enter the amount of any excise tax incurred by the organization under section 4955 ................................ SchCMd Bullet

Enter the amount of any excise tax incurred by organization managers under section 4955 ....................... SchCMd Bullet

If the organization incurred a section 4955 tax, did it file Form 4720 for this year? .........................................

Yes No

Was a correction made? ......................................................................................................................

Yes No

If "Yes," describe in Part IV.

Part I-C

Complete if the organization is exempt under section 501(c), except section 501(c)(3).

Enter the amount directly expended by the filing organization for section 527 exempt function activities ..... SchCMd Bullet

Enter the amount of the filing organization's funds contributed to other organizations for section 527 exempt function activities ............................................................................................................................ SchCMd Bullet

Total exempt function expenditures. Add lines 1 and 2. Enter here and on Form 1120-POL, line 17b........... SchCMd Bullet

Did the filing organization file Form 1120-POL for this year? ...................................................................

Yes No

Enter the names, addresses and employer identification number (EIN) of all section 527 political organizations to which the filing
organization made payments. For each organization listed, enter the amount paid from the filing organization’s funds. Also enter the amount of political contributions received that were promptly and directly delivered to a separate political organization, such as a separate segregated fund or a political action committee (PAC). If additional space is needed, provide information in Part IV.

(a) Name	(b) Address	(c) EIN	(d) Amount paid from filing organization's funds. If none, enter -0-.	(e) Amount of political contributions received and promptly and directly delivered to a separate political organization. If none, enter -0-.
1
2
3
4
5
6

For Paperwork Reduction Act Notice, see the instructions for Form 990 or 990-EZ.

Cat. No. 50084S

Schedule C (Form 990 or 990-EZ) 2020

Page 2

Part II-A

Complete if the organization is exempt under section 501(c)(3) and filed Form 5768 (election under section 501(h)).

A Check SchCMd Bullet

if the filing organization belongs to an affiliated group (and list in Part IV each affiliated group member's name, address, EIN, expenses, and share of excess lobbying expenditures).
B Check SchCMd Bullet

if the filing organization checked box A and "limited control" provisions apply.

Limits on Lobbying Expenditures (The term "expenditures" means amounts paid or incurred.)		(a) Filing organization's totals	(b) Affiliated group totals
1a	Total lobbying expenditures to influence public opinion (grass roots lobbying) ......................	405
b	Total lobbying expenditures to influence a legislative body (direct lobbying) ........................	134,788
c	Total lobbying expenditures (add lines 1a and 1b) ............................................................	135,193
d	Other exempt purpose expenditures ...............................................................................	292,924,290
e	Total exempt purpose expenditures (add lines 1c and 1d) ..................................................	293,059,483
f	Lobbying nontaxable amount. Enter the amount from the following table in both columns.	1,000,000
	If the amount on line 1e, column (a) or (b) is:The lobbying nontaxable amount is:
	Not over $500,00020% of the amount on line 1e.
	Over $500,000 but not over $1,000,000$100,000 plus 15% of the excess over $500,000.
	Over $1,000,000 but not over $1,500,000$175,000 plus 10% of the excess over $1,000,000.
	Over $1,500,000 but not over $17,000,000$225,000 plus 5% of the excess over $1,500,000.
	Over $17,000,000$1,000,000.

g	Grassroots nontaxable amount (enter 25% of line 1f) .................................................	250,000
h	Subtract line 1g from line 1a. If zero or less, enter -0-. ................................................	0
i	Subtract line 1f from line 1c. If zero or less, enter -0-. ................................................	0
j	If there is an amount other than zero on either line 1h or line 1i, did the organization file Form 4720 reporting section 4911 tax for this year? ...................................................................................................................		Yes No

4-Year Averaging Period Under Section 501(h) (Some organizations that made a section 501(h) election do not have to complete all of the five columns below. See the separate instructions for lines 2a through 2f.)
Lobbying Expenditures During 4-Year Averaging Period
	Calendar year (or fiscal year beginning in)	(a) 2017	(b) 2018	(c) 2019	(d) 2020	(e) Total

2a	Lobbying nontaxable amount	1,000,000	1,000,000	1,000,000	1,000,000	4,000,000

b	Lobbying ceiling amount (150% of line 2a, column(e))					6,000,000

c	Total lobbying expenditures	294,096	224,944	163,912	135,193	818,145

d	Grassroots nontaxable amount	250,000	250,000	250,000	250,000	1,000,000

e	Grassroots ceiling amount (150% of line 2d, column (e))					1,500,000

f	Grassroots lobbying expenditures	127,336	7,856		405	135,597

Schedule C (Form 990 or 990-EZ) 2020

Page 3

Part II-B

Complete if the organization is exempt under section 501(c)(3) and has NOT filed Form 5768 (election under section 501(h)).

For each "Yes" response on lines 1a through 1i below, provide in Part IV a detailed description of the lobbying activity.

(a)

Yes|No

(b)

Amount

During the year, did the filing organization attempt to influence foreign, national, state or local legislation, including any attempt to influence public opinion on a legislative matter or referendum, through the use of:

Volunteers? ...........................................................................................................

Paid staff or management (include compensation in expenses reported on lines 1c through 1i)? ........

Media advertisements? ...................................................................................................

Mailings to members, legislators, or the public? .............................................................................

Publications, or published or broadcast statements? ...........................................................

Grants to other organizations for lobbying purposes? ..........................................................

Direct contact with legislators, their staffs, government officials, or a legislative body? .......................

Rallies, demonstrations, seminars, conventions, speeches, lectures, or any similar means? ..................

Other activities? ...................................................................................................................

Total. Add lines 1c through 1i ....................................................................................................

Did the activities in line 1 cause the organization to be not described in section 501(c)(3)? .....

If "Yes," enter the amount of any tax incurred under section 4912 ...........................................

If "Yes," enter the amount of any tax incurred by organization managers under section 4912 ...................

If the filing organization incurred a section 4912 tax, did it file Form 4720 for this year? ........................

Part III-A

Complete if the organization is exempt under section 501(c)(4), section 501(c)(5), or section 501(c)(6).

Yes

Were substantially all (90% or more) dues received nondeductible by members? ...............................................

Did the organization make only in-house lobbying expenditures of $2,000 or less? ............................................

Did the organization agree to carry over lobbying and political expenditures from the prior year? .................................

Part III-B

Complete if the organization is exempt under section 501(c)(4), section 501(c)(5), or section 501(c)(6) and if either (a) BOTH Part III-A, lines 1 and 2, are answered "No" OR (b) Part III-A, line 3, is answered “Yes."

Dues, assessments and similar amounts from members ......................................................................

Section 162(e) nondeductible lobbying and political expenditures (do not include amounts of political expenses for which the section 527(f) tax was paid).

Current year .............................................................................................................................

Carryover from last year ............................................................................................................

Total ...........................................................................................................................................

Aggregate amount reported in section 6033(e)(1)(A) notices of nondeductible section 162(e) dues .

If notices were sent and the amount on line 2c exceeds the amount on line 3, what portion of the excess does the organization agree to carryover to the reasonable estimate of nondeductible lobbying and political expenditure next year? ......................................................................................................................

Taxable amount of lobbying and political expenditures (see instructions) .........................................

Part IV

Supplemental Information

Provide the descriptions required for Part l-A, line 1; Part l-B, line 4; Part l-C, line 5; Part II-A (affiliated group list); Part II-A, lines 1 and 2 (see instructions), and Part ll-B, line 1. Also, complete this part for any additional information.

Return Reference	Explanation

Schedule C (Form 990 or 990EZ) 2020

Additional Data

Software ID:
Software Version:

- TIN:

SCHEDULE D
(Form 990)

Department of the Treasury
Internal Revenue Service

Supplemental Financial Statements

Complete if the organization answered "Yes," on Form 990,
Part IV, line 6, 7, 8, 9, 10, 11a, 11b, 11c, 11d, 11e, 11f, 12a, or 12b.
SchDMd Bullet

Attach to Form 990.
SchDMd Bullet

Go to www.irs.gov/Form990 for instructions and the latest information.

OMB No. 1545-0047

2020

Open to Public Inspection

Name of the organization

PATH

Employer identification number

91-1157127

Part I

Organizations Maintaining Donor Advised Funds or Other Similar Funds or Accounts. Complete if the organization answered "Yes" on Form 990, Part IV, line 6.

		(a) Donor advised funds	(b) Funds and other accounts
1	Total number at end of year .........
2	Aggregate value of contributions to (during year)
3	Aggregate value of grants from (during year)
4	Aggregate value at end of year ........

Did the organization inform all donors and donor advisors in writing that the assets held in donor advised funds are the organization’s property, subject to the organization’s exclusive legal control? ............

Yes No

Did the organization inform all grantees, donors, and donor advisors in writing that grant funds can be used only for charitable purposes and not for the benefit of the donor or donor advisor, or for any other purpose conferring impermissible private benefit? ...................................

Yes No

Part II

Conservation Easements.
Complete if the organization answered "Yes" on Form 990, Part IV, line 7.

Purpose(s) of conservation easements held by the organization (check all that apply).

Preservation of land for public use (e.g., recreation or education) Preservation of an historically important land area

Protection of natural habitat Preservation of a certified historic structure

Preservation of open space

Complete lines 2a through 2d if the organization held a qualified conservation contribution in the form of a conservation easement on the last day of the tax year.


a	Total number of conservation easements ......................	2a
b	Total acreage restricted by conservation easements ....................	2b
c	Number of conservation easements on a certified historic structure included in (a) .....	2c
d	Number of conservation easements included in (c) acquired after 7/25/06, and not on a historic structure listed in the National Register ...	2d

Number of conservation easements modified, transferred, released, extinguished, or terminated by the organization during the
tax year SchDMd Bullet

Number of states where property subject to conservation easement is located SchDMd Bullet

Does the organization have a written policy regarding the periodic monitoring, inspection, handling of violations, and enforcement of the conservation easements it holds? ............

Yes No

Staff and volunteer hours devoted to monitoring, inspecting, handling of violations, and enforcing conservation easements during the year
SchDMd Bullet

Amount of expenses incurred in monitoring, inspecting, handling of violations, and enforcing conservation easements during the year
SchDMd Bullet

Does each conservation easement reported on line 2(d) above satisfy the requirements of section 170(h)(4)(B)(i) and section 170(h)(4)(B)(ii)? .............................

Yes No

In Part XIII, describe how the organization reports conservation easements in its revenue and expense statement, and
balance sheet, and include, if applicable, the text of the footnote to the organization’s financial statements that describes
the organization’s accounting for conservation easements.

Part III

Organizations Maintaining Collections of Art, Historical Treasures, or Other Similar Assets.
Complete if the organization answered "Yes" on Form 990, Part IV, line 8.

If the organization elected, as permitted under FASB ASC 958, not to report in its revenue statement and balance sheet works of art, historical treasures, or other similar assets held for public exhibition, education, or research in furtherance of public service, provide, in Part XIII, the text of the footnote to its financial statements that describes these items.

If the organization elected, as permitted under FASB ASC 958, to report in its revenue statement and balance sheet works of art, historical treasures, or other similar assets held for public exhibition, education, or research in furtherance of public service, provide the following amounts relating to these items:

(i)

Revenue included on Form 990, Part VIII, line 1 ......................... SchDMd Bullet

(ii)

Assets included in Form 990, Part X ............................... SchDMd Bullet

If the organization received or held works of art, historical treasures, or other similar assets for financial gain, provide the
following amounts required to be reported under FASB ASC 958 relating to these items:

Revenue included on Form 990, Part VIII, line 1 .......................... SchDMd Bullet

Assets included in Form 990, Part X ............................... SchDMd Bullet

For Paperwork Reduction Act Notice, see the Instructions for Form 990.

Cat. No. 52283D

Schedule D (Form 990) 2020

Page 2

Part III

Organizations Maintaining Collections of Art, Historical Treasures, or Other Similar Assets (continued)

Using the organization’s acquisition, accession, and other records, check any of the following that are a significant use of its collection items (check all that apply):

Public exhibition

Loan or exchange programs

Scholarly research

Other

Preservation for future generations

Provide a description of the organization’s collections and explain how they further the organization’s exempt purpose in
Part XIII.

During the year, did the organization solicit or receive donations of art, historical treasures or other similar
assets to be sold to raise funds rather than to be maintained as part of the organization’s collection?...

Yes No

Part IV

Escrow and Custodial Arrangements. Complete if the organization answered "Yes" on Form 990, Part IV, line 9, or reported an amount on Form 990, Part X, line 21.

Is the organization an agent, trustee, custodian or other intermediary for contributions or other assets not
included on Form 990, Part X? ....................................

Yes No


b	If "Yes," explain the arrangement in Part XIII and complete the following table:		Amount
c	Beginning balance .............................	1c
d	Additions during the year ............................	1d
e	Distributions during the year ..........................	1e
f	Ending balance ................................	1f

Did the organization include an amount on Form 990, Part X, line 21, for escrow or custodial account liability? ...

Yes No

If "Yes," explain the arrangement in Part XIII. Check here if the explanation has been provided in Part XIII ....

Part V

Endowment Funds.
Complete if the organization answered "Yes" on Form 990, Part IV, line 10.

		(a) Current year	(b) Prior year	(c) Two years back	(d) Three years back	(e) Four years back

1a	Beginning of year balance ....	10,287,113	9,095,917	10,056,545	9,339,249	8,897,224
b	Contributions ...	2,745	2,100	1,240	3,410	4,256
c	Net investment earnings, gains, and losses	1,095,576	1,691,617	-494,491	1,159,282	907,978
d	Grants or scholarships ...
e	Other expenditures for facilities and programs ...	454,711	502,521	467,377	445,396	470,209
f	Administrative expenses ....
g	End of year balance ......	10,930,723	10,287,113	9,095,917	10,056,545	9,339,249

Provide the estimated percentage of the current year end balance (line 1g, column (a)) held as:

Board designated or quasi-endowment SchDMd Bullet

36.000 %

Permanent endowment SchDMd Bullet

31.000 %

Term endowment SchDMd Bullet

33.000 %

The percentages on lines 2a, 2b, and 2c should equal 100%.

Are there endowment funds not in the possession of the organization that are held and administered for the
organization by:

Yes

(i) Unrelated organizations .......................

3a(i)

(ii) Related organizations .......................

3a(ii)

If "Yes" on 3a(ii), are the related organizations listed as required on Schedule R? .........

Describe in Part XIII the intended uses of the organization's endowment funds.

Part VI

Land, Buildings, and Equipment.
Complete if the organization answered "Yes" on Form 990, Part IV, line 11a. See Form 990, Part X, line 10.

Description of property		(a) Cost or other basis (investment)	(b) Cost or other basis (other)	(c) Accumulated depreciation	(d) Book value

1a	Land .....
b	Buildings ....
c	Leasehold improvements	22,350,295	15,697,322	6,652,973
d	Equipment ....	10,509,124	8,976,229	1,532,895
e	Other .....	5,253,369	5,025,934	227,435
Total. Add lines 1a through 1e. (Column (d) must equal Form 990, Part X, column (B), line 10(c).)..				8,413,303

Schedule D (Form 990) 2020

Page 3

Part VII

Investments - Other Securities.
Complete if the organization answered "Yes" on Form 990, Part IV, line 11b. See Form 990, Part X, line 12.

(a) Description of security or category (including name of security)	(b) Book value	(c) Method of valuation: Cost or end-of-year market value
(1) Financial derivatives.........
(2) Closely-held equity interests........
(3)Other
(B)
(C)
(D)
(E)
(F)
(G)
(H)
(I)
Total. (Column (b) must equal Form 990, Part X, col. (B) line 12.)

Part VIII

Investments - Program Related. Complete if the organization answered 'Yes' on Form 990, Part IV, line 11c. See Form 990, Part X, line 13.

(a) Description of investment	(b) Book value	(c) Method of valuation: Cost or end-of-year market value

(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
Total. (Column (b) must equal Form 990, Part X, col.(B) line 13.)

Part IX

Other Assets.
Complete if the organization answered 'Yes' on Form 990, Part IV, line 11d. See Form 990, Part X, line 15.

(a) Description				(b) Book value

(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
Total. (Column (b) must equal Form 990, Part X, col.(B) line 15.)...........

Part X

Other Liabilities.
Complete if the organization answered 'Yes' on Form 990, Part IV, line 11e or 11f. See Form 990, Part X, line 25.

1.(a) Description of liability	(b) Book value
(1) Federal income taxes

(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
Total. (Column (b) must equal Form 990, Part X, col.(B) line 25.)
2. Liability for uncertain tax positions. In Part XIII, provide the text of the footnote to the organization's financial statements that reports the organization's liability for uncertain tax positions under FIN 48 (ASC 740). Check here if the text of the footnote has been provided in Part XIII

Schedule D (Form 990) 2020

Page 4

Part XI Reconciliation of Revenue per Audited Financial Statements With Revenue per Return. Complete if the organization answered 'Yes' on Form 990, Part IV, line 12a.
1	Total revenue, gains, and other support per audited financial statements .......		1
2	Amounts included on line 1 but not on Form 990, Part VIII, line 12:
a	Net unrealized gains (losses) on investments ....	2a
b	Donated services and use of facilities .........	2b
c	Recoveries of prior year grants ...........	2c
d	Other (Describe in Part XIII.) ............	2d
e	Add lines 2a through 2d .....................		2e
3	Subtract line 2e from line 1..................		3
4	Amounts included on Form 990, Part VIII, line 12, but not on line 1:
a	Investment expenses not included on Form 990, Part VIII, line 7b .	4a
b	Other (Describe in Part XIII.) ...........	4b
c	Add lines 4a and 4b....................		4c
5	Total revenue. Add lines 3 and 4c. (This must equal Form 990, Part I, line 12.) ......		5

Part XII Reconciliation of Expenses per Audited Financial Statements With Expenses per Return. Complete if the organization answered 'Yes' on Form 990, Part IV, line 12a.
1	Total expenses and losses per audited financial statements ...........		1
2	Amounts included on line 1 but not on Form 990, Part IX, line 25:
a	Donated services and use of facilities .........	2a
b	Prior year adjustments ............	2b
c	Other losses ................	2c
d	Other (Describe in Part XIII.) ............	2d
e	Add lines 2a through 2d....................		2e
3	Subtract line 2e from line 1...................		3
4	Amounts included on Form 990, Part IX, line 25, but not on line 1:
a	Investment expenses not included on Form 990, Part VIII, line 7b ..	4a
b	Other (Describe in Part XIII.) ............	4b
c	Add lines 4a and 4b.....................		4c
5	Total expenses. Add lines 3 and 4c. (This must equal Form 990, Part I, line 18.) ......		5

Part XIII

Supplemental Information

Provide the descriptions required for Part II, lines 3, 5, and 9; Part III, lines 1a and 4; Part lV, lines 1b and 2b; Part V, line 4; Part X, line 2; Part XI, lines 2d and 4b; and Part XII, lines 2d and 4b. Also complete this part to provide any additional information.

Return Reference	Explanation
PART V, LINE 4:	PATH UTILIZES THE INVESTED INTREST EARNINGS FROM THE ENDOWMENT AS AN IMPORTANT FUNDING SOURCE TO FUND NEW OPPORTUNITIES TO EXPAND ITS REACH AND IMPACT AS AN ORGANIZATION IN THE FIELD OF GLOBAL HEALTH, IN ACCORDANCE WITH PATH'S ENDOWMENT SPENDING POLICY.

Schedule D (Form 990) 2020

Additional Data

Software ID:
Software Version:

- TIN:

SCHEDULE F(Form 990)

Department of the Treasury
Internal Revenue Service

Statement of Activities Outside the United States

Complete if the organization answered "Yes" to Form 990, Part IV, line 14b, 15, or 16. Right pointing arrow large image

Attach to Form 990. Right pointing arrow large image

Go to www.irs.gov/Form990 for instructions and the latest information.

OMB No. 1545-0047

2020

Open to Public Inspection

Name of the organization
PATH

Employer identification number

91-1157127

Part I

General Information on Activities Outside the United States. Complete if the organization answered "Yes" on Form 990, Part IV, line 14b.

For grantmakers. Does the organization maintain records to substantiate the amount of its grants and

other assistance, the grantees’ eligibility for the grants or assistance, and the selection criteria used

to award the grants or assistance? . . . . . . . . . . . . . . . . . . . . . . . . .

Yes

For grantmakers. Describe in Part V the organization’s procedures for monitoring the use of its grants and other assistance outside the United States.

Activites per Region. (The following Part I, line 3 table can be duplicated if additional space is needed.)

(a) Region		(b) Number of offices in the region	(c) Number of employees, agents, and independent contractors in the region	(d) Activities conducted in region (by type) (such as, fundraising, program services, investments, grants to recipients located in the region)	(e) If activity listed in (d) is a program service, describe specific type of service(s) in the region	(f) Total expenditures for and investments in the region
	CENTRAL AMERICA AND THE CARIBBEAN	0	0	MANAGEMENT & GENERAL	MANAGEMENT & GENERAL	3,972,740
	CENTRAL AMERICA AND THE CARIBBEAN	0	0	PROGRAM SERVICES	GLOBAL HEALTH PROGRAM	223,997
	CENTRAL AMERICA AND THE CARIBBEAN	0	0	PROGRAM SERVICES	ESSENTIAL MEDICINE	71,241
	CENTRAL AMERICA AND THE CARIBBEAN	0	0	PROGRAM SERVICES	TECHNOLOGY, ANALYTICS AND MARKET INNOVATION	282,879
	CENTRAL AMERICA AND THE CARIBBEAN	0	0	PROGRAM SERVICES	OTHER	18,974
	CENTRAL AMERICA AND THE CARIBBEAN	0	0	BID & PROPOSAL	BID & PROPOSAL	17,083
	CENTRAL AMERICA AND THE CARIBBEAN	0	0	FUNDRAISING	FUNDRAISING	88,125
	CENTRAL AMERICA AND THE CARIBBEAN	0	0	GRANTMAKING		101,723
	EAST ASIA AND THE PACIFIC	5	110	MANAGEMENT & GENERAL	MANAGEMENT & GENERAL	1,168,919
	EAST ASIA AND THE PACIFIC	0	0	PROGRAM SERVICES	GLOBAL HEALTH PROGRAM	6,333,906
	EAST ASIA AND THE PACIFIC	0	0	PROGRAM SERVICES	ESSENTIAL MEDICINE	298,774
	EAST ASIA AND THE PACIFIC	0	0	PROGRAM SERVICES	TECHNOLOGY, ANALYTICS AND MARKET INNOVATION	253,294
	EAST ASIA AND THE PACIFIC	0	0	BID & PROPOSAL	BID & PROPOSAL	62,526
	EAST ASIA AND THE PACIFIC	0	0	PROGRAM SERVICES	OTHER	40,996
	EAST ASIA AND THE PACIFIC	0	0	FUNDRAISING	FUNDRAISING	2,700
	EAST ASIA AND THE PACIFIC	0	0	GRANTMAKING		10,343,468
	EUROPE	1	4	MANAGEMENT & GENERAL	MANAGEMENT & GENERAL	1,574,825
	EUROPE	0	0	PROGRAM SERVICES	GLOBAL HEALTH PROGRAM	3,336,671
	EUROPE	0	0	PROGRAM SERVICES	ESSENTIAL MEDICINE	7,675,989
	EUROPE	0	0	PROGRAM SERVICES	TECHNOLOGY, ANALYTICS AND MARKET INNOVATION	1,469,697
	EUROPE	0	0	PROGRAM SERVICES	OTHER	48,919
	EUROPE	0	0	BID & PROPOSAL	BID & PROPOSAL	4,900
	EUROPE	0	0	GRANTMAKING		23,791,380
	MIDDLE EAST AND NORTH AFRICA	0	0	PROGRAM SERVICES	GLOBAL HEALTH PROGRAM	3,238
	NORTH AMERICA	0	0	MANAGEMENT & GENERAL	MANAGEMENT & GENERAL	74,544
	NORTH AMERICA	0	0	PROGRAM SERVICES	GLOBAL HEALTH PROGRAM	188,511
	NORTH AMERICA	0	0	PROGRAM SERVICES	ESSENTIAL MEDICINE	1,164,008
	NORTH AMERICA	0	0	PROGRAM SERVICES	TECHNOLOGY, ANALYTICS AND MARKET INNOVATION	8,008
	NORTH AMERICA	0	0	PROGRAM SERVICES	OTHER	15,896
	NORTH AMERICA	0	0	FUNDRAISING	FUNDRAISING	4,595
	NORTH AMERICA	0	0	GRANTMAKING		383,489
	RUSSIA AND NEIGHBORING STATES	1	25	MANAGEMENT & GENERAL	MANAGEMENT & GENERAL	457,221
	RUSSIA AND NEIGHBORING STATES	0	0	PROGRAM SERVICES	GLOBAL HEALTH PROGRAM	3,283,227
	RUSSIA AND NEIGHBORING STATES	0	0	PROGRAM SERVICES	ESSENTIAL MEDICINE	1,590
	RUSSIA AND NEIGHBORING STATES	0	0	PROGRAM SERVICES	TECHNOLOGY, ANALYTICS AND MARKET INNOVATION	3,950
	RUSSIA AND NEIGHBORING STATES	0	0	PROGRAM SERVICES	OTHER	12
	RUSSIA AND NEIGHBORING STATES	0	0	BID & PROPOSAL	BID & PROPOSAL	1,150
	RUSSIA AND NEIGHBORING STATES	0	0	GRANTMAKING		1,556,551
	SOUTH AMERICA	1	3	MANAGEMENT & GENERAL	MANAGEMENT & GENERAL	46,002
	SOUTH AMERICA	0	0	PROGRAM SERVICES	GLOBAL HEALTH PROGRAM	274,890
	SOUTH AMERICA	0	0	PROGRAM SERVICES	ESSENTIAL MEDICINE	7,574
	SOUTH AMERICA	0	0	PROGRAM SERVICES	TECHNOLOGY, ANALYTICS AND MARKET INNOVATION	60,715
	SOUTH AMERICA	0	0	PROGRAM SERVICES	OTHER	1,340
	SOUTH AMERICA	0	0	BID & PROPOSAL	BID & PROPOSAL	339
	SOUTH AMERICA	0	0	GRANTMAKING		219,648
	SOUTH ASIA	6	133	MANAGEMENT & GENERAL	MANAGEMENT & GENERAL	2,234,260
	SOUTH ASIA	0	0	PROGRAM SERVICES	GLOBAL HEALTH PROGRAM	4,834,839
	SOUTH ASIA	0	0	PROGRAM SERVICES	ESSENTIAL MEDICINE	1,496,048
	SOUTH ASIA	0	0	PROGRAM SERVICES	TECHNOLOGY, ANALYTICS AND MARKET INNOVATION	435,904
	SOUTH ASIA	0	0	PROGRAM SERVICES	OTHER	4,000
	SOUTH ASIA	0	0	BID & PROPOSAL	BID & PROPOSAL	51,747
	SOUTH ASIA	0	0	GRANTMAKING		2,491,733
	SUB-SAHARAN AFRICA	43	621	MANAGEMENT & GENERAL	MANAGEMENT & GENERAL	7,301,830
	SUB-SAHARAN AFRICA	0	0	PROGRAM SERVICES	GLOBAL HEALTH PROGRAM	40,342,367
	SUB-SAHARAN AFRICA	0	0	PROGRAM SERVICES	ESSENTIAL MEDICINE	2,110,189
	SUB-SAHARAN AFRICA	0	0	PROGRAM SERVICES	TECHNOLOGY, ANALYTICS AND MARKET INNOVATION	2,250,189
	SUB-SAHARAN AFRICA	0	0	PROGRAM SERVICES	OTHER	2,228,030
	SUB-SAHARAN AFRICA	0	0	BID & PROPOSAL	BID & PROPOSAL	206,210
	SUB-SAHARAN AFRICA	0	0	GRANTMAKING		9,298,586
3a	Sub-total ....	0	0			4,776,762
b	Total from continuation sheets to Part I ...	57	896			139,449,394
c	Totals (add lines 3a and 3b)	57	896			144,226,156

For Paperwork Reduction Act Notice, see the Instructions for Form 990.Cat. No. 50082W Schedule F (Form 990) 2020

Schedule F (Form 990) 2020

Page 2

Part II

Grants and Other Assistance to Organizations or Entities Outside the United States. Complete if the organization answered "Yes" on Form 990, Part IV, line 15, for any recipient who received more than $5,000. Part II can be duplicated if additional space is needed.

(c) Region	(d) Purpose of grant	(e) Amount of cash grant	(f) Manner of cash disbursement
CENTRAL AMERICA AND THE CARIBBEAN	GLOBAL HEALTH PROGRAMS	26,270	CHECK/WIRE
CENTRAL AMERICA AND THE CARIBBEAN	GLOBAL HEALTH PROGRAMS	45,720	CHECK/WIRE
CENTRAL AMERICA AND THE CARIBBEAN	GLOBAL HEALTH PROGRAMS	29,733	CHECK/WIRE
EAST ASIA AND THE PACIFIC	GLOBAL HEALTH PROGRAMS	40,314	CHECK/WIRE
EAST ASIA AND THE PACIFIC	GLOBAL HEALTH PROGRAMS	27,468	CHECK/WIRE
EAST ASIA AND THE PACIFIC	GLOBAL HEALTH PROGRAMS	37,301	CHECK/WIRE
EAST ASIA AND THE PACIFIC	ESSENTIAL MEDICINE	1,101,162	CHECK/WIRE
EAST ASIA AND THE PACIFIC	GLOBAL HEALTH PROGRAMS	41,367	CHECK/WIRE
EAST ASIA AND THE PACIFIC	TECHNOLOGY ANALYTICS AND MARKET INNOVATIONS	88,615	CHECK/WIRE
EAST ASIA AND THE PACIFIC	GLOBAL HEALTH PROGRAMS	103,203	CHECK/WIRE
EAST ASIA AND THE PACIFIC	GLOBAL HEALTH PROGRAMS	21,619	CHECK/WIRE
EAST ASIA AND THE PACIFIC	GLOBAL HEALTH PROGRAMS	236,201	CHECK/WIRE
EAST ASIA AND THE PACIFIC	GLOBAL HEALTH PROGRAMS	36,707	CHECK/WIRE
EAST ASIA AND THE PACIFIC	GLOBAL HEALTH PROGRAMS	150,857	CHECK/WIRE
EAST ASIA AND THE PACIFIC	GLOBAL HEALTH PROGRAMS	7,196	CHECK/WIRE
EAST ASIA AND THE PACIFIC	GLOBAL HEALTH PROGRAMS	17,892	CHECK/WIRE
EAST ASIA AND THE PACIFIC	ESSENTIAL MEDICINE	248,606	CHECK/WIRE
EAST ASIA AND THE PACIFIC	GLOBAL HEALTH PROGRAMS	40,822	CHECK/WIRE
EAST ASIA AND THE PACIFIC	GLOBAL HEALTH PROGRAMS	40,286	CHECK/WIRE
EAST ASIA AND THE PACIFIC	ESSENTIAL MEDICINE	14,241	CHECK/WIRE
EAST ASIA AND THE PACIFIC	ESSENTIAL MEDICINE	167,362	CHECK/WIRE
EAST ASIA AND THE PACIFIC	TECHNOLOGY ANALYTICS AND MARKET INNOVATIONS	89,721	CHECK/WIRE
EAST ASIA AND THE PACIFIC	GLOBAL HEALTH PROGRAMS	122,878	CHECK/WIRE
EAST ASIA AND THE PACIFIC	GLOBAL HEALTH PROGRAMS	74,096	CHECK/WIRE
EAST ASIA AND THE PACIFIC	ESSENTIAL MEDICINE	51,839	CHECK/WIRE
EAST ASIA AND THE PACIFIC	GLOBAL HEALTH PROGRAMS	81,635	CHECK/WIRE
EAST ASIA AND THE PACIFIC	GLOBAL HEALTH PROGRAMS	122,963	CHECK/WIRE
EAST ASIA AND THE PACIFIC	ESSENTIAL MEDICINE	6,022,820	CHECK/WIRE
EAST ASIA AND THE PACIFIC	GLOBAL HEALTH PROGRAMS	17,200	CHECK/WIRE
EAST ASIA AND THE PACIFIC	GLOBAL HEALTH PROGRAMS	133,107	CHECK/WIRE
EAST ASIA AND THE PACIFIC	TECHNOLOGY ANALYTICS AND MARKET INNOVATIONS	90,043	CHECK/WIRE
EAST ASIA AND THE PACIFIC	ESSENTIAL MEDICINE	572,600	CHECK/WIRE
EAST ASIA AND THE PACIFIC	GLOBAL HEALTH PROGRAMS	175,178	CHECK/WIRE
EAST ASIA AND THE PACIFIC	GLOBAL HEALTH PROGRAMS	247,758	CHECK/WIRE
EAST ASIA AND THE PACIFIC	GLOBAL HEALTH PROGRAMS	12,162	CHECK/WIRE
EAST ASIA AND THE PACIFIC	GLOBAL HEALTH PROGRAMS	29,370	CHECK/WIRE
EAST ASIA AND THE PACIFIC	ESSENTIAL MEDICINE	20,000	CHECK/WIRE
EAST ASIA AND THE PACIFIC	GLOBAL HEALTH PROGRAMS	25,962	CHECK/WIRE
EAST ASIA AND THE PACIFIC	GLOBAL HEALTH PROGRAMS	28,454	CHECK/WIRE
EUROPE	GLOBAL HEALTH PROGRAMS	732,113	CHECK/WIRE
EUROPE	TECHNOLOGY ANALYTICS AND MARKET INNOVATIONS	179,882	CHECK/WIRE
EUROPE	ESSENTIAL MEDICINE	446,581	CHECK/WIRE
EUROPE	GLOBAL HEALTH PROGRAMS	286,668	CHECK/WIRE
EUROPE	GLOBAL HEALTH PROGRAMS	9,377	CHECK/WIRE
EUROPE	ESSENTIAL MEDICINE	1,921,597	CHECK/WIRE
EUROPE	ESSENTIAL MEDICINE	36,965	CHECK/WIRE
EUROPE	GLOBAL HEALTH PROGRAMS	29,264	CHECK/WIRE
EUROPE	ESSENTIAL MEDICINE	891,713	CHECK/WIRE
EUROPE	ESSENTIAL MEDICINE	6,572,907	CHECK/WIRE
EUROPE	GLOBAL HEALTH PROGRAMS	14,025	CHECK/WIRE
EUROPE	TECHNOLOGY ANALYTICS AND MARKET INNOVATIONS	257,454	CHECK/WIRE
EUROPE	TECHNOLOGY ANALYTICS AND MARKET INNOVATIONS	21,720	CHECK/WIRE
EUROPE	GLOBAL HEALTH PROGRAMS	20,018	CHECK/WIRE
EUROPE	TECHNOLOGY ANALYTICS AND MARKET INNOVATIONS	235,172	CHECK/WIRE
EUROPE	ESSENTIAL MEDICINE	834,665	CHECK/WIRE
EUROPE	TECHNOLOGY ANALYTICS AND MARKET INNOVATIONS	16,465	CHECK/WIRE
EUROPE	ESSENTIAL MEDICINE	108,000	CHECK/WIRE
EUROPE	GLOBAL HEALTH PROGRAMS	5,475	CHECK/WIRE
EUROPE	TECHNOLOGY ANALYTICS AND MARKET INNOVATIONS	923,552	CHECK/WIRE
EUROPE	GLOBAL HEALTH PROGRAMS	1,038,048	CHECK/WIRE
EUROPE	GLOBAL HEALTH PROGRAMS	85,046	CHECK/WIRE
EUROPE	ESSENTIAL MEDICINE	52,330	CHECK/WIRE
EUROPE	ESSENTIAL MEDICINE	15,820	CHECK/WIRE
EUROPE	ESSENTIAL MEDICINE	200,378	CHECK/WIRE
EUROPE	ESSENTIAL MEDICINE	375,000	CHECK/WIRE
EUROPE	GLOBAL HEALTH PROGRAMS	3,748,324	CHECK/WIRE
EUROPE	TECHNOLOGY ANALYTICS AND MARKET INNOVATIONS	23,132	CHECK/WIRE
EUROPE	GLOBAL HEALTH PROGRAMS	93,845	CHECK/WIRE
EUROPE	ESSENTIAL MEDICINE	80,877	CHECK/WIRE
EUROPE	ESSENTIAL MEDICINE, GLOBAL HEALTH PROGRAMS, TECHNOLOGY ANALYTICS AND MARKET INNOVATIONS, AND OTHER	4,534,968	CHECK/WIRE
NORTH AMERICA	ESSENTIAL MEDICINE	123,207	CHECK/WIRE
NORTH AMERICA	GLOBAL HEALTH PROGRAMS	25,000	CHECK/WIRE
NORTH AMERICA	ESSENTIAL MEDICINE	88,141	CHECK/WIRE
NORTH AMERICA	TECHNOLOGY ANALYTICS AND MARKET INNOVATIONS	147,141	CHECK/WIRE
RUSSIA AND NEIGHBORING STATES	GLOBAL HEALTH PROGRAMS	24,863	CHECK/WIRE
RUSSIA AND NEIGHBORING STATES	GLOBAL HEALTH PROGRAMS	44,978	CHECK/WIRE
RUSSIA AND NEIGHBORING STATES	GLOBAL HEALTH PROGRAMS	13,118	CHECK/WIRE
RUSSIA AND NEIGHBORING STATES	GLOBAL HEALTH PROGRAMS	7,300	CHECK/WIRE
RUSSIA AND NEIGHBORING STATES	GLOBAL HEALTH PROGRAMS	67,764	CHECK/WIRE
RUSSIA AND NEIGHBORING STATES	GLOBAL HEALTH PROGRAMS	18,856	CHECK/WIRE
RUSSIA AND NEIGHBORING STATES	GLOBAL HEALTH PROGRAMS	61,591	CHECK/WIRE
RUSSIA AND NEIGHBORING STATES	GLOBAL HEALTH PROGRAMS	14,589	CHECK/WIRE
RUSSIA AND NEIGHBORING STATES	GLOBAL HEALTH PROGRAMS	75,073	CHECK/WIRE
RUSSIA AND NEIGHBORING STATES	GLOBAL HEALTH PROGRAMS	17,646	CHECK/WIRE
RUSSIA AND NEIGHBORING STATES	GLOBAL HEALTH PROGRAMS	430,980	CHECK/WIRE
RUSSIA AND NEIGHBORING STATES	GLOBAL HEALTH PROGRAMS	18,758	CHECK/WIRE
RUSSIA AND NEIGHBORING STATES	GLOBAL HEALTH PROGRAMS	22,231	CHECK/WIRE
RUSSIA AND NEIGHBORING STATES	GLOBAL HEALTH PROGRAMS	65,868	CHECK/WIRE
RUSSIA AND NEIGHBORING STATES	GLOBAL HEALTH PROGRAMS	15,353	CHECK/WIRE
RUSSIA AND NEIGHBORING STATES	GLOBAL HEALTH PROGRAMS	30,681	CHECK/WIRE
RUSSIA AND NEIGHBORING STATES	GLOBAL HEALTH PROGRAMS	32,256	CHECK/WIRE
RUSSIA AND NEIGHBORING STATES	GLOBAL HEALTH PROGRAMS	33,427	CHECK/WIRE
RUSSIA AND NEIGHBORING STATES	GLOBAL HEALTH PROGRAMS	114,951	CHECK/WIRE
RUSSIA AND NEIGHBORING STATES	GLOBAL HEALTH PROGRAMS	149,600	CHECK/WIRE
RUSSIA AND NEIGHBORING STATES	GLOBAL HEALTH PROGRAMS	58,055	CHECK/WIRE
RUSSIA AND NEIGHBORING STATES	GLOBAL HEALTH PROGRAMS	72,813	CHECK/WIRE
RUSSIA AND NEIGHBORING STATES	GLOBAL HEALTH PROGRAMS	9,762	CHECK/WIRE
RUSSIA AND NEIGHBORING STATES	GLOBAL HEALTH PROGRAMS	104,693	CHECK/WIRE
RUSSIA AND NEIGHBORING STATES	GLOBAL HEALTH PROGRAMS	23,730	CHECK/WIRE
RUSSIA AND NEIGHBORING STATES	GLOBAL HEALTH PROGRAMS	24,210	CHECK/WIRE
SOUTH AMERICA	GLOBAL HEALTH PROGRAMS	108,625	CHECK/WIRE
SOUTH AMERICA	GLOBAL HEALTH PROGRAMS	10,816	CHECK/WIRE
SOUTH AMERICA	TECHNOLOGY ANALYTICS AND MARKET INNOVATIONS	16,445	CHECK/WIRE
SOUTH AMERICA	GLOBAL HEALTH PROGRAMS	83,762	CHECK/WIRE
SOUTH ASIA	GLOBAL HEALTH PROGRAMS	175,937	CHECK/WIRE
SOUTH ASIA	TECHNOLOGY ANALYTICS AND MARKET INNOVATIONS	7,801	CHECK/WIRE
SOUTH ASIA	GLOBAL HEALTH PROGRAMS	285,788	CHECK/WIRE
SOUTH ASIA	GLOBAL HEALTH PROGRAMS	55,019	CHECK/WIRE
SOUTH ASIA	GLOBAL HEALTH PROGRAMS	87,424	CHECK/WIRE
SOUTH ASIA	GLOBAL HEALTH PROGRAMS	38,652	CHECK/WIRE
SOUTH ASIA	TECHNOLOGY ANALYTICS AND MARKET INNOVATIONS	24,470	CHECK/WIRE
SOUTH ASIA	ESSENTIAL MEDICINE	296,153	CHECK/WIRE
SOUTH ASIA	TECHNOLOGY ANALYTICS AND MARKET INNOVATIONS	137,360	CHECK/WIRE
SOUTH ASIA	GLOBAL HEALTH PROGRAMS	165,311	CHECK/WIRE
SOUTH ASIA	ESSENTIAL MEDICINE	79,111	CHECK/WIRE
SOUTH ASIA	ESSENTIAL MEDICINE	989,230	CHECK/WIRE
SOUTH ASIA	ESSENTIAL MEDICINE	84,312	CHECK/WIRE
SOUTH ASIA	ESSENTIAL MEDICINE	65,165	CHECK/WIRE
SUB-SAHARAN AFRICA	GLOBAL HEALTH PROGRAMS	13,911	CHECK/WIRE
SUB-SAHARAN AFRICA	GLOBAL HEALTH PROGRAMS	124,740	CHECK/WIRE
SUB-SAHARAN AFRICA	GLOBAL HEALTH PROGRAMS	104,229	CHECK/WIRE
SUB-SAHARAN AFRICA	GLOBAL HEALTH PROGRAMS	5,046	CHECK/WIRE
SUB-SAHARAN AFRICA	GLOBAL HEALTH PROGRAMS	145,235	CHECK/WIRE
SUB-SAHARAN AFRICA	GLOBAL HEALTH PROGRAMS	46,437	CHECK/WIRE
SUB-SAHARAN AFRICA	GLOBAL HEALTH PROGRAMS	26,070	CHECK/WIRE
SUB-SAHARAN AFRICA	ESSENTIAL MEDICINE	1,616,490	CHECK/WIRE
SUB-SAHARAN AFRICA	GLOBAL HEALTH PROGRAMS	21,305	CHECK/WIRE
SUB-SAHARAN AFRICA	OTHER	6,582	CHECK/WIRE
SUB-SAHARAN AFRICA	GLOBAL HEALTH PROGRAMS	21,615	CHECK/WIRE
SUB-SAHARAN AFRICA	ESSENTIAL MEDICINE	1,009,409	CHECK/WIRE
SUB-SAHARAN AFRICA	ESSENTIAL MEDICINE	820,924	CHECK/WIRE
SUB-SAHARAN AFRICA	TECHNOLOGY ANALYTICS AND MARKET INNOVATIONS	139,523	CHECK/WIRE
SUB-SAHARAN AFRICA	GLOBAL HEALTH PROGRAMS	437,058	CHECK/WIRE
SUB-SAHARAN AFRICA	TECHNOLOGY ANALYTICS AND MARKET INNOVATIONS	33,819	CHECK/WIRE
SUB-SAHARAN AFRICA	GLOBAL HEALTH PROGRAMS	37,762	CHECK/WIRE
SUB-SAHARAN AFRICA	GLOBAL HEALTH PROGRAMS	98,022	CHECK/WIRE
SUB-SAHARAN AFRICA	GLOBAL HEALTH PROGRAMS	26,585	CHECK/WIRE
SUB-SAHARAN AFRICA	GLOBAL HEALTH PROGRAMS	13,210	CHECK/WIRE
SUB-SAHARAN AFRICA	GLOBAL HEALTH PROGRAMS	25,791	CHECK/WIRE
SUB-SAHARAN AFRICA	GLOBAL HEALTH PROGRAMS	226,644	CHECK/WIRE
SUB-SAHARAN AFRICA	TECHNOLOGY ANALYTICS AND MARKET INNOVATIONS	12,000	CHECK/WIRE
SUB-SAHARAN AFRICA	ESSENTIAL MEDICINE	314,600	CHECK/WIRE
SUB-SAHARAN AFRICA	TECHNOLOGY ANALYTICS AND MARKET INNOVATIONS	54,880	CHECK/WIRE
SUB-SAHARAN AFRICA	GLOBAL HEALTH PROGRAMS	12,911	CHECK/WIRE
SUB-SAHARAN AFRICA	GLOBAL HEALTH PROGRAMS	6,720	CHECK/WIRE
SUB-SAHARAN AFRICA	OTHER	14,480	CHECK/WIRE
SUB-SAHARAN AFRICA	TECHNOLOGY ANALYTICS AND MARKET INNOVATIONS	125,404	CHECK/WIRE
SUB-SAHARAN AFRICA	ESSENTIAL MEDICINE	208,292	CHECK/WIRE
SUB-SAHARAN AFRICA	GLOBAL HEALTH PROGRAMS AND TECHNOLOGY ANALYTICS AND MARKET INNOVATIONS	39,725	CHECK/WIRE
SUB-SAHARAN AFRICA	GLOBAL HEALTH PROGRAMS	217,405	CHECK/WIRE
SUB-SAHARAN AFRICA	GLOBAL HEALTH PROGRAMS	184,370	CHECK/WIRE
SUB-SAHARAN AFRICA	GLOBAL HEALTH PROGRAMS	6,883	CHECK/WIRE
SUB-SAHARAN AFRICA	GLOBAL HEALTH PROGRAMS	134,626	CHECK/WIRE
SUB-SAHARAN AFRICA	GLOBAL HEALTH PROGRAMS AND OTHER	47,900	CHECK/WIRE
SUB-SAHARAN AFRICA	TECHNOLOGY ANALYTICS AND MARKET INNOVATIONS	57,658	CHECK/WIRE
SUB-SAHARAN AFRICA	GLOBAL HEALTH PROGRAMS	69,703	CHECK/WIRE
SUB-SAHARAN AFRICA	ESSENTIAL MEDICINE	439,709	CHECK/WIRE
SUB-SAHARAN AFRICA	OTHER	8,659	CHECK/WIRE
SUB-SAHARAN AFRICA	GLOBAL HEALTH PROGRAMS	18,450	CHECK/WIRE
SUB-SAHARAN AFRICA	GLOBAL HEALTH PROGRAMS	50,069	CHECK/WIRE
SUB-SAHARAN AFRICA	GLOBAL HEALTH PROGRAMS	6,286	CHECK/WIRE
SUB-SAHARAN AFRICA	GLOBAL HEALTH PROGRAMS	6,271	CHECK/WIRE
SUB-SAHARAN AFRICA	GLOBAL HEALTH PROGRAMS	5,350	CHECK/WIRE
SUB-SAHARAN AFRICA	ESSENTIAL MEDICINE	450,000	CHECK/WIRE
SUB-SAHARAN AFRICA	GLOBAL HEALTH PROGRAMS	8,343	CHECK/WIRE
SUB-SAHARAN AFRICA	GLOBAL HEALTH PROGRAMS	83,928	CHECK/WIRE
SUB-SAHARAN AFRICA	GLOBAL HEALTH PROGRAMS	45,130	CHECK/WIRE
SUB-SAHARAN AFRICA	TECHNOLOGY ANALYTICS AND MARKET INNOVATIONS	8,795	CHECK/WIRE
SUB-SAHARAN AFRICA	GLOBAL HEALTH PROGRAMS	6,134	CHECK/WIRE
SUB-SAHARAN AFRICA	GLOBAL HEALTH PROGRAMS	5,787	CHECK/WIRE
SUB-SAHARAN AFRICA	GLOBAL HEALTH PROGRAMS	67,892	CHECK/WIRE
SUB-SAHARAN AFRICA	ESSENTIAL MEDICINE	20,000	CHECK/WIRE
SUB-SAHARAN AFRICA	TECHNOLOGY ANALYTICS AND MARKET INNOVATIONS	211,644	CHECK/WIRE
SUB-SAHARAN AFRICA	GLOBAL HEALTH PROGRAMS	7,344	CHECK/WIRE
SUB-SAHARAN AFRICA	GLOBAL HEALTH PROGRAMS	807,930	CHECK/WIRE
SUB-SAHARAN AFRICA	ESSENTIAL MEDICINE	426,057	CHECK/WIRE
SUB-SAHARAN AFRICA	GLOBAL HEALTH PROGRAMS	58,129	CHECK/WIRE
SUB-SAHARAN AFRICA	GLOBAL HEALTH PROGRAMS	7,558	CHECK/WIRE
SUB-SAHARAN AFRICA	GLOBAL HEALTH PROGRAMS	8,775	CHECK/WIRE
SUB-SAHARAN AFRICA	GLOBAL HEALTH PROGRAMS	19,052	CHECK/WIRE

2	Enter total number of recipient organizations listed above that are recognized as charities by the foreign country, recognized as tax-exempt by the IRS, or for which the grantee or counsel has provided a section 501(c)(3) equivalency letter .......	139
3	Enter total number of other organizations or entities .......................	41

Schedule F (Form 990) 2020

Schedule F (Form 990) 2020Page 3

Part III

Grants and Other Assistance to Individuals Outside the United States. Complete if the organization answered "Yes" on Form 990, Part IV, line 16.

Part III can be duplicated if additional space is needed.

(a) Type of grant or assistance		(b) Region	(c) Number of recipients	(d) Amount of cash grant	(e) Manner of cash disbursement	(f) Amount of noncash assistance	(g) Description of noncash assistance	(h) Method of valuation (book, FMV, appraisal, other)

Schedule F (Form 990) 2020

Page 4

Part IV

Foreign Forms

Schedule F (Form 990) 2020

Page 5

Part V

Supplemental Information
Provide the information required by Part I, line 2 (monitoring of funds); Part I, line 3, column (f) (accounting method; amounts of investments vs. expenditures per region); Part II, line 1 (accounting method); Part III (accounting method); and Part III, column (c) (estimated number of recipients), as applicable. Also complete this part to provide any additional information. See instructions.

ReturnReference	Explanation
PART I, LINE 2:	PATH HAS A SUBRECIPIENT POLICY AND PROCEDURES IN PLACE TO GUIDE THE WAY OUR PROJECT TEAMS MONITOR SUBRECIPIENTS. THIS INCLUDES BOTH FINANCIAL AND TECHNICAL MONITORING. PATH USES RISK ASSESSMENTS, REPORTING, SITE VISITS, REGULAR CONTACT, AND OTHER MEANS TO PROVIDE THE MONITORING REQUIRED BY FUNDERS AND TO ENSURE GOOD PROJECT STEWARDSHIP. THESE ACTIVITIES ALSO PROVIDE RESPONSIBLE ASSURANCE THAT THE SUBRECIPIENT ADMINISTERS FUNDS IN COMPLIANCE WITH LAWS, REGULATIONS, AND PRIME AWARD TERMS AND ACHIEVES PERFORMANCE GOALS. PATH HAS ESTABLISHED COMPREHENSIVE POLICIES AND PROCEDURES TO PROMOTE BEST BUSINESS PRACTICES AND ENSURE EFFICIENT AND EFFECTIVE INTERNAL CONTROL. THESE ARE COMBINED WITH AN INTERNAL AUDIT FUNCTION THROUGH WHICH PATH CONDUCTS AUDITS ON GRANT-FUNDED PROGRAMS TO ENSURE COMPLIANCE WITH REGULATORY REQUIREMENTS.
PART III ACCOUNTING METHOD:

Schedule F (Form 990) 2020

Additional Data

Software ID:
Software Version:

- TIN:

Note: To capture the full content of this document, please select landscape mode (11" x 8.5") when printing.

Schedule I
(Form 990)

Department of the Treasury
Internal Revenue Service

Grants and Other Assistance to Organizations,
Governments and Individuals in the United States

Complete if the organization answered "Yes," on Form 990, Part IV, line 21 or 22.
lBullet

Attach to Form 990.
lBullet

Go to www.irs.gov/Form990 for the latest information.

OMB No. 1545-0047

2020

Open to Public
Inspection

Name of the organization
PATH

Employer identification number
91-1157127

Part I

General Information on Grants and Assistance

Does the organization maintain records to substantiate the amount of the grants or assistance, the grantees' eligibility for the grants or assistance, and
the selection criteria used to award the grants or assistance? ........................

Yes No

Describe in Part IV the organization's procedures for monitoring the use of grant funds in the United States.

Part II

Grants and Other Assistance to Domestic Organizations and Domestic Governments. Complete if the organization answered "Yes" on Form 990, Part IV, line 21, for any recipient

that received more than $5,000. Part II can be duplicated if additional space is needed.

(a) Name and address of organization or government	(b) EIN	(c) IRC section (if applicable)	(d) Amount of cash grant	(h) Purpose of grant or assistance
(1) ADARA DEVELOPMENT (USA) 300 ADMIRAL WY SUITE 106 EDMONDS,WA98020	98-0634789	501(C)(3)	14,499	TECHNOLOGY ANALYTICS AND MARKET INNOVATIONS
(2) BAGAMIAN SCIENTIFIC CONSULTING 222 NW 3RD AVE GAINESVILLE,FL32601	82-1347380	OTHER	24,350	ESSENTIAL MEDICINE
(3) BEHAVIORAL IDEAS LAB INC (DBA IDEAS42) 80 BROAD STREET 30TH FLOOR NEW YORK,NY10004	27-1678009	501(C)(3)	85,721	GLOBAL HEALTH PROGRAMS
(4) BIOIVT LLC 123 FROST ST STE 115 WESTBURY,NY11590	27-1867431	OTHER	38,950	TECHNOLOGY ANALYTICS AND MARKET INNOVATIONS
(5) CENTERS FOR DISEASE CONTROL AND PREVENTION 1600 CLIFTON ROAD ATLANTA,GA30333	58-6051157	GOV	71,016	ESSENTIAL MEDICINE
(6) CHILDREN'S HOSPITAL BOSTON RESEARCH FINANCE PO BOX 414413 BOSTON,MA022414413	04-2774441	501(C)(3)	599,612	ESSENTIAL MEDICINE
(7) CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER 3333 BURNET AVE ML 6014 CINCINNATI,OH452293039	31-0833936	501(C)(3)	407,166	ESSENTIAL MEDICINE
(8) CLINTON HEALTH ACCESS INITIATIVE 383 DORCHESTER AVE SUITE 400 BOSTON,MA02127	27-1414646	501(C)(3)	2,624,024	TECHNOLOGY ANALYTICS AND MARKET INNOVATIONS
(9) COOPERSMITH 4206 RIVER RD NW WASHINGTON,DC20016	47-2387850	OTHER	116,315	GLOBAL HEALTH PROGRAMS
(10) DIMAGI INC 585 MASSACHUSETTS AVE SUITE 4 CAMBRIDGE,MA02139	83-0343298	501(C)(3)	40,477	GLOBAL HEALTH PROGRAMS
(11) FINA BIOSOLUTIONS LLC 9430 KEY WEST AVE SUITE 200 ROCKVILLE,MD20850	20-5448275	OTHER	217,000	ESSENTIAL MEDICINE
(12) FOOD AND DRUG ADMINISTRATION 5600 FISHERS LANEHFA-140 ROOM 11-40 11-40 ROCKVILLE,MD20857	53-0196965	GOV	103,750	ESSENTIAL MEDICINE
(13) FRED HUTCHINSON CANCER RESEARCH CENTER 1100 FAIRVIEW AVE N PO BOX 19024 SEATTLE,WA981091024	23-7156071	501(C)(3)	26,177	TECHNOLOGY ANALYTICS AND MARKET INNOVATIONS
(14) G&L SCIENTIFIC INC 25 INDEPENDENCE BLVD SUITE 404 WARREN,NJ07059	81-1114075	OTHER	8,185	TECHNOLOGY ANALYTICS AND MARKET INNOVATIONS
(15) GLOBAL CONNECT DEVELOPMENT GROUP LLC 480 BEACH ST BOSTON,MA02131	82-3433604	OTHER	71,525	GLOBAL HEALTH PROGRAMS
(16) GLOBAL HEALTH CORPS 318 WEST 39TH STREET ROOM 9L NEW YORK,NY10018	80-0512336	501(C)(3)	6,045	GLOBAL HEALTH PROGRAMS
(17) GLOBAL HEALTH STRATEGIES LLC 27 WEST 24TH STREET SUITE 900 NEW YORK,NY10010	27-2494697	501(C)(3)	280,713	TECHNOLOGY ANALYTICS AND MARKET INNOVATIONS
(18) GUARALDI SYSTEMS LLC 97 ALGER BROOK RD SOUTH STAFFORD,VT05070	85-1148274	OTHER	117,040	GLOBAL HEALTH PROGRAMS
(19) HARVARD SCHOOL OF PUBLIC HEALTH 677 HUNTINGTON AVENUE BOSTON,MA02215	04-2103580	501(C)(3)	691,653	ESSENTIAL MEDICINE
(20) HARVARD UNIVERSITY 1033 MASSACHUSETTS AVE 2ND FLOOR CAMBRIDGE,MA02115	04-2103580	501(C)(3)	165,466	ESSENTIAL MEDICINE AND GLOBAL HEALTH PROGRAMS
(21) HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE INC 6720-A ROCKLEDGE DRIVE STE 100 BETHESDA,MD20817	52-1317896	501(C)(3)	69,910	ESSENTIAL MEDICINE
(22) HISP US LLC 31 ANCONA AVE OCEAN PARK,ME04063	85-0894858	OTHER	121,924	GLOBAL HEALTH PROGRAMS
(23) HJF MEDICAL RESEARCH INTERNATIONAL INC 6720A ROCKLEDGE DRIVE SUITE 100 BETHESDA,MD20817	52-2322791	501(C)(3)	815,715	ESSENTIAL MEDICINE
(24) ICF MACRO INC 9300 LEE HIGHWAY FAIRFAX,VA22031	22-3661438	OTHER	1,432,031	GLOBAL HEALTH PROGRAMS
(25) INTERNATIONAL FOOD POLICY RESEARCH INSTITUTE ( IFPRI ) 1201 EYE STREET NW WASHINGTON,DC20005	52-1041632	501(C)(3)	118,841	GLOBAL HEALTH PROGRAMS
(26) INTRAHEALTH INTERNATIONAL INC 6340 QUADRANGLE DRIVE SUITE 200 CHAPEL HILL,NC27517	55-0825466	501(C)(3)	490,617	GLOBAL HEALTH PROGRAMS
(27) IPAS 300 MARKET ST 200 CHAPEL HILL,NC27516	56-1071085	501(C)(3)	20,000	GLOBAL HEALTH PROGRAMS
(28) JHPIEGO 1615 THAMES STREET SUITE 200 BALTIMORE,MD212313447	23-7424444	501(C)(3)	59,904	GLOBAL HEALTH PROGRAMS
(29) JOHNS HOPKINS UNIVERSITY BLOOMBERG SCHL OF PUB HLTH 615 N WOLFE STREET BALTIMORE,MD21205	52-0595110	501(C)(3)	47,858	GLOBAL HEALTH PROGRAMS
(30) JSI RESEARCH AND TRAINING INSTITUTE INC 1616 NORTH FORT MYER DR 16TH FLOOR ARLINGTON,VA222093100	04-2679824	501(C)(3)	1,101,159	GLOBAL HEALTH PROGRAMS
(31) LINKSBRIDGE SPC 101 TAYLOR AVE N 105 SEATTLE,WA98109	26-3067893	OTHER	57,926	ESSENTIAL MEDICINE
(32) MAGEE-WOMENS RESEARCH INSTITUTE AND FOUNDATION 3339 WARD ST PITTSBURGH,PA15213	25-1462312	501(C)(3)	13,300	TECHNOLOGY ANALYTICS AND MARKET INNOVATIONS
(33) MANAGEMENT SCIENCES FOR HEALTH INC 200 RIVERS EDGE DRIVE SUITE 320 MEDFORD,MA02155	04-2482188	501(C)(3)	60,827	GLOBAL HEALTH PROGRAMS
(34) MASS DESIGN GROUP LTD 334 BOYLSTON ST STE 400 BOSTON,MA02116	61-1659704	501(C)(3)	50,000	GLOBAL HEALTH PROGRAMS
(35) MASSACHUSETTS GENERAL HOSPITAL DEPT OF EMERGENCY MEDICINE ZERO EMERSON PL 104 BOSTON,MA02114	04-1564655	501(C)(3)	236,406	ESSENTIAL MEDICINE
(36) MASSACHUSETTS INSTITUTE OF TECHNOLOGY 77 MASSACHUSETTS AVENUE CAMBRIDGE,MA02139	04-2103594	501(C)(3)	20,443	ESSENTIAL MEDICINE
(37) MEDIC MOBILE INC 3254 19TH STREET FLOOR 2 SAN FRANCISCO,CA94110	27-5104203	501(C)(3)	31,647	GLOBAL HEALTH PROGRAMS
(38) MICHIGAN STATE UNIVERSITY 3900 COLLINS RD SUITE 1044 LANSING,MI48910	38-6005984	501(C)(3)	132,399	TECHNOLOGY ANALYTICS AND MARKET INNOVATIONS
(39) MICRON BIOMEDICAL INC 311 FERST DR NW SUITE L1309 ATLANTA,GA30332	47-1692844	OTHER	113,633	TECHNOLOGY ANALYTICS AND MARKET INNOVATIONS
(40) NATIONAL FOUNDATION FOR THE CDC 55 PARK PLACE SUITE 400 ATLANTA,GA30303	58-2106707	501(C)(3)	185,563	ESSENTIAL MEDICINE
(41) NAT'L INST OF ALLERGY & INFECTIOUS DISEASES 6610 ROCKLEDGE DR ROOM 2800 BETHESDA,MD208926606	52-0858115	GOV	480,134	ESSENTIAL MEDICINE
(42) NICHOLAS INSTITUTE FOR ENVIRONMENTAL POLICY SOLUTIONS AT DUKE UNIVERSITY 2117 CAMPUS DRIVE PO BOX 90335 DURHAM,NC27708	56-0532129	501(C)(3)	5,418	GLOBAL HEALTH PROGRAMS
(43) ONA SYSTEMS INC 126 E 12TH ST SUITE 4A NEW YORK,NY100035320	38-3940780	OTHER	134,412	GLOBAL HEALTH PROGRAMS
(44) OPENMRS INC 10425 COMMERCE DR STE 110 CARMEL,IN460327643	45-5316647	501(C)(3)	36,768	GLOBAL HEALTH PROGRAMS
(45) PARSYL INC 3963 WALNUT STREET STE 200 DENVER,CO80205	81-4027966	OTHER	8,500	TECHNOLOGY ANALYTICS AND MARKET INNOVATIONS
(46) PATHFINDER INTERNATIONAL 9 GALEN STREET SUITE 217 WATERTOWN,MA02472	53-0235320	501(C)(3)	116,459	GLOBAL HEALTH PROGRAMS
(47) PHARMARON CPC INC 800 W BALTIMORE STREET 5TH FLOOR BALTIMORE,MD21201	20-8419781	OTHER	1,321,003	ESSENTIAL MEDICINE
(48) POPULATION COUNCIL ONE DAG HAMMERKJOLD PLAZA NEW YORK,NY10017	13-1687001	501(C)(3)	127,341	TECHNOLOGY ANALYTICS AND MARKET INNOVATIONS
(49) POPULATION SERVICES INTERNATIONAL INC 1120 19TH ST NW STE 600 WASHINGTON,DC20036	56-0942853	501(C)(3)	268,142	GLOBAL HEALTH PROGRAMS AND TECHNOLOGY ANALYTICS AND MARKET INNOVATIONS
(50) REGENSTRIEF INSTITUTE INC 1101 W 10TH ST INDIANAPOLIS,IN46202	30-0007730	501(C)(3)	57,528	GLOBAL HEALTH PROGRAMS
(51) ROSTROPOVICH-VISHNEVSKAYA FOUNDATION 1776 K STREET NW SUITE 700 WASHINGTON,DC20006	52-1752473	501(C)(3)	58,486	ESSENTIAL MEDICINE
(52) SOLAR ELECTRIC LIGHT FUND 1612 K STREET NW SUITE 300 WASHINGTON,DC20006	52-1701564	501(C)(3)	39,729	TECHNOLOGY ANALYTICS AND MARKET INNOVATIONS
(53) SYSTEMONE LLC 5 BRIDGE STREET SHELBURNE FALLS,MA01370	46-1066795	OTHER	86,525	GLOBAL HEALTH PROGRAMS
(54) TECHCHANGE INC 2001 13TH ST NW 2ND FLOOR WASHINGTON,DC20009	27-3358772	OTHER	321,300	GLOBAL HEALTH PROGRAMS
(55) THE ALBERT B SABIN VACCINE INSTITUTE INC 2175 K STREET NW SUITE 400 WASHINGTON,DC20037	06-1389829	501(C)(3)	50,000	ESSENTIAL MEDICINE
(56) THE NATURE CONSERVANCY 4245 FAIRFAX DRIVE ARLINGTON,VA22203	53-0242652	501(C)(3)	18,500	GLOBAL HEALTH PROGRAMS
(57) THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN FRANCISCO UCSF OFFICE OF SPONSORED RES 3333 CALIFORNIA ST STE 315 SAN FRANCISCO,CA94118	94-6036493	501(C)(3)	182,685	GLOBAL HEALTH PROGRAMS AND TECHNOLOGY ANALYTICS AND MARKET INNOVATIONS
(58) THE STATE UNIVERSITY OF NEW YORK 35 STATE STREET ALBANY,NY122072826	14-1368361	501(C)(3)	155,082	ESSENTIAL MEDICINE
(59) TULANE UNIVERSITY 6823 ST CHARLES AVE NEW ORLEANS,LA70112	72-0423889	501(C)(3)	459,580	ESSENTIAL MEDICINE AND GLOBAL HEALTH PROGRAMS
(60) UNIVERSITY OF ALABAMA GRANTS CONTRACTS ACCOUNTING AB 990 BIRMINGHAM,AL352940109	63-6005396	GOV	85,011	ESSENTIAL MEDICINE
(61) UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL 55 LAKE AVENUE NORTH NORTH WORCESTER,MA01655	04-3167352	GOV	31,089	TECHNOLOGY ANALYTICS AND MARKET INNOVATIONS
(62) UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL CENTER FOR INFECTIOUS DISEASES CHAPEL HILL,NC275993368	56-6001393	501(C)(3)	137,024	GLOBAL HEALTH PROGRAMS
(63) UNIVERSITY OF WASHINGTON GRANT CONTRACT ACCOUNTING 12455 COLLECTIONS DRIVE CHICAGO,IL60693	91-6001537	501(C)(3)	1,542,732	ESSENTIAL MEDICINE, GLOBAL HEALTH PROGRAMS, AND TECHNOLOGY ANALYTICS AND MARKET INNOVATIONS
(64) VILLAGEREACH 2900 EASTLAKE AVE E SUITE 230 SEATTLE,WA981023012	91-2088484	501(C)(3)	256,118	GLOBAL HEALTH PROGRAMS
(65) VITAL STRATEGIES INC 100 BROADWAY 4TH FLOOR NEW YORK,NY10005	22-3419667	501(C)(3)	9,488	GLOBAL HEALTH PROGRAMS
(66) VITAL WAVE INC 555 BRYANT STREET 226 PALO ALTO,CA94301	20-3208079	OTHER	284,978	GLOBAL HEALTH PROGRAMS
(67) WALTER REED ARMY INSTITUTE OF RESEARCH US TREASURY 503 ROBERT GRANT AVE SILVER SPRING,MD20910	52-0664528	GOV	2,487,368	ESSENTIAL MEDICINE
(68) WASHINGTON STATE UNIVERSITY 901 5TH AVE SUITE 2900 SEATTLE,WA98164	91-6001108	GOV	104,777	GLOBAL HEALTH PROGRAMS
(69) PATH VACCINE SOLUTIONS 2201 WESTLAKE AVE SUITE 200 SEATTLE,WA98121	94-3384500	501(C)(3)	46,272	ESSENTIAL MEDICINE, GLOBAL HEALTH PROGRAMS, AND MANAGEMENT

Enter total number of section 501(c)(3) and government organizations listed in the line 1 table ................. Bullet Image

Enter total number of other organizations listed in the line 1 table ........................ . Bullet Image

For Paperwork Reduction Act Notice, see the Instructions for Form 990.

Cat. No. 50055P

Schedule I (Form 990) 2020

Page 2

Part III

Grants and Other Assistance to Domestic Individuals. Complete if the organization answered "Yes" on Form 990, Part IV, line 22.
Part III can be duplicated if additional space is needed.

(a) Type of grant or assistance	(b) Number of recipients	(c) Amount of cash grant	(d) Amount of noncash assistance	(e) Method of valuation (book, FMV, appraisal, other)	(f) Description of noncash assistance
(1)
(2)
(3)
(4)
(5)
(6)
(7)

Part IV

Supplemental Information. Provide the information required in Part I, line 2; Part III, column (b); and any other additional information.

Return Reference

Explanation

PART I, LINE 2:

PATH HAS A SUBRECIPIENT POLICY AND PROCEDURES IN PLACE TO GUIDE THE WAY OUR PROJECT TEAMS MONITOR SUBRECIPIENTS. THIS INCLUDES BOTH FINANCIAL AND TECHNICAL MONITORING. PATH USES RISK ASSESSMENTS, REPORTING, SITE VISITS, REGULAR CONTACT, AND OTHER MEANS TO PROVIDE THE MONITORING REQUIRED BY FUNDERS AND TO ENSURE GOOD PROJECT STEWARDSHIP. THESE ACTIVITIES ALSO PROVIDE RESPONSIBLE ASSURANCE THAT THE SUBRECIPIENT ADMINISTERS FUNDS IN COMPLIANCE WITH LAWS, REGULATIONS, AND PRIME AWARD TERMS AND ACHIEVES PERFORMANCE GOALS. PATH HAS ESTABLISHED COMPREHENSIVE POLICIES AND PROCEDURES TO PROMOTE BEST BUSINESS PRACTICES AND ENSURE EFFICIENT AND EFFECTIVE INTERNAL CONTROL. THESE ARE COMBINED WITH AN INTERNAL AUDIT FUNCTION THROUGH WHICH PATH CONDUCTS AUDITS ON GRANT-FUNDED PROGRAMS TO ENSURE COMPLIANCE WITH REGULATORY REQUIREMENTS.

Schedule I (Form 990) 2020

Additional Data

Software ID:
Software Version:

- TIN:

Schedule J
(Form 990)

Department of the Treasury
Internal Revenue Service

Compensation Information

For certain Officers, Directors, Trustees, Key Employees, and Highest
Compensated Employees
Graphic Arrow

Complete if the organization answered "Yes" on Form 990, Part IV, line 23.
Graphic Arrow

Attach to Form 990.
Graphic Arrow

Go to www.irs.gov/Form990 for instructions and the latest information.

OMB No. 1545-0047

2020

Open to Public Inspection

Name of the organization

PATH

Employer identification number

91-1157127

Part I

Questions Regarding Compensation

Yes

Check the appropiate box(es) if the organization provided any of the following to or for a person listed on Form
990, Part VII, Section A, line 1a. Complete Part III to provide any relevant information regarding these items.

First-class or charter travel Housing allowance or residence for personal use

Travel for companions Payments for business use of personal residence

Tax idemnification and gross-up payments Health or social club dues or initiation fees

Discretionary spending account Personal services (e.g., maid, chauffeur, chef)

If any of the boxes on Line 1a are checked, did the organization follow a written policy regarding payment or reimbursement or provision of all of the expenses described above? If "No," complete Part III to explain .....

Yes

Did the organization require substantiation prior to reimbursing or allowing expenses incurred by all
directors, trustees, officers, including the CEO/Executive Director, regarding the items checked on Line 1a? ....

Yes

Indicate which, if any, of the following the filing organization used to establish the compensation of the
organization's CEO/Executive Director. Check all that apply. Do not check any boxes for methods
used by a related organization to establish compensation of the CEO/Executive Director, but explain in Part III.

Compensation committee Written employment contract

Independent compensation consultant Compensation survey or study

Form 990 of other organizations Approval by the board or compensation committee

During the year, did any person listed on Form 990, Part VII, Section A, line 1a, with respect to the filing organization or a related organization:

Receive a severance payment or change-of-control payment? .............

Participate in, or receive payment from, a supplemental nonqualified retirement plan? .........

Participate in, or receive payment from, an equity-based compensation arrangement? .........

If "Yes" to any of lines 4a-c, list the persons and provide the applicable amounts for each item in Part III.

Only 501(c)(3), 501(c)(4), and 501(c)(29) organizations must complete lines 5-9.

For persons listed on Form 990, Part VII, Section A, line 1a, did the organization pay or accrue any
compensation contingent on the revenues of:

The organization? ....................

Any related organization? .......................

If "Yes," on line 5a or 5b, describe in Part III.

For persons listed on Form 990, Part VII, Section A, line 1a, did the organization pay or accrue any
compensation contingent on the net earnings of:

The organization? ..................

Any related organization? ......................

If "Yes," on line 6a or 6b, describe in Part III.

For persons listed on Form 990, Part VII, Section A, line 1a, did the organization provide any nonfixed
payments not described in lines 5 and 6? If "Yes," describe in Part III ............

Yes

Were any amounts reported on Form 990, Part VII, paid or accured pursuant to a contract that was
subject to the initial contract exception described in Regulations section 53.4958-4(a)(3)? If "Yes," describe
in Part III ..........................

If "Yes" on line 8, did the organization also follow the rebuttable presumption procedure described in Regulations section 53.4958-6(c)? .........................

For Paperwork Reduction Act Notice, see the Instructions for Form 990.

Cat. No. 50053T

Schedule J (Form 990) 2020

Page 2

Part II

Officers, Directors, Trustees, Key Employees, and Highest Compensated Employees. Use duplicate copies if additional space is needed.

For each individual whose compensation must be reported on Schedule J, report compensation from the organization on row (i) and from related organizations, described in the
instructions, on row (ii). Do not list any individuals that are not listed on Form 990, Part VII.
Note. The sum of columns (B)(i)-(iii) for each listed individual must equal the total amount of Form 990, Part VII, Section A, line 1a, applicable column (D) and (E) amounts for that individual.

(A) Name and Title		(B) Breakdown of W-2 and/or 1099-MISC compensation			(C) Retirement and other deferred compensation	(D) Nontaxable benefits	(E) Total of columns (B)(i)-(D)	(F) Compensation in column (B) reported as deferred on prior Form 990
(A) Name and Title		(i) Base compensation	(ii) Bonus & incentive compensation	(iii) Other reportable compensation	(C) Retirement and other deferred compensation	(D) Nontaxable benefits	(E) Total of columns (B)(i)-(D)
1NIKOLAJ JESTED GILBERT PRESIDENT AND CEO (FROM 1/2020)	(i) (ii)	183,894 ------------- 292,691	0 ------------- 0	72,661 ------------- 22,694	9,000 ------------- 23,249	11,176 ------------- 629	276,731 ------------- 339,263	0 ------------- 0
2DAVID C KASLOW VP - ESSENTIAL MEDICNES	(i) (ii)	425,987 ------------- 0	0 ------------- 0	1,950 ------------- 0	34,200 ------------- 0	35,191 ------------- 0	497,328 ------------- 0	0 ------------- 0
3TRAD M HATTON COUNTRY DIRECTOR	(i) (ii)	196,161 ------------- 0	0 ------------- 0	180,515 ------------- 0	19,167 ------------- 0	35,370 ------------- 0	431,213 ------------- 0	0 ------------- 0
4JOHN O KONZ GLOBAL HEAD, FINANCIAL MANAGEMENT	(i) (ii)	346,062 ------------- 0	0 ------------- 0	840 ------------- 0	34,200 ------------- 0	32,932 ------------- 0	414,034 ------------- 0	0 ------------- 0
5DAVID W FLEMING VP - PUBLIC HEALTH	(i) (ii)	362,605 ------------- 0	0 ------------- 0	1,950 ------------- 0	34,200 ------------- 0	10,632 ------------- 0	409,387 ------------- 0	0 ------------- 0
6JAMES B MCKENNA DEPUTY DIRECTOR	(i) (ii)	271,132 ------------- 0	0 ------------- 0	50,613 ------------- 0	26,023 ------------- 0	58,914 ------------- 0	406,682 ------------- 0	0 ------------- 0
7ASHLEY J BIRKETT GLOBAL HEAD, MALARIA VACCINES	(i) (ii)	345,577 ------------- 0	0 ------------- 0	1,195 ------------- 0	27,138 ------------- 0	29,047 ------------- 0	402,957 ------------- 0	0 ------------- 0
8BRUCE LAMONT INNIS GLOBAL HEAD, RESPIRATORY INFECTIONS	(i) (ii)	356,827 ------------- 0	0 ------------- 0	910 ------------- 0	32,603 ------------- 0	0 ------------- 0	390,340 ------------- 0	0 ------------- 0
9JEFFREY D BERNSON VP - TECH, ANALYTICS, MRKT INNOV.	(i) (ii)	322,366 ------------- 0	0 ------------- 0	375 ------------- 0	32,680 ------------- 0	24,513 ------------- 0	379,934 ------------- 0	0 ------------- 0
10ELAINE L GIBBONS VP - GLOBAL ENGAGEMENT	(i) (ii)	289,328 ------------- 0	0 ------------- 0	1,950 ------------- 0	33,296 ------------- 0	43,428 ------------- 0	368,002 ------------- 0	0 ------------- 0
11MOLLI M BARNES CHIEF PEOPLE OFFICER	(i) (ii)	278,509 ------------- 0	0 ------------- 0	0 ------------- 0	29,341 ------------- 0	22,726 ------------- 0	330,576 ------------- 0	0 ------------- 0
12JERRY KUO CHIEF OF STRATEGIC FINANCE	(i) (ii)	251,067 ------------- 0	0 ------------- 0	1,830 ------------- 0	30,616 ------------- 0	27,610 ------------- 0	311,123 ------------- 0	0 ------------- 0
13BRIAN N NEVILLE CHIEF OF ACCOUNTING	(i) (ii)	258,594 ------------- 0	0 ------------- 0	1,920 ------------- 0	27,852 ------------- 0	8,974 ------------- 0	297,340 ------------- 0	0 ------------- 0
14ERICA JANE SESSLE CHIEF OF STAFF	(i) (ii)	236,865 ------------- 0	0 ------------- 0	1,950 ------------- 0	28,554 ------------- 0	26,045 ------------- 0	293,414 ------------- 0	0 ------------- 0
15PHILIPPE GUINOT CHIEF OF BUSINESS, FIN. & OPS.	(i) (ii)	0 ------------- 251,954	0 ------------- 0	0 ------------- 6,077	0 ------------- 21,918	0 ------------- 959	0 ------------- 280,908	0 ------------- 0
16SABRINA L POWERS GENERAL COUNSEL	(i) (ii)	232,120 ------------- 0	0 ------------- 0	330 ------------- 0	27,838 ------------- 0	9,364 ------------- 0	269,652 ------------- 0	0 ------------- 0
17STEPHEN B DAVIS PRESIDENT AND CEO (RESIGNED 1/2020)	(i) (ii)	50,912 ------------- 0	156,629 ------------- 0	41,516 ------------- 0	11,120 ------------- 0	2,482 ------------- 0	262,659 ------------- 0	0 ------------- 0

Schedule J (Form 990) 2020

Page 3

Part III

Supplemental Information

Provide the information, explanation, or descriptions required for Part I, lines 1a, 1b, 3, 4a, 4b, 4c, 5a, 5b, 6a, 6b, 7, and 8, and for Part II. Also complete this part for any additional information.

Return Reference	Explanation
PART I, LINE 1A	HOUSING ALLOWANCES & TAX INDEMNIFICATIONS ARE ONLY PROVIDED TO THOSE INDIVIDUALS WHO ARE EXPATRIATE EMPLOYEES. ALL BENEFIT PAYMENTS ARE MADE ACCORDING TO OUR EXPATRIATE POLICY. PART I, LINE 3: PATH ENGAGES WITH A CONSULTING FIRM TO REVIEW THE COMPENSATION FOR EACH OF THE SENIOR MANAGEMENT POSITIONS. PATH PROVIDES AN ANNUAL SALARY ADJUSTMENT EACH JANUARY BASED ON THE OVERALL LABOR MARKET MOVEMENT.
PART I, LINE 7	BONUS COMPENSATION HAS BEEN REFLECTED IN PART II, COLUMN (B)(II).

Schedule J (Form 990) 2020

Additional Data

Software ID:
Software Version:

- TIN:

SCHEDULE M
(Form 990)

Department of the Treasury

Internal Revenue Service

Noncash Contributions

Complete if the organizations answered "Yes" on Form 990, Part IV, lines 29 or 30.
Right pointing arrow large image

Attach to Form 990.
Right pointing arrow large image

Go to www.irs.gov/Form990 for the latest information.

OMB No. 1545-0047

2020

Open to Public Inspection

Name of the organization

PATH

Employer identification number

91-1157127

Part I

Types of Property

	(a) Check if applicable	(b) Number of contributions or items contributed	(c) Noncash contribution amounts reported on Form 990, Part VIII, line 1g	(d) Method of determining noncash contribution amounts
1 Art—Works of art ....
2 Art—Historical treasures .
3 Art—Fractional interests ..
4 Books and publications ..
5 Clothing and household goods .......
6 Cars and other vehicles ..
7 Boats and planes ....
8 Intellectual property ...
9 Securities—Publicly traded .	X	14	92,087	FMV
10 Securities—Closely held stock .
11 Securities—Partnership, LLC, or trust interests ....
12 Securities—Miscellaneous ..
13 Qualified conservation contribution—Historic structures .....
14 Qualified conservation contribution—Other ...
15 Real estate—Residential .
16 Real estate—Commercial ..
17 Real estate—Other ...
18 Collectibles .....
19 Food inventory ...
20 Drugs and medical supplies .
21 Taxidermy ......
22 Historical artifacts ....
23 Scientific specimens ..
24 Archeological artifacts ...
25 Other ( SOFTWARE/SUPP. )	X	5	668,965	COST
26 Other ( )
27 Other ( )
28 Other ( )

Number of Forms 8283 received by the organization during the tax year for contributions
for which the organization completed Form 8283, Part IV, Donee Acknowledgement

Yes

30a

During the year, did the organization receive by contribution any property reported in Part I, lines 1 through 28, that it must hold for at least three years from the date of the initial contribution, and which isn't required to be used for exempt purposes for the entire holding period? ...................

30a

If "Yes," describe the arrangement in Part II.

Does the organization have a gift acceptance policy that requires the review of any nonstandard contributions?

Yes

32a

Does the organization hire or use third parties or related organizations to solicit, process, or sell noncash

contributions? ..........................

32a

If "Yes," describe in Part II.

If the organization didn't report an amount in column (c) for a type of property for which column (a) is checked,

describe in Part II.

For Paperwork Reduction Act Notice, see the Instructions for Form 990.

Cat. No. 51227J

Schedule M (Form 990) (2020)

Page 2

Part IISupplemental Information. Provide the information required by Part I, lines 30b, 32b, and 33, and whether the organization is reporting in Part I, column (b), the number of contributions, the number of items received, or a combination of both. Also complete this part for any additional information.

Return Reference	Explanation
PART I, COLUMN (B):	THIS COLUMN REFLECTS THE NUMBER OF CONTRIBUTIONS.

Schedule M (Form 990) (2020)

Additional Data

Software ID:
Software Version:

- TIN:

SCHEDULE O
(Form 990 or 990-EZ)

Department of the Treasury
Internal Revenue Service

Supplemental Information to Form 990 or 990-EZ

Complete to provide information for responses to specific questions on
Form 990 or 990-EZ or to provide any additional information.
MediumBullet

Attach to Form 990 or 990-EZ.
MediumBullet

Go to www.irs.gov/Form990 for the latest information.

OMB No. 1545-0047

2020

Open to Public
Inspection

Name of the organization

PATH

Employer identification number

91-1157127

Return Reference	Explanation
FORM 990, PART III, LINE 1, DESCRIPTION OF ORGANIZATION MISSION:	PATH IS A GLOBAL ORGANIZATION THAT WORKS TO ACCELERATE HEALTH EQUITY BY BRINGING TOGETHER PUBLIC INSTITUTIONS, BUSINESSES, SOCIAL ENTERPRISES, AND INVESTORS TO SOLVE THE WORLD'S MOST PRESSING HEALTH CHALLENGES. WITH EXPERTISE IN SCIENCE, HEALTH, ECONOMICS, TECHNOLOGY, ADVOCACY, AND DOZENS OF OTHER SPECIALTIES, PATH DEVELOPS AND SCALES UP SOLUTIONS-INCLUDING VACCINES, DRUGS, DEVICES, DIAGNOSTICS, AND INNOVATIVE APPROACHES TO STRENGTHENING HEALTH SYSTEMS WORLDWIDE. SINCE 2011, PATH AND OUR PARTNERS AND SUPPORTERS HAVE IMPROVED HEALTH FOR MORE THAN 150 MILLION PEOPLE ON AVERAGE EACH YEAR.
FORM 990, PART III, LINE 4A, DESCRIPTION OF PROGRAM SERVICE:	IN UKRAINE, PATH CONTINUED TO LEAD THE USAID-FUNDED SERVING LIFE PROJECT, WHICH REDUCES TB, HIV, AND HEPATITIS C VIRUS (HCV) TRANSMISSION IN THE PENAL SYSTEM AND COMMUNITIES ACROSS 12 REGIONS. RESPONDING TO COVID-19, WE OFFERED MULTIPLE OPTIONS FOR HIVST KIT DELIVERY AND ADVOCATED FOR VIRTUAL ART INITIATION AND MONITORING; WITHIN TWO MONTHS OF ENACTMENT OF A NEW POLICY, ALMOST 400 VIRTUAL CONSULTATIONS WERE HELD. IN ADDITION, WITH PATH'S TECHNICAL SUPPORT AND SUCCESSFUL ADVOCACY, THE MINISTRY OF JUSTICE PROCURED 60,000 HCV RAPID TESTS AND THE DRUGS REQUIRED TO TREAT NEARLY 500 PRISONERS WITH HCV. AS A PARTNER IN THE UNITAID-FUNDED ADHERENCE SUPPORT COALITION TO END TB PROJECT, PATH BEGAN A STUDY IN UKRAINE ON IMPLEMENTATION OF DIGITAL ADHERENCE TECHNOLOGIES (DATS) AND WORKED TO ESTABLISH A GLOBAL MARKET FOR DATS; FOR EXAMPLE, THE WISEPILL DIGITAL PILLBOX. BY THE END OF 2020, WISEPILL WAS THE FIRST-EVER DAT INCLUDED IN THE GLOBAL DRUG FACILITY CATALOGUE. PATH ALSO CONTINUED TO IMPLEMENT THE USAID-FUNDED SUPPORT TB CONTROL EFFORTS IN UKRAINE (STBCEU) PROJECT, WHICH FOCUSES ON PREVENTION, DETECTION, AND TREATMENT OF TB, DRUG-RESISTANT TB, AND TB/HIV. IN 2020, STBCEU RAPIDLY ADAPTED PROJECT ACTIVITIES TO A REMOTE MODEL. WE ALSO BEGAN SCALE-UP OF A SUCCESSFUL NEW APPROACH FOR TRANSPORTING DIAGNOSTIC SPECIMENS AND DELIVERING DRUGS TO TREAT TB AND HIV. WHEN USAID PROVIDED ADDITIONAL FUNDING FOR EMERGENCY RESPONSE TO COVID-19, PATH PROCURED DNA EXTRACTORS AND CONDUCTED ON-THE-JOB TRAINING TO DRAMATICALLY INCREASE THE NUMBER OF SAMPLES FOR COVID-19 (AND OTHER DISEASES) THAT COULD BE TESTED IN A DAY. THE NUMBER OF UNPROCESSED SAMPLES AT ONE LABORATORY WENT FROM 800 TO ZERO IN LESS THAN A MONTH AND REMAINED AT ZERO THROUGH THE END OF 2020. IN INDIA, PATH ENHANCED HIV SERVICE DELIVERY THROUGH AUTOMATION OF DATA AND DEVELOPMENT OF A MACHINE-LEARNING-ENABLED TOOL TO REDUCE LOSS OF PATIENTS FROM TREATMENT. TO IMPROVE TB SERVICES, WE PILOTED ARTIFICIAL INTELLIGENCE TO STREAMLINE CHEST X-RAY READINGS, ENABLING QUICKER DIAGNOSIS AND INITIATION ON TREATMENT. IN TAJIKISTAN, KAZAKHSTAN, AND UZBEKISTAN, PATH DEVELOPED DRUG-RESISTANT TB CASE MANAGEMENT GUIDELINES, SET UP A DIGITAL TB PREVENTION PLATFORM, PROVIDED TECHNICAL EXPERTISE ON LATENT TB INFECTION, AND MORE FOR THE USAID ELIMINATING TB IN CENTRAL ASIA PROJECT. IN TANZANIA, THE USAID-FUNDED INFECTIOUS DISEASE DETECTION AND SURVEILLANCE (IDDS) PROJECT SUPPORTED KEY FUNCTIONS AT THE CENTRAL TB REFERENCE LABORATORY, FACILITATED REPORTING FROM GENEXPERT TESTING SITES, AND ASSESSED THE TB DIAGNOSTIC NETWORK. IN VIETNAM, PATH CONTINUED TO PIONEER DIFFERENTIATED AND INTEGRATED SERVICE DELIVERY THROUGH THE USAID HEALTHY MARKETS PROJECT. IN 2020, HEALTHY MARKETS ADDED NEW MODES OF DELIVERY FOR PRE-EXPOSURE PROPHYLAXIS AND HIVST. THE PROJECT ALSO CREATED ONE-STOP SHOPS OFFERING PREVENTION, TESTING, AND TREATMENT FOR HIV AND SEXUALLY TRANSMITTED INFECTIONS; MENTAL HEALTH SCREENING AND REFERRALS; GENDER-AFFIRMING SERVICES; AND HEPATITIS B AND C SCREENING AND TREATMENT FOR PLHIV. THE PROJECT USED SOCIAL MEDIA, WEBSITES, AND TELEPHONE HOTLINES TO PROMOTE AND SUPPORT THESE SERVICES AND RAISE AWARENESS OF COVID-19. THESE ADAPTATIONS WERE CRITICAL TO NOT ONLY CONTINUING BUT ACTUALLY INCREASING SERVICES DURING THE PANDEMIC; FOR EXAMPLE, THE PROJECT'S ONLINE HIVST 3.0 ORDERING PLATFORM AND HOME DELIVERY RESULTED IN A 93 PERCENT INCREASE IN THE NUMBER OF HIVST KITS DISTRIBUTED TO KEY POPULATIONS. THROUGH THE IDDS PROJECT IN VIETNAM, PATH CONTINUED TO SUPPORT THE NATIONAL TUBERCULOSIS PROGRAM (NTP). IDDS ASSESSED PROGRESS ON THE "DOUBLE X" STRATEGY (CHEST X-RAY AND GENEXPERT TEST) AND PUT FORTH EVIDENCE-BASED RECOMMENDATIONS TO IMPROVE IMPLEMENTATION. THE BREATH FOR LIFE (B4L) PROJECT 2.0 IN VIETNAM IMPROVED AND SCALED UP THE B4L MODEL DEVELOPED IN PRIOR YEARS. B4L 2.0 INCREASED ACCURATE DIAGNOSIS OF PEDIATRIC TB, TREATMENT OF TB AND LATENT TB, AND TB PREVENTION. FOLLOWING A STOOL-BASED GENEXPERT TESTING PILOT, B4L 2.0 AND IDDS PAIRED UP TO SUPPORT THE NTP IN THE USE OF STOOL SAMPLES TO INCREASE TB DETECTION AMONG CHILDREN. IMPORTANTLY, THE VIETNAM NTP INCLUDED PEDIATRIC TB ACTIVITIES INFORMED BY B4L IN ITS STRATEGIC PLAN 2021-2025. IN ZAMBIA, PATH CONTINUED TO IMPLEMENT THE USAID-FUNDED ERADICATE TB PROJECT, WHICH TESTED NEARLY 150,000 PEOPLE AND DIAGNOSED APPROXIMATELY 21,000 WITH TB. OF THE NEARLY 9,000 BACTERIOLOGICALLY CONFIRMED INDIVIDUALS, 95 PERCENT WERE INITIATED ON TREATMENT. TO MITIGATE COVID-19, THE PROJECT CONDUCTED INFECTION PREVENTION AND CONTROL TRAININGS FOR MORE THAN 500 HEALTH CARE WORKERS, COMPLETED FOLLOW-UP FACILITY ASSESSMENTS, ACTIVATED THREE TESTING SITES, AND ORIENTED 500 COMMUNITY-BASED VOLUNTEERS. MATERNAL, NEWBORN, AND CHILD HEALTH AND NUTRITION MATERNAL, NEWBORN, AND CHILD HEALTH AND NUTRITION (MNCHN) IS PART OF PATH'S COMPREHENSIVE, ONE HEALTH, PEOPLE- AND COMMUNITY-CENTERED PRIMARY HEALTH CARE MODEL, WHICH ADDRESSES BROADER DETERMINANTS OF HEALTH (E.G., SOCIAL, ECONOMIC, ENVIRONMENTAL). WE FOCUS ON INNOVATIVE, EVIDENCE-BASED TOOLS AND APPROACHES TO MEET PEOPLE'S NEEDS AND PREFERENCES ACROSS THEIR LIFETIME. TOGETHER WITH PARTNERS AROUND THE WORLD, WE DEVELOP, ADAPT, AND SCALE UP TECHNOLOGIES AND SYSTEMS TO REDUCE ILLNESS AND DEATH AND GIVE CHILDREN THE BEST POSSIBLE START IN LIFE. IN 2020, PATH CONTINUED TO EXPAND OUR GLOBAL AND NATIONAL LEADERSHIP IN EARLY CHILDHOOD DEVELOPMENT (ECD); FOR INSTANCE, WITH PATH SUPPORT, THE GOVERNMENTS OF ETHIOPIA, KENYA, AND MOZAMBIQUE CONTINUED TO INCORPORATE ECD SERVICES INTO BASIC HEALTH CARE. THIS PIONEERING WORK CENTERS AROUND BUILDING AN ENABLING LEADERSHIP AND POLICY ENVIRONMENT WHILE STRENGTHENING THE CAPACITY OF HEALTH SYSTEMS AND HEALTH SERVICE PROVIDERS. ALONG WITH WHO, UNICEF, THE WORLD BANK, AND OTHERS, PATH PROMOTED THE NURTURING CARE FOR ECD FRAMEWORK-A STRUCTURE FOR COUNTRIES TO ADOPT, ADAPT, AND SCALE UP ECD SERVICES. TO ENSURE THAT ALL INFANTS HAVE ACCESS TO HUMAN MILK, PATH FOCUSES ON BREASTFEEDING PROMOTION, INCLUDING PROVISION OF SAFE DONOR MILK THROUGH LOCAL HUMAN MILK BANKS. IN 2020, WE CONTINUED TO ADVOCATE FOR UPTAKE AND USE OF GLOBAL STANDARDS FOR STRENGTHENING HUMAN MILK BANKING. WE ALSO BEGAN CO-DEVELOPING A DIGITAL KIT TO OPTIMIZE NEWBORN FEEDING AND THE PROVISION OF LACTATION SUPPORT. IN GHANA, PATH IS LEADING A FOUR-YEAR (2020-2024) INITIATIVE, ADVANCED NEWBORN CARE IN GHANA: BEYOND MAKING EVERY BABY COUNT INITIATIVE (MEBCI 2.0), TO REDUCE PERINATAL MORTALITY IN FOUR HIGH-VOLUME REFERRAL HOSPITALS. IN 2020, MEBCI 2.0 ENGAGED WITH THE GHANA HEALTH SERVICE TO DESIGN ITS NEWBORN ACTION PLAN, MOBILIZE REGIONAL STAKEHOLDERS AND RESOURCES, AND DRIVE ADVOCACY AND POLICY ACTION. IN FOUR FOCUS COUNTRIES, PATH EMBARKED ON LESSONS LEARNED IN ESTABLISHING IN-PATIENT NEWBORN CARE, A PLATFORM FOR UNDERSTANDING AND SHOWCASING COUNTRY-LEVEL JOURNEYS TO PROVIDING CRITICAL CARE FOR SMALL AND SICK NEWBORNS. PATH ALSO LED THE ASSET TRACKER PROJECT TO DOCUMENT UPTAKE OF 14 KEY MNCHN ASSETS IN 81 COUNTDOWN TO 2030 COUNTRIES ACROSS AFRICA AND SOUTH ASIA. THROUGH KEY INFORMANT INTERVIEWS AND POLICY REVIEWS IN SEVEN TARGET COUNTRIES, PATH IDENTIFIED BARRIERS AND ENABLERS TO SCALE-UP AND PRESENTED AN INTERACTIVE DASHBOARD TO GUIDE STRATEGIES TO ACCELERATE COVERAGE. RECOGNIZING THAT NUTRITION IS AFFECTED BY A VARIETY OF ECONOMIC AND ENVIRONMENTAL FACTORS, PATH'S NUTRITION TEAM DRIVES NOVEL APPROACHES TO ADDRESS THE MASSIVE BURDEN OF MALNUTRITION IN COMMUNITIES AROUND THE WORLD. IN 2020, PATH COMPLETED A SEVEN-YEAR PROJECT, MAXIMISING THE QUALITY OF SCALING UP NUTRITION PLUS (MQSUN+), WHICH ENGAGED MORE THAN 50 COUNTRIES AND THE GLOBAL SUN MOVEMENT SECRETARIAT IN DEMAND-DRIVEN, ADAPTIVE COLLABORATIONS. MQSUN+ EMPHASIZED COUNTRY-LED MULTISECTOR PLANNING, OFTEN IN FRAGILE CONTEXTS. IN THE LAST YEAR, SIX MQSUN+ COUNTRIES PRODUCED ENDORSED, COSTED PLANS TO REDUCE FOOD INSECURITY AND IMPROVE NUTRITION. OTHER ACTIVITIES IN 2020 INCLUDED PARTNERING WITH THE NATURE CONSERVANCY, DUKE UNIVERSITY, AND THE INTERNATIONAL FOOD POLICY RESEARCH INSTITUTE ON USE OF ALTERNATIVE PROTEINS. WE ALSO PARTNERED WITH HARVESTPLUS TO EXPAND THE REACH OF BIOFORTIFIED CROPS. PATH CONTINUED OUR WORK ON THE BRIDGE COLLABORATIVE, A TRAILBLAZING, CROSS-DISCIPLINARY EFFORT OF MORE THAN 150 LEADING TECHNICAL EXPERTS FROM THE HEALTH, DEVELOPMENT, AND ENVIRONMENTAL SECTORS TO ADDRESS HUMAN AND PLANETARY HEALTH. IN CONJUNCTION WITH THE WILDLIFE CONSERVATION SOCIETY AND THE NATURE CONSERVANCY, THE BRIDGE COLLABORATIVE FOCUSED ATTENTION ON FOOD SYSTEMS AND THE INTERSECTION OF HUMAN AND PLANETARY HEALTH.
FORM 990, PART III, LINE 4A, DESCRIPTION OF PROGRAM SERVICE:	IN 2020, MNCHN STAFF SERVED GLOBALLY IN LEADERSHIP ROLES RELATED TO COVID-19 AND THE PROTECTION OF WOMEN AND CHILDREN. WE PRESENTED (MOSTLY VIRTUALLY) AT KEY GLOBAL AND NATIONAL MEETINGS AND AUTHORED AND CONTRIBUTED TO HIGH-PROFILE PEER-REVIEWED JOURNAL ARTICLES, BOOK CHAPTERS, GLOBAL REPORTS, AND SYSTEMATIC REVIEWS. THESE EFFORTS ADVANCED THINKING ON BROAD, EFFECTIVE SOLUTIONS TO THE MOST PRESSING CHALLENGES IN MNCHN. SEXUAL AND REPRODUCTIVE HEALTH PATH'S WORK IN SEXUAL AND REPRODUCTIVE HEALTH (SRH) IS GUIDED BY THE KEY PRINCIPLES OF CHOICE, EQUITY, AND DIGNITY FOR ALL PEOPLE. AND BECAUSE WE UNDERSTAND THE COMPLEX SOCIAL, BEHAVIORAL, AND GENDER DIMENSIONS OF WOMEN'S REPRODUCTIVE HEALTH, WE BUILD EVIDENCE AROUND TOOLS AND SERVICES THAT ARE BEST SUITED TO ADDRESS THEIR DIVERSE NEEDS AND CIRCUMSTANCES. WE SPECIALIZE IN REDUCING BARRIERS TO ACCESS AND INTRODUCING WOMAN-INITIATED PRODUCTS. PATH CHAMPIONS PEOPLE'S RIGHT TO MANAGE THEIR OWN SRH BY CREATING AND ADVANCING IMPROVED TOOLS AND PRACTICES THAT MAKE SELF-CARE FOR SRH POSSIBLE. IN 2020, WE CO-CREATED WITH THE GOVERNMENTS OF NIGERIA, SENEGAL, AND UGANDA THEIR FIRST-EVER NATIONAL SELF-CARE GUIDELINES. OUR INTEGRATED APPROACH INCLUDES ATTENTION TO CONTRACEPTION, CERVICAL AND BREAST CANCER, SEXUALLY TRANSMITTED INFECTIONS, AND A WOMAN'S RIGHT TO DECIDE WHETHER AND WHEN TO BECOME A MOTHER. OUR EFFORTS TO EXPAND ACCESS TO THE SELF-INJECTABLE CONTRACEPTIVE SUBCUTANEOUS DMPA (DMPA-SC, OR SAYANA PRESS) CONTINUED IN 2020. THE DMPA-SC ACCESS COLLABORATIVE WORKED WITH MINISTRIES OF HEALTH AND MULTISECTOR PARTNERS IN SIX COUNTRIES TO FACILITATE SELF-INJECTION INTRODUCTION AND SCALE-UP PLANNING FOR A RANGE OF CONTRACEPTIVES. DATA FROM 11 COUNTRIES SHOWED NEARLY 300,000 CLIENT VISITS FOR CONTRACEPTIVE SELF-INJECTION IN 2020; THE ACCESS COLLABORATIVE ALSO LAUNCHED AND SUPPORTED A CADRE OF "SELF-INJECTION AMBASSADORS" TO ADVANCE CONTRACEPTIVE SELF-INJECTION AND SELF-CARE OPTIONS MORE BROADLY. PATH ALSO WORKED TO IMPROVE THE PREVENTION, DETECTION, AND TREATMENT OF CERVICAL PRECANCER CAUSED BY INFECTION WITH HUMAN PAPILLOMAVIRUS (HPV). WE CONTINUED OUR PARTNERSHIP WITH THE MINISTRIES OF HEALTH IN GUATEMALA, HONDURAS, AND NICARAGUA TO SCALE UP HPV TESTING IN THE PUBLIC SECTOR. WE ALSO EVALUATED FOLLOW-UP AND TREATMENT STRATEGIES TO ENSURE WOMEN RECEIVE APPROPRIATE, COMPREHENSIVE CARE. AS THE PROJECT NEARED CLOSEOUT, WE WORKED TO TRANSITION ACTIVITIES TO THE MINISTRIES. GLOBALLY, PATH HELPED SHAPE STRATEGIES FOR LOW- AND MIDDLE-INCOME COUNTRIES AS PART OF WHO'S CALL FOR GLOBAL CERVICAL CANCER ELIMINATION. IN PERU, PATH CONTINUED TO IMPLEMENT A MODEL FOR EARLY DETECTION OF BREAST CANCER APPROPRIATE AND FEASIBLE FOR LOW- AND MIDDLE-RESOURCE SETTINGS. WE PARTNERED WITH THE MOH TO DESIGN AND IMPLEMENT A REAL-TIME DIGITAL PATIENT TRACKING SYSTEM FOR BREAST CANCER DETECTION. IN MYANMAR, PATH SUPPORTED THE CREATION OF THE NATIONAL STRATEGIC PLAN FOR REPRODUCTIVE, MATERNAL, NEWBORN, CHILD, AND ADOLESCENT HEALTH; DRAFTED A NATIONAL OPERATIONAL PLAN FOR CERVICAL PRECANCER SCREENING AND TREATMENT; CREATED A TRAINING CURRICULUM FOR HEALTH WORKERS ON SEXUAL AND REPRODUCTIVE HEALTH AND RIGHTS (SRHR), INCLUDING SELF-CARE INTERVENTIONS; HELD ADVOCACY WORKSHOPS; DEVELOPED SRHR AWARENESS TOOLKITS FOR PEOPLE LIVING WITH DISABILITIES; AND RESPONDED TO COVID-19 BY PARTNERING WITH LOCAL CIVIL-SOCIETY ORGANIZATIONS TO DISTRIBUTE INFECTION PREVENTION INFORMATION AND SUPPLIES IN REFUGEE CAMPS AND HARD-TO-REACH AREAS OF TWO STATES. IN INDIA, WE WORKED WITH THE ODISHA STATE GOVERNMENT TO LEVERAGE THE NATION'S POSTAL SERVICE TO DELIVER CONTRACEPTIVES BY MAIL-AND SO MAINTAIN ACCESS THROUGHOUT COVID-19. PATH CONTINUED TO SERVE AS THE SECRETARIAT FOR THE REPRODUCTIVE HEALTH SUPPLIES COALITION, A GLOBAL PARTNERSHIP OF MORE THAN 540 PUBLIC AND PRIVATE ENTITIES AND NONGOVERNMENTAL ORGANIZATIONS WORKING TO EXPAND ACCESS TO CRITICAL SRH AND FAMILY PLANNING SUPPLIES AND SERVICES. NONCOMMUNICABLE DISEASES PATH IS AT THE FOREFRONT OF THE FIGHT AGAINST NONCOMMUNICABLE DISEASES (NCDS), INCLUDING DIABETES AND CARDIOVASCULAR DISEASE, IN LOW-RESOURCE SETTINGS WORLDWIDE, WHERE THE BURDEN OF THESE DISEASES IS RISING DISPROPORTIONATELY. IN 2020, PATH CONTINUED TO SERVE AS THE SECRETARIAT OF THE COALITION FOR ACCESS TO NCD MEDICINES AND PRODUCTS. THIS GLOBAL, MULTISECTORAL COLLABORATION WORKS TO INCREASE ACCESS TO NCD MEDICINES AND HEALTH PRODUCTS IN LOW- AND MIDDLE-INCOME COUNTRIES. IN ADDITION TO GLOBAL ADVOCACY, THE COALITION LED THE DEVELOPMENT OF A FORECASTING TOOL FOR NCD MEDICINES AND PRODUCTS, PILOTED THE TOOL IN KENYA, AND LAID THE GROUNDWORK FOR ITS INTRODUCTION IN UGANDA. PATH IMPLEMENTED NCD PROJECTS IN GHANA, KENYA, AND VIETNAM THAT BUILD STRONGER PRIMARY HEALTH CARE SYSTEMS, SUPPLY CHAINS, AND DATA-DRIVEN DECISION-MAKING-ALL CRITICAL COMPONENTS OF HEALTH SYSTEM RESILIENCY: OUR EFFORTS IN GHANA INCLUDED SUPPLY CHAIN STRENGTHENING, MESSAGING TO SUPPORT THE COVID-19 RESPONSE, AND INTRODUCTION OF THE NCD NAVIGATOR-A FIRST-OF-ITS-KIND, LOCALLY MANAGED, NCD DIGITAL INFORMATION SYSTEM FOR RESOURCE PLANNING AND ALLOCATION. IN PARTNERSHIP WITH THE GHANA HEALTH SERVICE, PATH'S HEALTHY HEART AFRICA PROJECT CONDUCTED MORE THAN 500,000 BLOOD PRESSURE SCREENINGS AND LINKED THOSE DIAGNOSED TO TREATMENT. IN KENYA, PATH DEPLOYED A CUTTING-EDGE PROGRAM THAT ENABLES COMMUNITY AND HOUSEHOLD SCREENINGS FOR HYPERTENSION, REMOTE BLOOD PRESSURE AND BLOOD SUGAR MONITORING, TELEMEDICINE, COMMUNITY-BASED DRUG DELIVERY, AND ENHANCED DATA MANAGEMENT. WE TRAINED 2,815 HEALTH CARE WORKERS ON COVID-19 INFECTION PREVENTION AND CONTROL, WITH AN EMPHASIS ON PEOPLE LIVING WITH NCDS. AS THE MOH SEEKS TO IMPROVE THE NCD SUPPLY CHAIN IN PREPARATION FOR UNIVERSAL HEALTH COVERAGE, WE TRANSITIONED OWNERSHIP OF THE NCD NAVIGATOR TO THE MOH AND FINALIZED OUR KENYA NCD SUPPLY CHAIN REPORT. RECOMMENDATIONS FROM THE REPORT WERE ADOPTED IN THE KENYA NCD STRATEGY 2021-2025. OUR FOCUS IN VIETNAM WAS ON A PRIMARY HEALTH CARE MODEL THAT USES PUBLIC-PRIVATE PARTNERSHIPS, DIGITAL TOOLS, AND COMMUNITY HEALTH WORKERS TO SUPPORT SCREENING AND LINKAGES TO CARE; FOR EXAMPLE, WE BROKERED A PARTNERSHIP BETWEEN THE MOH, CO.OPMART (A LARGE, PRIVATE-SECTOR SUPERMARKET CHAIN), AND PATH TO LAUNCH THE FIRST-EVER SUPERMARKET BLOOD PRESSURE CHECKPOINT IN HO CHI MINH CITY. THE CHECKPOINT SCREENED ALMOST 1,000 PEOPLE BY THE END OF 2020, DEMONSTRATING THE FEASIBILITY OF THE APPROACH. FINALLY, PATH LED AND CONTRIBUTED TO CONVENINGS TO RAISE AWARENESS OF NCDS AND ORCHESTRATE ACTION TO IMPROVE ACCESS TO NCD PREVENTION AND CARE. HEALTH SYSTEMS INNOVATION AND DELIVERY PATH'S HEALTH SYSTEMS INNOVATION AND DELIVERY (HSID) PROGRAM STRENGTHENS HEALTH SYSTEMS AND ENHANCES COUNTRY CAPACITY FOR DATA-DRIVEN DECISION-MAKING. OUR PORTFOLIO SERVES AS AN ORGANIZING MECHANISM FOR PATH PROJECTS AND INITIATIVES THAT STRENGTHEN HEALTH SYSTEMS. HSID'S HEALTH SYSTEMS ANALYTICS UNIT PROMOTES SYSTEMS THINKING. WITHIN AND OUTSIDE OF PATH, THE UNIT LEADS COMPLEX EVALUATIONS OF HEALTH PROGRAMS, ENGAGES IN IMPLEMENTATION SCIENCE RESEARCH, FACILITATES HEALTH TECHNOLOGY INTRODUCTION AND SCALE-UP, AND IMPROVES DATA QUALITY AND USE FOR DECISION-MAKING. IN 2020, AS PART OF THE GLOBAL FUND'S PROSPECTIVE COUNTRY EVALUATIONS, THE UNIT EVALUATED THE GLOBAL FUND'S BUSINESS MODEL IN THE DRC, GUATEMALA, SENEGAL, AND UGANDA-EXAMINING BARRIERS AND FACILITATORS TO IMPACT. THE GLOBAL HEALTH SECURITY TEAM CONTINUED TO INNOVATE FOR THE PREVENTION, DETECTION, AND CONTROL OF INFECTIOUS DISEASE OUTBREAKS. WITH SUPPORT FROM THE US CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC), THE TEAM WORKED WITH NATIONAL LEADERS IN THE DRC, SENEGAL, TANZANIA, AND VIETNAM TO BUILD THEIR CAPACITY FOR EPIDEMIC PREPAREDNESS AND RESPONSE. THE TEAM ALSO WORKED AS A MAJOR SUBGRANTEE ON THE USAID IDDS PROJECT. OUR CROSS-ORGANIZATIONAL IMPACT TEAM FOR EPIDEMIC PREPAREDNESS AND RESPONSE REMAINED AT THE FOREFRONT OF THE EBOLA RESPONSE IN THE DRC-ENHANCING SURVEILLANCE, DETECTION, AND RESOURCE MOBILIZATION. OTHER EFFORTS INCLUDED STRENGTHENING ELECTRONIC HEALTH INFORMATION SYSTEMS, ADVANCING DIAGNOSTIC NETWORK CAPABILITIES, AND LINKING THIS WORK WITH DEVELOPMENT OF NEW DIAGNOSTICS, VACCINES, AND DATA TOOLS. COUNTRY PROGRAMS PATH'S COUNTRY PROGRAMS SUPPORT WORK RANGING FROM SMALL-SCALE PILOTS TO LARGE, MULTI-COUNTRY EFFORTS. IN 2020, WE OPERATED FULL-SCALE "COUNTRY" OFFICES IN THE DRC, CHINA, ETHIOPIA, INDIA, KENYA, MYANMAR, SENEGAL, TANZANIA, UGANDA, UKRAINE, VIETNAM, AND ZAMBIA, AS WELL AS SMALLER "PROJECT" OFFICES IN MANY OTHER COUNTRIES. OUR EXAMPLES THIS YEAR FOCUS ON INDIA, UGANDA, AND VIETNAM.
FORM 990, PART III, LINE 4A, DESCRIPTION OF PROGRAM SERVICE:	INDIA: PATH HAS WORKED IN INDIA FOR MORE THAN 20 YEARS TO IMPROVE HEALTH AND SAVE LIVES THROUGH INNOVATION AND COLLABORATION WITH LOCAL PARTNERS. PATH'S PROJECTS IN INDIA FOCUS ON TB, HIV, NEGLECTED TROPICAL DISEASES, VACCINES (BOTH DEVELOPMENT AND DELIVERY), AND REPRODUCTIVE, MATERNAL, NEWBORN, CHILD, AND ADOLESCENT HEALTH. IN 2020, PATH PROVIDED TECHNICAL SUPPORT TO THE GOVERNMENT OF INDIA TO EXPAND OUR AWARD-WINNING PUBLIC-PRIVATE MODEL FOR TB DIAGNOSIS AND TREATMENT TO 15 STATES ACROSS THE COUNTRY. OUR PIONEERING WORK IN RICE FORTIFICATION CONTINUED AS WELL, BRINGING LIFESAVING NUTRITION TO NEARLY 1 MILLION PEOPLE, INCLUDING MORE THAN 650,000 SCHOOLCHILDREN. WITH THE ONSET OF COVID-19, PATH IMMEDIATELY LEVERAGED OUR PROGRAMMATIC EXPERTISE AND WORKING RELATIONSHIPS WITH THE GOVERNMENT TO PREPARE HEALTH FACILITIES TO RESPOND TO THE DISEASE. WITH FUNDING FROM THE ROCKEFELLER FOUNDATION, PATH AND OUR PARTNERS WORKED WITH THE STATE GOVERNMENTS OF MAHARASHTRA AND PUNJAB TO IMPROVE ACCESS TO HIGH-QUALITY, AFFORDABLE TESTING FOR COVID-19 BY IMPLEMENTING NEWER DIAGNOSTIC TECHNOLOGIES AND NOVEL TESTING ALGORITHMS, AUTOMATING DATA ENTRY AND ANALYSIS, AND INCREASING HUMAN RESOURCE CAPACITY IN LABORATORIES. WE ALSO BEGAN IMPLEMENTING DECENTRALIZED GENE SEQUENCING PLATFORMS AT THE STATE LEVEL TO ACCELERATE IDENTIFICATION OF NEW VIRAL MUTATIONS AND VARIANTS. PATH'S INDIA TEAM IN 2020 CONTINUED OUR COLLABORATION WITH OTHER SOUTH ASIAN COUNTRIES; FOR EXAMPLE, WE SUPPORTED DEVELOPMENT OF A POINT-OF-CARE "SUITCASE LABORATORY" BASED ON RECOMBINASE POLYMERASE AMPLIFICATION FOR RAPID AND ACCURATE DIAGNOSIS OF KALA-AZAR AND POST-KALA-AZAR DERMAL LEISHMANIASIS IN BANGLADESH AND NEPAL. UGANDA: PATH'S UGANDA COUNTRY PROGRAM HAS BEEN PARTNERING CLOSELY WITH THE UGANDA MOH FOR MORE THAN 15 YEARS, IMPLEMENTING AN EVER-WIDER RANGE OF PROJECTS AIMED AT IMPROVING HEALTH. BELOW ARE A FEW HIGHLIGHTS FROM 2020. AS THE IDDS PROJECT LEAD IN UGANDA, PATH WORKED WITH THE UGANDA GOVERNMENT TO REVIEW EXISTING SURVEILLANCE SYSTEMS IN HUMAN AND ANIMAL HEALTH; SUPPORTED DEVELOPMENT OF NEW TESTING ALGORITHMS FOR PRIORITY ZOONOTIC DISEASES; DEVELOPED A STANDARDIZED QUALITY-CONTROL TOOLKIT; ASSESSED ANIMAL AND HUMAN SPECIMEN REFERRAL SYSTEMS; AND SUPPORTED LABORATORY TRAININGS. PATH'S LARGEST ADVOCACY AND PUBLIC POLICY PROJECT-OPERATING WORLDWIDE AND FUNDED BY THE BILL & MELINDA GATES FOUNDATION-CONTINUED TO FOCUS IN UGANDA ON IMMUNIZATION, PRIMARY HEALTH CARE, AND REPRODUCTIVE, MATERNAL, NEWBORN, CHILD, AND ADOLESCENT HEALTH. WITH COVID-19 DISRUPTING HEALTH SYSTEMS, PATH SUPPORTED THE MOH TO DEVELOP AND BROADLY DISSEMINATE MESSAGES ON COVID-19 PREVENTION AND THE CONTINUITY OF ESSENTIAL HEALTH SERVICES. PATH ALSO HELPED DRAFT THE UGANDA EXPANDED PROGRAM ON IMMUNIZATION RECOVERY PLAN FOR IMMUNIZATION SERVICES DURING COVID-19. OUR ADVOCACY FOR MEDICAL OXYGEN SCALE-UP IN UGANDA, LAUNCHED PRE-COVID-19, GAINED ADDED TRACTION IN THE PANDEMIC. PATH WORKED WITH THE KAMPALA CITY AUTHORITY AND TWO LEADING TELEVISION STATIONS TO AMPLIFY COVID-19 INFECTION PREVENTION AND CONTROL (IPC) MESSAGES; WE RECORDED A TALK SHOW THAT WAS HIGHLY PROMOTED AND FEATURED ON ONE OF THE TELEVISION STATIONS' TWITTER ACCOUNTS, WITH 1.2 MILLION FOLLOWERS. WITH FUNDING FROM THE HILTON FOUNDATION, PATH INTRODUCED ONSITE CHLORINE GENERATION FOR IPC AT HEALTH FACILITIES AND DONATED PERSONAL PROTECTIVE EQUIPMENT AND IPC MATERIALS TO 48 FACILITIES IN 11 DISTRICTS. WE PARTICIPATED IN A WATER FOR PEOPLE WORKING GROUP WITH INTERNATIONAL RESCUE COMMITTEE, WORLD VISION, AND THE US CDC TO IMPROVE WATER, SANITATION, AND HYGIENE IN HEALTH FACILITIES. AS PART OF A SUPPLY SYSTEMS INNOVATIONS GRANT, PATH COORDINATED THE SUCCESSFUL DISTRIBUTION AND INSTALLATION OF UPDATED COLD CHAIN EQUIPMENT IN TEN REGIONS OF UGANDA AND WORKED WITH THE MOH ON HPV VACCINE ACCESS AND COVERAGE. WE SUPPORTED WHO'S EFFECTIVE VACCINE MANAGEMENT INITIATIVE TO REVIEW STOCK STATUS, FORECASTING, COLD CHAIN EQUIPMENT MAINTENANCE, AND LOGISTICS PLANNING FOR COVID-19 AND OTHER VACCINES. TO PREPARE FOR COVID-19 VACCINE INTRODUCTION, PATH (WITH SUPPORT FROM GAVI, THE VACCINE ALLIANCE) DEVELOPED AN ADVOCACY AND ENGAGEMENT PLAN TO INCREASE STAKEHOLDER BUY-IN AND COMMUNITY ACCEPTANCE. WE THEN SUPPORTED THE SUCCESSFUL NATIONAL VACCINATION LAUNCH. THE BILL & MELINDA GATES FOUNDATION FAMILY PLANNING PROJECT AIMS TO IMPROVE THE HEALTH OF WOMEN AND GIRLS BY EXPANDING ACCESS TO RIGHTS-BASED FAMILY PLANNING, INCLUDING DMPA-SC, AN INJECTABLE CONTRACEPTIVE. IN UGANDA, PATH MOBILIZED FUNDING THAT LED TO THE CONTINUATION AND EVEN ACCELERATION OF FAMILY PLANNING EFFORTS, DESPITE CHALLENGES RELATED TO COVID-19. PATH WORKED WITH PARTNERS TO ENSURE DMPA-SC (INCLUDING SELF-INJECTION, WHERE APPROVED) WAS ACCEPTABLE TO USERS AND AVAILABLE AT AN AFFORDABLE PRICE AND AT A VARIETY OF SERVICE DELIVERY POINTS. FINALLY, THE HIV SELF-TESTING AFRICA (STAR) INITIATIVE (PHASE III) WORKED TO ESTABLISH THE STRUCTURES, SYSTEMS, AND OVERSIGHT NECESSARY FOR LONG-TERM SUSTAINABILITY OF THE HIVST MARKET IN UGANDA. COLLABORATING WITH THE MOH AND OTHER STAKEHOLDERS, THE STAR III TEAM DEVELOPED A FOUR-YEAR NATIONAL SCALE-UP PLAN FOR HIVST (2021-2024) AND MOBILIZED AND SUPPORTED A WHO PREQUALIFICATION TRAINING. THE TEAM MAPPED HIVST PARTNERS, TRAINED PEERS AND PROVIDERS, ASSESSED CURRENT REGULATIONS AND POLICIES, AND WORKING WITH THE NATIONAL DRUG AUTHORITY, DEVELOPED A POST-MARKET SURVEILLANCE PLAN. THE PROJECT REACHED NEARLY 16,000 CLIENTS, MAINLY THROUGH COMMUNITY DISTRIBUTION. VIETNAM: IN 2020, PATH CELEBRATED OUR 40TH ANNIVERSARY IN VIETNAM. THROUGH THE GLOBAL HEALTH SECURITY PARTNERSHIP FUNDED BY THE US CDC, PATH UPGRADED THE MOH'S ONLINE INFECTION SURVEILLANCE PORTAL, LAUNCHED A NEW ANTIMICROBIAL RESISTANCE (AMR) PORTAL, SUPPORTED DEVELOPMENT OF COVID-19 TRACKING AND SENTINEL SURVEILLANCE SYSTEMS, AND SUPPORTED TWO HOSPITALS IN QUALITY IMPROVEMENT IMPLEMENTATION. PATH ALSO ASSESSED VIETNAM'S ANIMAL HEALTH INFORMATION SYSTEM AS WELL AS THE LABORATORY CAPACITY, SPECIMEN REFERRAL, AND SURVEILLANCE SYSTEMS FOR ANIMAL AND HUMAN HEALTH. THROUGH THE FLEMING FUND, WE HELPED STRENGTHEN LABORATORY INFORMATION SYSTEMS AND BIOREPOSITORY MANAGEMENT, SUPPORTED HOSPITALS TO SUBMIT AMR REPORTS, DEVELOPED THE DEPARTMENT OF ANIMAL HEALTH'S AMR E-REPORTING PORTAL, AND ORGANIZED A WHONET WORKSHOP FOR THE DEPARTMENT AND THREE ANIMAL LABORATORIES. FOR COVID-19, PATH AND THE US CDC CONTRIBUTED TO THE NATIONAL GUIDELINES, DEVELOPED AN ONLINE SELF-ASSESSMENT FORM, AND SUPPORTED TRAINING FOR HOSPITALS AND 3,300 HEALTH CARE PROVIDERS. PATH ASSISTED THE MOH WITH COVID-19 VACCINE DEVELOPMENT AND INTRODUCTION EFFORTS AND SUPPORTED THE INTERNATIONAL VACCINE ACCESS CENTER TO PRODUCE COVID-19 VACCINE LOTS FOR USE IN CLINICAL TRIALS. THE USAID HEALTHY MARKETS PROJECT SCALED UP ACCESS TO HIVST AND HIV PREVENTION SERVICES, ENROLLING 6,177 NEW CLIENTS IN PRE-EXPOSURE PROPHYLAXIS AND REACHING MORE THAN 40,700 WITH HIV TESTING. PATH SUPPORTED A $2.5M+ PRIVATE-SECTOR INVESTMENT IN HIV RESPONSE AND BUILT THE CAPACITY AND SUSTAINABILITY OF KEY POPULATION ORGANIZATIONS. PATH ALSO SUPPORTED THE NATIONAL TB PROGRAM TO PILOT STOOL-BASED DIAGNOSIS OF PEDIATRIC TB AND CONSEQUENTLY UPDATE THE NATIONAL PEDIATRIC TB GUIDELINES. (SEE ALSO THE HIV AND TUBERCULOSIS SECTION.) THE INTRODUCING DIGITAL IMMUNIZATION INFORMATION SYSTEMS-EXCHANGE AND LEARNING PROJECT, FUNDED BY THE BILL & MELINDA GATES FOUNDATION, LAUNCHED AN E-LEARNING PLATFORM AND E-IMMUNIZATION CARD SYSTEM IN HANOI AND SON LA AND HELPED THE NATIONAL EXPANDED PROGRAM ON IMMUNIZATION TRANSITION TO PAPERLESS IN FOUR PROVINCES. FINALLY, TO COMBAT MALARIA, PATH CONDUCTED OPERATIONAL RESEARCH IN VIETNAM THAT PROVIDED EVIDENCE FOR ADOPTION OF G6PD TESTING.
FORM 990, PART III, LINE 4C, DESCRIPTION OF PROGRAM SERVICE:	WORK CONTINUED ON THE DATA USE PARTNERSHIP (DUP), WHICH SUPPORTS THE GOVERNMENT OF TANZANIA TO IMPROVE ITS HEALTH INFORMATION SYSTEMS. IN 2020, DUP REFRESHED THE TANZANIA DIGITAL HEALTH INVESTMENT ROAD MAP AND RECEIVED APPROVAL FOR THE COUNTRY'S NEW CENTRE FOR DIGITAL HEALTH. DUP ALSO FINALIZED THE TANZANIA HEALTH ENTERPRISE ARCHITECTURE, A BLUEPRINT FOR IDENTIFYING AND ALIGNING IMPORTANT INTERRELATIONSHIPS BETWEEN THE COUNTRY'S DIGITAL SYSTEMS TO AVOID FRAGMENTATION, DUPLICATION, AND LACK OF INTEROPERABILITY. PATH BEGAN A NEW PROJECT, DATA USE ACCELERATION AND LEARNING, TO DOCUMENT AND AMPLIFY LEARNINGS FROM FIVE FOCAL COUNTRIES DIGITALIZING THEIR HEALTH SYSTEMS. THE INFORMATION WILL SUPPORT GOVERNMENTS, IMPLEMENTERS, POLICYMAKERS, AND FUNDERS AS THEY SHIFT THEIR FINANCING, GUIDANCE, AND PROGRAMMATIC APPROACHES TO IMPROVE THE USE OF DATA. PATH ALSO LAUNCHED THE HEALTH INSIGHT PLATFORM, A NEW DATA ANALYTICS AND VISUALIZATION SERVICE THAT USES BEST-IN-CLASS TOOLS TO ADVANCE DATA USE. LAST, PATH INCREASED PARTICIPATION IN HIGH-LEVEL COALITIONS, INCLUDING TRANSFORM HEALTH, THE LANCET/FINANCIAL TIMES JOINT COMMISSION ON GOVERNING HEALTH FUTURES 2030, AND THE DIGITAL CONNECTED CARE COALITION.
FORM 990, PART VI, SECTION B, LINE 11B	THE FORM 990 WAS PREPARED BY AN OUTSIDE ACCOUNTING FIRM USING INFORMATION PROVIDED BY PATH ACCOUNTING SERVICES STAFF. PATH SENIOR MANAGEMENT REVIEWED THE DRAFT FORM. A COPY OF THE DRAFT WAS SENT TO THE BOARD OF DIRECTORS FOR COMMENT. AFTER THE COMMENT PERIOD, THE PRINCIPAL FINANCIAL OFFICER SIGNED THE FORM.
FORM 990, PART VI, SECTION B, LINE 12C	PATH HAS POLICIES AND PROCEDURES TO ADDRESS CONFLICTS OF INTEREST. PATH MANAGEMENT AND ALL STAFF AT A DESIGNATED LEVEL OR HIGHER WITHIN THE ORGANIZATION MUST COMPLETE A CONFLICT OF INTEREST DISCLOSURE FORM EACH YEAR. ALL FORMS ARE REVIEWED AND KEPT ON FILE. A CONFLICT MANAGEMENT PLAN IS DEVELOPED FOR ANY EMPLOYEE WITH A SIGNIFICANT ACTUAL OR PERCEIVED CONFLICT OF INTEREST. PATH ALSO HAS A WELL-DEFINED PROCEDURE FOR IDENTIFYING AND REPORTING ACTUAL AND POTENTIAL CONFLICTS OF INTEREST AMONG BOARD MEMBERS. NEW BOARD MEMBERS ARE ASKED TO COMPLETE A CONFLICT OF INTEREST DISCLOSURE FORM WITHIN 30 DAYS OF JOINING THE BOARD AND TO COMPLETE A NEW FORM ANNUALLY THEREAFTER. IN ADDITION, MEMBERS ARE REMINDED TO REPORT ANY NEW ISSUES THAT ARISE OUTSIDE OF THE ANNUAL DISCLOSURE PERIOD. THE DISCLOSURE FORMS ARE REVIEWED BY PATH'S GENERAL COUNSEL, AND IF ANY ACTUAL OR POTENTIAL CONFLICTS ARE IDENTIFIED, GENERAL COUNSEL MAKES A RECOMMENDATION TO THE CHAIR OF THE GOVERNANCE COMMITTEE AND THE CHAIR OF THE BOARD FOR A MANAGEMENT PLAN TO PROPERLY MANAGE ANY CONFLICTS. A FORMAL MANAGEMENT PLAN IS THEN AGREED UPON WITH THE BOARD MEMBER, AND THE ENTIRE BOARD OF DIRECTORS IS INFORMED AT THE NEXT REGULARLY SCHEDULED BOARD MEETING.
FORM 990, PART VI, SECTION B, LINE 15	THE BOARD'S EXECUTIVE COMPENSATION COMMITTEE ANNUALLY REVIEWS SALARIES AND BENEFITS FOR EXECUTIVE EMPLOYEE POSITIONS AND PROVIDES GUIDANCE TO THE PRESIDENT/CHIEF EXECUTIVE OFFICER (CEO) ON COMPENSATION DECISIONS FOR EXECUTIVE POSITIONS. THE COMPENSATION AND BENEFITS FOR PATH'S PRESIDENT/CEO ARE REVIEWED AND APPROVED BY THE ENTIRE BOARD OF DIRECTORS EACH YEAR. PATH ROUTINELY USES THE SERVICES OF EXTERNAL FIRMS TO ASSESS AND BENCHMARK EXECUTIVE COMPENSATION (PRESIDENT/CEO, VICE PRESIDENTS, AND EXECUTIVE TEAM MEMBERS). THE MOST RECENT MAJOR REVIEW WAS COMPLETED BY THE BOARD COMPENSATION COMMITTEE IN 2020. AT THE REQUEST OF THE BOARD, PATH ENGAGED MERCER (A COMPENSATION, BENEFITS, AND HUMAN RESOURCES CONSULTING FIRM) TO REVIEW CURRENT AND PROPOSED BASE SALARIES OF PATH'S PRESIDENT/CEO AND EXECUTIVE TEAM MEMBERS. MERCER USED DATA FROM MULTIPLE SOURCES TO EVALUATE CURRENT AND PROPOSED BASE SALARIES FOR THESE POSITIONS. THE BOARD'S EXECUTIVE COMPENSATION COMMITTEE REVIEWED THE MERCER REPORT AND APPROVED THE USE OF THE REPORT TO ESTABLISH A FRAMEWORK WITHIN WHICH THE PRESIDENT/CEO IS DELEGATED AUTHORITY TO ESTABLISH THE TOTAL COMPENSATION PACKAGES OF THE EXECUTIVE TEAM MEMBERS. ADDITIONALLY, MERCER REVIEWED THE PROPOSED TOTAL COMPENSATION AND BENEFITS PACKAGE FOR THE PRESIDENT/CEO POSITION AND OBTAINED A SIGNIFICANT NUMBER OF DATA POINTS TO ASCERTAIN ITS REASONABLENESS AND APPROPRIATENESS. THE BOARD APPROVED THE COMMITTEE'S RECOMMENDATION FOR THE PRESIDENT/CEO'S TOTAL COMPENSATION PACKAGE.
FORM 990, PART VI, SECTION C, LINE 19	PATH GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE AVAILABLE TO THE PUBLIC UPON REQUEST; MOST DOCUMENTS ARE ALSO AVAILABLE ONLINE.

For Paperwork Reduction Act Notice, see the Instructions for Form 990 or 990-EZ.

Cat. No. 51056K

Schedule O (Form 990 or 990-EZ) 2020

Additional Data

Software ID:
Software Version:

- TIN:

SCHEDULE R
(Form 990)

Department of the Treasury
Internal Revenue Service

Related Organizations and Unrelated Partnerships

Complete if the organization answered "Yes" on Form 990, Part IV, line 33, 34, 35b, 36, or 37.
MediumBullet

Attach to Form 990.
MediumBullet

Go to www.irs.gov/Form990 for instructions and the latest information.

OMB No. 1545-0047

2020

Open to Public Inspection

Name of the organization

PATH

Employer identification number

91-1157127

Part I

Identification of Disregarded Entities. Complete if the organization answered "Yes" on Form 990, Part IV, line 33.

(a) Name, address, and EIN (if applicable) of disregarded entity	(b) Primary activity	(c) Legal domicile (state or foreign country)	(d) Total income	(e) End-of-year assets	(f) Direct controlling entity

Part II

Identification of Related Tax-Exempt Organizations. Complete if the organization answered "Yes" on Form 990, Part IV, line 34 because it had one or more related tax-exempt organizations during the tax year.

(a) Name, address, and EIN of related organization	(b) Primary activity	(c) Legal domicile (state or foreign country)	(d) Exempt Code section	(e) Public charity status (if section 501(c)(3))	(f) Direct controlling entity	(g) Section 512(b)(13) controlled entity?
(a) Name, address, and EIN of related organization	(b) Primary activity	(c) Legal domicile (state or foreign country)	(d) Exempt Code section	(e) Public charity status (if section 501(c)(3))	(f) Direct controlling entity	Yes	No
(1)PATH VACCINE SOLUTIONS 2201 WESTLAKE AVENUE SEATTLE,WA98109 83-0431851	ADVANCE DEVELOPMENT OF VACCINES TO IMPROVE THE HEALTH OF CHILDREN	WA	501(C)(3)	LINE 12A, I	PATH	Yes
(2)FOUNDATION FOR APPROPRIATE TECHNOLOGIES IN HEALTH - SWITZERLAND 207 ROUTE DE FERNEY 1218 LE GRAND-S GENEVA SZ	EDUCATIONAL AND SCIENTIFIC PROMOTION OF HEALTH	SZ	501(C)(3)		PATH	Yes
(3)PROGRAM FOR APPROPRIATE TECHNOLOGY IN HEALTH -KENYA ACS PLAZA 4TH FL LENANA RD PO BOX NAIROBI KE	EDUCATIONAL AND SCIENTIFIC PROMOTION OF HEALTH	KE	501(C)(3)		PATH	Yes

For Paperwork Reduction Act Notice, see the Instructions for Form 990.

Cat. No. 50135Y

Schedule R (Form 990) 2020

Page 2

Part III

Identification of Related Organizations Taxable as a Partnership. Complete if the organization answered "Yes" on Form 990, Part IV, line 34, because it had one or more related organizations treated as a partnership during the tax year.

(a) Name, address, and EIN of related organization	(b) Primary activity	(c) Legal domicile (state or foreign country)	(d) Direct controlling entity	(f) Share of total income	(g) Share of end-of-year assets	(h) Disproprtionate allocations?		(i) Code V-UBI amount in box 20 of Schedule K-1 (Form 1065)	(j) General or managing partner?		(k) Percentage ownership
(a) Name, address, and EIN of related organization	(b) Primary activity	(c) Legal domicile (state or foreign country)	(d) Direct controlling entity	(f) Share of total income	(g) Share of end-of-year assets	Yes	No	(i) Code V-UBI amount in box 20 of Schedule K-1 (Form 1065)	Yes	No	(k) Percentage ownership

Part IV

Identification of Related Organizations Taxable as a Corporation or Trust. Complete if the organization answered "Yes" on Form 990, Part IV, line 34 because it had one or more related organizations treated as a corporation or trust during the tax year.

(a) Name, address, and EIN of related organization	(b) Primary activity	(c) Legal domicile (state or foreign country)	(d) Direct controlling entity	(e) Type of entity (C corp, S corp, or trust)	(f) Share of total income	(g) Share of end-of-year assets	(h) Percentage ownership	(i) Section 512(b)(13) controlled entity?
(a) Name, address, and EIN of related organization	(b) Primary activity	(c) Legal domicile (state or foreign country)	(d) Direct controlling entity	(e) Type of entity (C corp, S corp, or trust)	(f) Share of total income	(g) Share of end-of-year assets	(h) Percentage ownership	Yes	No

Schedule R (Form 990) 2020

Page 3

Part V

Transactions With Related Organizations. Complete if the organization answered "Yes" on Form 990, Part IV, line 34, 35b, or 36.

Note. Complete line 1 if any entity is listed in Parts II, III, or IV of this schedule.

Yes

1 During the tax year, did the orgranization engage in any of the following transactions with one or more related organizations listed in Parts II-IV?

a Receipt of (i) interest, (ii) annuities, (iii) royalties, or (iv) rent from a controlled entity .....................

b Gift, grant, or capital contribution to related organization(s) ............................

Yes

c Gift, grant, or capital contribution from related organization(s) ............................

Yes

d Loans or loan guarantees to or for related organization(s) ............................

e Loans or loan guarantees by related organization(s) ............................

f Dividends from related organization(s) ............................

g Sale of assets to related organization(s) ............................

h Purchase of assets from related organization(s) ............................

i Exchange of assets with related organization(s) ............................

j Lease of facilities, equipment, or other assets to related organization(s) .......................

k Lease of facilities, equipment, or other assets from related organization(s) ......................

l Performance of services or membership or fundraising solicitations for related organization(s) .....................

m Performance of services or membership or fundraising solicitations by related organization(s) .................

n Sharing of facilities, equipment, mailing lists, or other assets with related organization(s) ...................

o Sharing of paid employees with related organization(s) ............................

p Reimbursement paid to related organization(s) for expenses ............................

q Reimbursement paid by related organization(s) for expenses ............................

r Other transfer of cash or property to related organization(s) ............................

s Other transfer of cash or property from related organization(s) ............................

If the answer to any of the above is "Yes," see the instructions for information on who must complete this line, including covered relationships and transaction thresholds.

(a) Name of related organization	(b) Transaction type (a-s)	(c) Amount involved	(d) Method of determining amount involved
(1) PATH VACCINE SOLUTIONS	C	4,386,562	FMV
(2) PATH VACCINE SOLUTIONS	B	46,272	FMV
(3) FOUNDATION FOR APPROPRIATE TECHNOLOGIES IN HEALTH - SWITZERLAND	B	4,534,968	FMV

Schedule R (Form 990) 2020

Page 4

Part VI

Unrelated Organizations Taxable as a Partnership. Complete if the organization answered "Yes" on Form 990, Part IV, line 37.

Provide the following information for each entity taxed as a partnership through which the organization conducted more than five percent of its activities (measured by total assets or gross revenue) that was not a related organization. See instructions regarding exclusion for certain investment partnerships.

(a) Name, address, and EIN of entity	(b) Primary activity	(c) Legal domicile (state or foreign country)	(e) Are all partners section 501(c)(3) organizations?		(f) Share of total income	(g) Share of end-of-year assets	(h) Disproprtionate allocations?		(i) Code V-UBI amount in box 20 of Schedule K-1 (Form 1065)	(j) General or managing partner?		(k) Percentage ownership
(a) Name, address, and EIN of entity	(b) Primary activity	(c) Legal domicile (state or foreign country)	Yes	No	(f) Share of total income	(g) Share of end-of-year assets	Yes	No	(i) Code V-UBI amount in box 20 of Schedule K-1 (Form 1065)	Yes	No	(k) Percentage ownership

Schedule R (Form 990) 2020

Page 5

Part VII

Supplemental Information

Provide additional information for responses to questions on Schedule R. See instructions.

Return Reference	Explanation

Schedule R (Form 990) 2020

Additional Data

Software ID:
Software Version:

1	Was the organization a U.S. transferor of property to a foreign corporation during the tax year? If "Yes," the organization may be required to file Form 926, Return by a U.S. Transferor of Property to a Foreign Corporation (see Instructions for Form 926). . . . . . . . . . . . . . . . . . . . . . . . . . . . . .	Yes	No
2	Did the organization have an interest in a foreign trust during the tax year? If "Yes," the organization may be required to separately file Form 3520, Annual Return to Report Transactions with Foreign Trusts and Receipt of Certain Foreign Gifts, and/or Form 3520-A, Annual Information Return of Foreign Trust With a U.S. Owner (see Instructions for Forms 3520 and 3520-A; don't file with Form 990). . . . . . . . . . . . . . . . . . . . . . . .	Yes	No
3	Did the organization have an ownership interest in a foreign corporation during the tax year? If "Yes," the organization may be required to file Form 5471, Information Return of U.S. Persons with Respect to Certain Foreign Corporations. (see Instructions for Form 5471). . . . . . . . . . . . . . . . . . . . . . . . . . . .	Yes	No
4	Was the organization a direct or indirect shareholder of a passive foreign investment company or a qualified electing fund during the tax year? If “Yes,” the organization may be required to file Form 8621, Information Return by a Shareholder of a Passive Foreign Investment Company or Qualified Electing Fund. (see Instructions for Form 8621) .	Yes	No
5	Did the organization have an ownership interest in a foreign partnership during the tax year? If "Yes," the organization may be required to file Form 8865, Return of U.S. Persons with Respect to Certain Foreign Partnerships (see Instructions for Form 8865). . . . . . . . . . . . . . . . . . . . . . . . . . . . . .	Yes	No
6	Did the organization have any operations in or related to any boycotting countries during the tax year? If "Yes," the organization may be required to separately file Form 5713, International Boycott Report (see Instructions for Form 5713; don't file with Form 990).. . . . . . . . . . . . . . . . . . . . . . . . . . . .	Yes	No